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CHAPTER 1 
1.1 Magnetic resonance spectroscopy of energy metabolism in vivo 
Availability of energy is essential for all living organisms. Adenosine triphosphate 
(ATP) is the most important biochemical energy carrier and the main source of fuel for 
cellular processes. To control energy homeostasis, elaborate systems for the production, use 
and distribution of ATP have evolved. In (in)vertebrates, production of ATP via the glycolytic 
pathway and by oxidative phosphorylation in mitochondria occurs in close conjunction with 
energy buffering and transmission by creatine kinase (CK) (or arginine kinase) and adenylate 
kinase (AK) mediated reactions (1, 2). Together, these circuits provide an integrated 
metabolic network with high flexibility to meet sudden and large fluctuations in energy 
demand in tissues like muscle and brain. Studies by us and others have shown that disabling 
one or more enzymes of these circuits by genetic knock-out or knock-down, or 
pharmacological inhibition, will result in a re-routing of fluxes through the remaining systems 
to re-establish the balance between energy production and utilization. The general aim of this 
thesis is to further elucidate the role of the CK and AK systems in energy metabolism of 
skeletal muscle and brain. The use of mice in which the genes for these enzymes have been 
deleted (knock-out mice) is crucial for the present work and has helped us to uncover 
functions of both enzyme systems as well as the physiological adaptations that occur in 
response to genetic stress in the metabolic energy network upon their deletion. To study these 
enzyme systems we have used the technique of magnetic resonance spectroscopy (MRS). 
This technique enables the in vivo monitoring of the substrates of these enzymes and gives us 
a direct view on their action in the natural environment of the intact animal.  
This introductory chapter is divided into two sections. The first section will cover the 
basics of energy metabolism in skeletal muscle and in brain. A more comprehensive 
description of metabolic energy production and utilization is already given in several 
biochemical handbooks (see for instance (3-5)). Therefore, this section will only deal with 
those aspects of energy production and metabolism (and in particular the role of the CK- and 
AK-systems therein) that are of interest for studies with MRS in general and form a 
background for the specific studies described in this thesis. The second section of this chapter 
explains the basic principles of magnetic resonance (MR) and focuses on the specific MR 
techniques used in this thesis.  
 
1.1.1 ATP production and utilization 
ATP stores its energy in high-energy phosphoryl groups at the γ and β positions of the 
molecule. To release this energy from the γ-position, ATP-ases can hydrolyze ATP to 
adenosine diphosphate (ADP) and inorganic phosphate (Pi) according to the reaction:  
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ATP + H2O ↔ ADP + Pi + H+. Additional energy can be mobilized by utilizing the β-
phosphoryl energy in two ADP molecules in the reaction 2 ADP ↔ AMP + ATP (4).  
The main fuels for the generation of ATP are (poly)carbohydrates and lipids, while 
other compounds like ketone bodies and amino acids can also be used. Use of these fuel 
substrates depends on physiological conditions and tissue type. Carbohydrates are 
metabolized to glucose, which enters a chain of metabolic reactions whereby glucose is 
converted to pyruvate. This process is called glycolysis and takes place in the cytosol, 
yielding a net synthesis of about 2 ATP molecules per glucose molecule invested (5). 
Glycolysis is usually considered as an anaerobic process although it takes place in the absence 
as well as in the presence of oxygen (anaerobic and aerobic glycolysis). The first step of 
glycolysis, in which glucose is converted to glucose 6-phosphate (G6P) by hexokinase (or 
glycokinase), is of particular interest in MRS research as G6P is one of the components of the 
phosphomonoester signal (PME) observed in 31P MR spectra (see section 1.2.4). 
At the end of the glycolytic reaction chain, pyruvate is formed. This important 
metabolite can be converted to lactate, or to acetyl coenzyme A (acetyl CoA) in mitochondria 
where it serves a substrate for the citric acid cycle (or Krebs cycle). The citric acid cycle 
produces NADH and FADH2, which are used to transfer electrons to O2 synthesizing high 
amounts of ATP in a process called oxidative phosphorylation (OxPhos). OxPhos comprises a 
respiratory chain (also called electron transport chain) with proton pumps, which build up a 
proton motive force across the mitochondrial membrane. In turn, this proton motive force 
drives the yield of ATP, which is variably depending on intrinsic and extrinsic coupling (6). 
Under normal conditions, OxPhos can yield about 17 times more ATP than glycolysis (6) 
making it by far the most important process for generating ATP. Upon conditions of oxygen 
depletion (e.g. during ischemia), however, cells are constrained to (anaerobic) glycolysis 
which is much more inefficient and leads to acidification of the tissue via the formation of 
lactic acid. 
  
1.1.2 Creatine: formation, utilization and catabolism 
Creatine (Cr) plays a central role in energy metabolism in tissues with high and 
fluctuating energy demand such as muscle and brain. Phosphorylation of Cr to 
phosphocreatine (PCr) stores high-energy phosphate groups and is catalyzed in an equilibrium 
reaction by creatine kinase (CK): Cr + ATP ↔ PCr + ADP + H+ (see also section 1.1.3). To 
maintain a constant body pool of Cr, its breakdown and build-up via dietary intake and 
endogenous synthesis must be balanced.  
The first step on the synthetic route of Cr is catalyzed by L-arginine:glycine 
amidinotransferase (AGAT) and involves transfer of the amidino group of arginine to glycine, 
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to yield ornithine and guanidinoacetate (Gua). Since this process occurs mainly in the 
kidneys, Gua must subsequently be transported by the blood to the liver, where it is 
methylated to Cr by guanidinoacetate methyltransferase (GAMT) (7) (figure 1.1). Cr itself is 
then transported through the blood to the different tissues where it is taken up by Cr 
transporters (7, 8) situated in the cellular and mitochondrial membrane(s). Finally, a constant 
fraction of the Cr and PCr pool is catabolized non-enzymatically to creatinine (Crn), which is 
excreted in the urine (9, 10).  
 
Figure 1.1: Schematic overview of the biosynthesis of Cr. 
Several inborn errors of Cr metabolism have recently been reported. The first report 
was on an infant with extrapyramidal movement disorder (11) which had low Crn in serum 
and urine (11-14). 1H MRS played a crucial role in the diagnosis of this patient by revealing 
low Cr signals and elevated levels of guanidinoacetate in brain which partially normalized 
upon oral administration of Cr (11). The absence of Cr was attributed to a deficiency of 
GAMT and since then several case reports on GAMT deficiency have appeared in literature 
(15-20). Decreased tissue Cr levels are also observed in other forms of inborn errors of Cr 
metabolism, for example in patients with Cr transporter deficiency (21, 22) or deficiency of 
AGAT (23, 24). 
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1.1.3 Occurrence and functions of creatine kinase  
In vertebrate brain and muscle, 4 genes of CK are identified coding for the subunits of 
altogether five different isoenzymes (for a more extended review see (25-27)). M-CK and  
B-CK subunits can assemble into the hetero- or homodimeric isoenzymes MM-CK, MB-CK 
and BB-CK which are present in the cytosol. Of those, MM-CK is predominantly expressed 
in striated and heart muscle, while BB-CK is expressed at high concentrations in brain, but 
also in kidney, intestine, spermatozoa, smooth muscle and other tissues (28). Trace amounts 
of BB-CK may be present in skeletal muscle originating from satellite cells ((29) and 
references therein). MB-CK is a transitional hybrid which is present during differentiation of 
muscular tissues, but permanently expressed in (adult) heart ((26) and references therein).  
Ubiquitous CK (UbCKmit) and sarcomeric CK (ScCKmit) are present as dimeric and 
octameric isoforms located between the inner and outer membrane of mitochondria (27) and 
associated with the cardiolipid moieties in these membranes (30). ScCKmit is mainly 
expressed in striated and heart muscle, while UbCKmit appears to be co-expressed with  
B-CK. The ratio mitochondrial/cytosolic CK differs for specific tissues and cell-types. 
Generally, mitochondrial CK will be present at relatively larger amounts in tissues with 
higher aerobic capacity (27). For skeletal muscle, 1-10 % of total CK activity is of 
mitochondrial origin (26, 31). Differences reported are due to physiological differences 
between muscle types examined, since the level of mitochondrial CK is considerably higher 
in slow twitch compared to fast twitch muscles (27), but cytosolic CK is relatively high in fast 
muscle. Cardiac muscle shows relatively high amounts of mitochondrial CK, which can be on 
the order of 30% (26, 27). Brain, a highly oxidative organ, shows mitochondrial CK levels 
which represent 0.5-15% of total CK activity (27) depending on the cell types investigated. In 
tissue extracts of the whole brain, even up to 30% of normal CK activity was attributed to 
mitochondrial UbCKmit (Jost et al., unpublished result). 
Several global regulatory and buffering functions are ascribed to the CK system (25, 
26). The first and main function is that of a temporal energy buffer. Because the magnitude of 
free energy (∆G0’) for hydrolysis of PCr is higher than that of ATP (-10.3 kcal/mol compared 
to -7.3 kcal/mol, respectively (5)), ~P groups are effectively stored in this compound. In times 
of energy demand, CK can regenerate ATP by transferring its ~P to ADP to yield additional 
energy. A second proposed function of the CK system is that of a spatial energy buffer. Cr 
and PCr are smaller in size than ATP and ADP which, together with the high concentrations 
of PCr and Cr in comparison to ATP and ADP, make it easier to diffuse through the cell 
thereby connecting sites of energy production (e.g. mitochondria) and energy demand (e.g. 
ATP-ases) (see figure 1.2 and the discussion in section 1.1.6 below). Another function is 
buffering of protons, preventing (local) acidification of tissues when ATP-ase activity is 
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increased or during anoxia (32-35). The net CK reaction also releases Pi which is of 
importance to stimulate glycolysis and glycogenolysis (36, 37). Finally, a consequence of the 
local presence of the CK reaction is that it will keep ATP/ADP ratios locally balanced at sites 
of energy production and consumption (26, 38, 39).  
 
1.1.4 Uptake of Cr and Cr analogues  
Although the above description covers all main aspects of the Cr-CK system, our 
current picture is certainly not complete. The distribution of Cr among tissues is a complex 
process and uptake and metabolic conversion rates may differ between tissues, like in the case 
of muscle and brain. For example, it is generally agreed that the main synthesis of Cr occurs 
in pancreas and liver (10). However, other tissues like brain, where Cr is suggested to fulfill a 
neuroprotective role (40), are also capable of synthesizing (part of) their own creatine needs 
(7, 8, 41). In muscle, GAMT activity appears to be high enough to synthesize all Cr needed 
(Isbrandt, personal communication).  
Additionally, in order for Cr to be absorbed by the brain, it has to pass the blood-brain 
barrier (BBB) and there is evidence that the BBB is not fully (and perhaps also not equally) 
permeable for guanidino compounds (see e.g. (7)). Therefore, care has to be taken in drawing 
conclusions from pharmacological studies with Cr-analogues which can be utilized by CK as 
a substrate (7, 42, 43). For analogues like β-guanidinopropionic acid (β-GPA), which is often 
used as a competitor of Cr (36, 44, 45) it is known that uptake and clearance kinetics differs 
between tissues. Studies in which β-GPA was fed to rats and mice showed an (almost) 
complete replacement of PCr by phosphorylated β-GPA in muscle (36, 44, 46), but only a 
partial replacement in brain (47). Long term feeding of β-GPA induced profound 
physiological changes in muscle (48). Changes (involving alterations in phosphorylated  
β-GPA and PCr levels) in brain were much slower upon starting of β-GPA feeding or 
stopping after a period of β-GPA feeding (47). These findings could be explained by the 
already mentioned limited permeability of the BBB, but also by a slower Cr turnover in brain. 
The former explanation may be the most likely as it is supported by the observation that in 
patients with Cr deficiency restoration of Cr levels in brain upon administration of high oral 
doses of Cr is slow (in the order of months) (11, 12, 15-17, 49, 50). In mice with creatine 
deficiency, PCr levels in muscle reached approximately 50% of original values after only two 
days of 1% Cr substitution in the drinking water (51).  
 To better understand Cr’s role it is therefore imperative that we develop a better 
picture of the integral physiological aspects of metabolic cooperation between organs and 
tissues, and the effects of nutrient regimes and intrinsic and extrinsic stimulation of energetic 
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and osmolar activity. Special emphasis is needed for the study of species specific differences 
in the synthesis and utilization of creatine, before we can extrapolate findings in animal 
models to those in human patients.  
    
1.1.5 Functions and isoforms of adenylate kinase 
For adenylate kinase (AK), which also contributes to cellular energy homeostasis (52) 
by catalyzing the reaction: 2 ADP ↔ ATP + AMP, five isoforms, labeled AK1 to AK5, are 
known (53-56), In skeletal muscle, AK1 is the major isoform representing approximately 99% 
of AK activity (54). The only other AK isoform present at low activity in skeletal muscle is 
AK3, and is in fact an enzyme which uses GTP and AMP as substrates (54). In contrast to 
AK1 which is solely expressed in the cytosol of skeletal muscle, a variant of AK1 (AK1β) is 
present in a membrane-bound form (53), possibly for quick ATP supply close to ATP-ases or 
ATP sensitive sites (57).  
AK is thought to increase the efficiency of ATP production during high metabolic 
stress by locally balancing ATP/ADP ratios (58). By further releasing the energy stored in the 
pool of adenine β-phosphoryls, the AK-mediated circuit allows cellular energy metabolism to 
occur in a highly efficient mode. In this way, AK increases the tolerance to metabolic stress 
(59, 60). 
 
1.1.6 Diffusion or compartmentation: CK and AK systems work in concert 
Almost two decades ago it was proposed that the AK and CK enzyme systems work in 
close harmony, forming a shuttle system for exchanging ~P groups between compartments of 
production and utilization (61, 62) (see also chapter 4). A more modern version of this model, 
acting as a “vectorial ligand conduction” network, was proposed by Goldberg and coworkers 
(63) and investigated in more detail later (64). This model assumes a dense distribution of 
enzymes such that substrates can be ‘passed’ from one enzyme to the other, with 
exchangeability of the CK and AK relay systems. The model also proposes an integrated role 
for glycolytic pathways (see figure 1.2). Together these enzyme systems form an intertwined 
network for transport of high energy phosphates only, rather than the entire phosphorylated 
metabolite itself, forming a circuit that is more efficient in terms of reaction velocity and flux 
rate than pure diffusion (2).   
15 
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Figure 1.2: Schematic view of high-energy phosphoryl transfer systems in the cell.  
Note: enzymatic reactions of CK and AK are equilibrium reactions; the direction of the 
arrows indicates the main flux of substrates. 
Mitochondrial compartmentation of the CK enzyme – and also AK isoenzymes – is a 
key element in this hypothesis. Mitochondrial CK has preferential access to ATP formed in 
the mitochondria by OXPHOS (27, 65, 66) and plays an important role in ATP/ADP 
exchange between the mitochondrial matrix and the cytosol, a process in which also other 
enzymes like the ANT and VDAC (porin) are involved (67, 68). It is important to note here 
that not all mitochondrial and cytosolic components of the network as drawn in figure 1.2 
occur in all cell types.  
Also other hypothetical models have been proposed. Meyer and coworkers proposed a 
model of facilitated diffusion (69). This model implies that the diffusive flux of PCr is 
increased when PCr is in equilibrium with ATP through the CK reaction. In their model, 
buffering of ATP/ADP and diffusion of PCr are closely related, however, physical or 
functional compartmentation of substrates is not needed (69, 70). In simulations they showed 
that when diffusion distances are small, CK is not necessary for spatial buffering of 
ATP/ADP ratios (69). In the PCr-Cr shuttle hypothesis the different isoenzymes are 
functionally coupled to the physical location, in the diffusion model they are not. Although 
the pros and cons of both models are still fiercely discussed, often with subjective and 
selective use of circumstantial evidence of cell biological and kinetic studies, both theories 
agree on PCr being the main transporter of high-energy phosphoryls. 
16 
INTRODUCTION  
1.1.7 Energy metabolism of skeletal muscle: metabolic challenges vs. basal activity 
Already since the early days of in vivo magnetic resonance spectroscopy, a technique 
which is described in more detail in section 1.2, skeletal muscle has served as one of the best 
accessible systems to study mammalian energy metabolism. Studies performed have been 
conducted on a variety of muscles of human patients or healthy individuals and animal 
models as well. Even in in vivo MR studies on small animals like mice, hind leg muscle can 
easily be spatially constrained to reduce motion artefacts without compromising the space 
necessary for spontaneous breathing. Although many studies are performed during resting 
conditions, when the animal that is investigated is under slight anaesthesia, differential effects 
of genetic or physiological stress conditions are likely to become more apparent in MR 
spectra under conditions of metabolic challenge (see e.g. chapter 4). For muscle, two general 
approaches for applying metabolic challenge are used. The first method involves the 
induction of muscle contraction (i.e. labour) by electric stimulation. The other method is the 
use of ischemia-reperfusion protocols. Unfortunately, these two methods induce vastly 
different effects on muscle metabolism, and therefore cannot be easily compared. To better 
understand these differences we have to draw an adequate picture of the principal metabolic 
fuels and pathways that play a role in muscle energetics. During the first minutes of a 
moderate metabolic challenge, in which oxidative phosphorylation is the primary process 
responsible for generation of ATP, muscle glycogen is the major fuel (71). During prolonged 
metabolic demand, glucose and fatty acids from the blood will serve as substrate for 
generating ATP. If the metabolic challenge is more severe or in case there is a lack of oxygen, 
muscle and other tissues can switch to anaerobic glycolysis (see section 1.1.1). In that case, 
both muscle glycogen and glucose from the blood can serve as substrates of ATP production 
(71). Also PCr can serve as fuel, but its main role is in fast buffering of mismatches between 
ATP production and utilization.  
Skeletal muscle fibers can roughly be divided into two groups. Slow twitch fibers 
(type 1) are adapted for long term exercise with oxidative phosphorylation as its major energy 
producing pathway. Fast type fibers are more suited for short term work with high metabolic 
demand, relying mostly on glycolysis (type 2b) and PCr buffering for fast availability of 
energy, but also on oxidative processes (type 2a). Because metabolite and enzyme levels 
differ significantly between these muscle types (7, 8, 26), MRS can yield different results 
depending on the position of the volume of interest. In unlocalized experiments of hind leg 
muscle, the main contribution to the MR signal comes from the gastrocnemius muscle, which 
is predominantly composed of fast-type fibers. 
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1.1.8 Energy metabolism of the brain: neurotransmitter cycling activity vs. isoelectric state 
For brain, in contrast to muscle, the arrangement of energy compartmentalization is 
inherently more complex. Glucose (together with ketone bodies) is virtually the only energy 
source of the brain (see e.g. (72) and references therein; (73)). From the ratio of utilization of 
glucose over the utilization of O2 (CMRglc/CMRO2), which is about 5.5 for the resting brain, it 
can be derived that the brain is a highly oxidative organ (74). The numerous cell types present 
in the brain can be roughly divided in two types: neuronal and glial cells (75). Neurons have 
long axons and are responsible for impuls transduction while glial cells, e.g. astrocytes, were 
until recently thought to function only in support of neurons. However, experimental data 
indicated that astrocytes fulfill much more important functions in neurotransmitter cycling 
and energy metabolism (76).  
Glutamate (Glu), the major excitatory neurotransmitter (77), is recycled from the 
synaptic cleft by astrocytes and converted to glutamine. Glutamine (Gln) is then transported 
back to the neurons where it can be converted to Glu (78). This way of recycling Glu reduces 
the amount of carbon chains needed from the Krebs cycle. Although the anaplerotic pathway 
through pyruvate carboxylase (see figure 1.3), can replace carbon chains lost from the Krebs 
cycle to form neurotransmitters, recycling of Glu via astrocyte-neuron cooperation is 
considered more efficient (79).  
Besides its function in recycling Glu, astrocytes have been proposed to play a more 
general role in energy metabolism of the brain (76) as well as in brain development. As 
astrocytes are in close vicinity to blood vessels, they can easily take up glucose. This glucose 
can be converted to lactate by glycolysis, which is assumed to be transferred to neurons, 
where it is then metabolized further in the Krebs cycle and by oxidative phosphorylation. The 
energy yielded from glycolysis in the astrocytes can be used to recycle Glu. In this way, Glu 
has been shown to stimulate glycolysis, creating a tight coupling between neuronal activity 
and glucose utilization (76, 80-82). Although it has been shown that neurons may 
preferentially use lactate over glucose, they can also use glucose itself as a substrate for 
energy production (83). Furthermore, a linear relation has been determined between Glu/Gln 
cycling and oxidative glucose metabolism in active brain (84), despite the fact that Glu/Gln 
cycling itself is estimated to account for only 3% of total energy consumption during 
activation (85). The amount of glucose utilization in the isoelectric brain (when no electric 
activity is detected in the EEG) is a point of intense debate, as is the percentage of lactate 
shuttling under isoelectric and more active conditions (86). Certainly not all energy in normal 
active brain is utilized for neurotransmitter cycling and ion homeostasis activity to sustain de- 
and repolarization activity. Some reports claim that up to 50% of energy may be spend to 
18 
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actin related motility processes, including vesicle secretion. Neurogenesis, neuritogenesis and 
axonal pruning in development may also represent relative large energy challenges (87).  
Figure 1.3: Schematic view of metabolic link between astrocytes and neurons, adapted from 
(88-90). The bold arrows indicate the main flux of substrates when glucose enters the 
astrocyte-neuron system. Subsequently lactate is transported from the astrocyte to the neuron. 
Glutamate and glutamine are cycled between the astrocyte and the neuron; the main pool of 
glutamate is located in the neurons, while the main pool of glutamine is situated in the 
astrocytes.  
Abbreviations of metabolites (see also text for details): OAA, oxaloacetate, OG, 
oxaloglutarate. Abbreviations of specific fluxes: vPC, pyruvate carboxylase; vPDHg, glial 
pyruvate dehydrogenase; vPDHn, neuronal pyruvate dehydrogenase, vx, multiple reactions 
which combine to the exchange between OG and Glu; vcycle, glu/gln cycle rate; vgln, glutamine 
synthetase. 
Brain energy metabolites and Glu/Gln pools are considered to be distributed over 
neuronal and glial compartments. A large Glu pool is present in the neuronal compartment 
and a small Glu pool is present in glial compartments (89-91) (figure 1.3). 13C MR 
spectroscopy (see also section 1.2.5) has proven to be a powerful tool in elucidating carbon 
fluxes through the brain and brain compartments. Labeling one of the carbons, in for instance 
glucose, and following its fate over time when this label is transferred biochemically to other 
substrates yields information on conversion rates (91-94). By modeling the increase and 
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decrease of the different 13C labeled compounds which are formed and broken down after 
infusion of a 13C labeled substance, rates can be derived for the TCA cycle, Glu/Gln cycle, 
and oxidative metabolism or the anaplerotic pathway (89) depending on position of the label 
in the infused compound. For example, glucose may be labeled at the C1 or C6 position (or 
labeled both at the first and 6th carbon position). These carbons will firstly be transferred to 
the C3 position of pyruvate and then to the C4 position of Glu (Glu4) after which it is 
biochemically passed on to the C4 position of Gln (Gln4). Due to the symmetry in the 
succinate moiety, an Krebs-cycle intermediate, labeled carbons of pyruvate will be transferred 
to Glu2 and Glu3 with equal probability after it has made a full turn in the TCA cycle (91). 
Using the incorporation kinetics of these labels into various compounds, rates for the TCA 
cycle and Glu/Gln cycle rates can be determined (78, 84, 89, 95). A serious drawback in this 
modelling is that no discrimination is allowed between the extend of coupling and flux rates 
through glycolytic and mitochondrial systems in neurons and glial cells. The use of 2-13C or 
5-13C glucose enables calculation of flux through the anaplerotic pathway (79). Other labeled 
substrates can also be used to determine reaction rates in vivo. 1,2-13C2 acetate, for instance, 
is believed to be directly converted to acetyl-CoA, a process that occurs only in glial cells (91, 
96).  
When calculating fluxes using a biochemical model, care has to be taken which 
assumptions are used in that model. It has been shown that when the exchange rate between 
oxoglutarate and glutamine, for instance, is assumed to be fast, this may influence the 
estimated TCA cycle rate dramatically (Henry, personal communication). Future efforts in 
this field therefore must be directed to interdisciplinary approaches, in which cell biological 
and physiological knowledge is joined with biophysical (MRS) knowledge to develop models 
which reflect in vivo physiology more faithfully.  
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1.2 Magnetic Resonance Spectroscopy 
In the last two decades, magnetic resonance (MR) has become a powerful technique to 
study anatomy, physiology and metabolism in a non-destructive way in animals and humans. 
While MR imaging (MRI) provides a non-invasive tool to study anatomy and distribution of 
biomaterial (fluid, solutes, (bio)molecules) of the body, MR spectroscopy (MRS) provides a 
window on metabolism, physiology and morphology in selected volumes of interest. This 
section deals with the basic principles of MR. Firstly, the parameters that play a role in the 
basic understanding of a general MR experiment will be described. The remaining part 
focuses on specific MRS techniques of particular interest for this thesis. 
 
1.2.1 From Nuclear Magnetic Resonance to biomedical Magnetic Resonance 
The principles of Nuclear Magnetic Resonance (NMR) were firstly demonstrated 
independently by Bloch et al. and Purcell et al. (97, 98). For this discovery they received the 
Nobel prize in physics in 1952. They showed that certain atomic nuclei, when placed in a 
magnetic field, are able to absorb energy in the form of radio frequencies (RF). A set of 
equations describing the time dependent behavior of magnetization are the Bloch equations 
(99), in which also the longitudinal and transversal relaxation times are included (see below). 
Since its discovery, NMR has been used to determine properties of solid state 
materials and to elucidate structures of molecules. In 1971 Damadian demonstrated the first 
potential medical application by showing that the water NMR relaxation times of tumor tissue 
and healthy tissue are different (100). In 1973, Lauterbur demonstrated the use of MR for 
imaging by introducing magnetic field gradients (101). Mansfield independently presented a 
similar MR method for displaying structures of materials (102) and further developed the 
utilization of magnetic field gradients and the mathematical methods necessary to analyze the 
MR signals (103-106). For their work, Lauterbur and Mansfield received the 2003 Nobel 
Prize in Physiology or Medicine. Ernst introduced the use of the Fourier transformation in RF 
pulsed NMR (107), which is the basis of modern MR spectroscopy, and he was one of the 
founders of modern MR imaging by proposing phase and frequency encoding (108). For his 
work he received the Nobel prize in Chemistry in 1991.  
In a (bio)medical environment, NMR is abbreviated to MR because of negative 
associations with the term nuclear, although at chemistry and physics departments the term 
NMR is still in use. In the remainder of this thesis the term MR will be used. 
 
1.2.2 Basics of MR 
The technique of MR is based on the property that certain nuclei posses a spin (see for 
instance (109)). Protons (1H nuclei), phosphorus nuclei (31P) and carbon nuclei (13C), the most 
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common nuclei used in MR experiments in vivo, have spin value of ½. Although spin is a 
quantum mechanical property, it can be described relatively well in a semi classical context.   
Spin can be considered as a rotation of the nucleus around its own axis, giving it an 
intrinsic angular momentum I§, orientated along the axis of that nucleus. This angular 
momentum induces a magnetic dipole moment µ, which is also an intrinsic property of the 
nucleus orientated in the same direction as I. The magnitude of µ, however, is characteristic 
of that nucleus and is described by the gyromagnetic ratio γ (eq. 1.1).  
 
 µ = γ . I        [1.1] 
 
In the absence of a strong magnetic field, the orientation of all these magnetic dipole 
momenta is random. In the presence of an external magnetic field, however, a torque arises 
which causes the magnetic dipole momentum to precess around an axis parallel to the external 
field (B0) (figure 1.4). 
Figure 1.4: Precession movement of a nucleus with magnetic dipole moment µ. The rotational 
movement is around an axis parallel to the external field B0. 
The angular frequency with which the spin precesses (Larmor frequency, ω) is dependent on 
the external magnetic field strength, and is given by equation 1.2. 
 
 ω = γ.B0        [1.2] 
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The gyromagnetic constant γ is a characteristic property of a nucleus, determining the Larmor 
frequency of the nucleus in an external field. For example, at 7 T (the strength of the magnet 
used for most of the work described in this thesis) protons resonate at a frequency (ω / 2π) of 
300 MHz, 31P nuclei at 122 MHz and 13C nuclei at 75 MHz. 
Apart from the external magnetic field, also small internal magnetic fields have an 
influence on the resonance frequency. For instance, the main magnetic field may induce a 
small counter field in the electron cloud surrounding the nucleus. This magnetic field is 
proportional to B0 and can partially shield the main magnetic field observed by the nucleus. 
The local field at the site of the nucleus is given by equation 1.3: 
 
 Beff = B0 (1 - σ)       [1.3] 
 
In eq. 1.3, σ represents a screening factor which is dependent on the chemical environment of 
the nucleus. Because the effective magnetic field (Beff) causes the resonance frequency of that 
particular nucleus to be slightly different from nuclei with other σ, a distinction between 
nuclei in different chemical surroundings can be made. This provides the basis of MR 
spectroscopy. 
The precession motion caused by B0 aligns µ in the parallel or anti-parallel direction 
with respect to B0. Because parallel is a state of lower energy, more spins will be in the 
parallel state with a distribution given by the Boltzmann equation (eq. 1.4): 
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where np is the number of spins parallel to the external magnetic field, na the number of spins 
anti-parallel, k the Boltzmann constant, T the absolute temperature,  the constant of Planck 
divided by 2π and ∆E the difference in energy between the upper and lover energy level. 
Since the sensitivity of an MR experiment is determined by the ratio n
h
a / np, it can be 
concluded from this equation that the sensitivity can be increased by increasing B0, choosing 
a nucleus with relatively large γ or lowering the thermal noise (i.e. decreasing T).  
When performing an MR experiment, the equilibrium of parallel and anti-parallel 
spins is perturbed by applying one or more radio frequency (RF) pulses. The macroscopic 
magnetization M, that is, the sum vector of all up and down spins, is tilted from its original 
orientation along B0 to the xy-plane by the RF pulse (when B0 was in the z-direction). 
Furthermore, the precession of the ensemble of individual spins obtain a coherent phase. 
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From this perturbation, the spin system will return to the original state before excitation by 
two processes which occur simultaneously. Firstly, M will return to the z-direction with a rate 
described by a time constant called the spin-lattice relaxation time, or T1. The surplus of 
energy induces an RF modulation in the detection coil in principle according to Faraday’s 
law. Besides T1 relaxation, dephasing of the individual spins will result in signal loss, with a 
characteristic time called spin-spin relaxation time, or T2.  
The acquired MR signal in the time domain is then Fourier transformed to obtain the 
frequency information, which is plotted to yield an MR spectrum (see below). The x-axis of 
the spectrum is denoted in parts per million (ppm) relative to a reference frequency. 1H is the 
most sensitive MR nucleus and has a natural abundance of 99.98%. Furthermore, because 
water is the most abundant compound in the body, the protons in water are by far the most 
common nuclei used in biomedical MR. Besides water, other molecules can also be detected 
using 1H MRS (see section 1.2.3). Moreover, additional metabolites are detectable by 31P 
MRS (section 1.2.4) or 13C MRS (section 1.2.5). Because of sensitivity limits and other 
restrictions, generally only small metabolites (molecular weight of 500 or less) at relatively 
high concentrations (> 0.1 mM) are detectable by in vivo MRS. In total, up to about 50 
metabolites or ions may be assessed by this approach in living tissue. 
 
1.2.3 In vivo 1H MR spectroscopy of brain and muscle 
1H MRS can be performed on relatively small volumes of interest (voxels) because of 
the high sensitivity and natural abundance of 1H compared to other nuclei. At 7 T, voxel sizes 
down to 1-2 mm3 can be achieved in the mouse brain, for instance. Good localization is 
essential, since contamination from signals originating from outside the voxel may lead to 
biased metabolite concentrations or spectra of poor quality e.g. in the case of lipid signal 
contamination.  
Depending on the research goal, a single voxel or a multi voxel selection pulse 
sequence method can be applied. Stimulated echo acquisition mode (STEAM) (110) and point 
resolved spectroscopy (PRESS) (111) are selection methods frequently used in 1H MRS. 
STEAM with only 90° pulses enables short echo times (TE) (down to about 10 ms on our 
scanner), especially of interest when looking at strongly coupled molecules like Glu, Gln and 
Ins. In PRESS sequences, however, two 180 ° pulses, which are in general long pulses, make 
the use of short echo times more difficult. The signal gain of a factor of two in PRESS with 
respect to STEAM (which gives a stimulated echo), however, motivated the development of 
short echo PRESS sequences using short asymmetrical 180 degree pulses (112).  
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One of the major challenges of 1H MRS is to measure metabolites at low concentration 
(down to 1-2 mM) in the presence of the large signal of water (~ 45 M in the body). Because 
of dynamic range and other problems, the water signal needs to be suppressed. Several 
techniques are available for this purpose, from specific selection with single Gaussian shaped 
pulses to more complex schemes like CHESS (113) and VAPOR (114). Essential for proper 
water suppression is good shimming, which can be performed manually or by automatic 
procedures like FASTMAP (115). A typical MR spectrum of the brain shows a large variety 
of molecules (116, 117) including Cr, Glu and Gln (figure 1.5). 
Figure 1.5: Single voxel 1H MRS of a 3x3x4.5 mm3 voxel of the mouse brain using a STEAM 
sequence (TE=10 ms, TM=15 ms, TR=5000 ms, 64 averages) and VAPOR water suppression 
at 7 T (see text for details).  
Abbreviations: Ins, myo-Inositol ; tCr, creatine and phosphocreatine; Glu, glutamate; Gln, 
glutamine; Tau, taurine; Cho, cholines; NAA, N-acetylaspartate; Ala, alanine; Lac, lactate. 
MR spectroscopic imaging (MRSI) (or chemical shift imaging; CSI) (118, 119) gives 
an overview of the distribution of metabolites in a larger area by pre-selecting a volume 
which is divided into multiple voxels by phase/frequency encoding. This technique can be 
used in combination with a STEAM or PRESS preselection (figure 1.6) A major advantage of 
MRSI is that after acquiring the MRSI data the voxels can be shifted such that the position of 
one of more voxels cover the anatomical region of interest. Disadvantages are the relatively 
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long minimal measurement time compared to single voxel techniques and contamination from 
one voxel to another through the point spread function. Dedicated MRSI sequences can 
partially overcome these problems by applying filters or by specific k-space sampling (120-
122). 
Figure 1.6: 1H MRSI of a slice through the mouse brain in vivo (adapted from (123)).  
Top left: Transversal localizer image showing the grid from which the spectroscopic imaging 
data set was obtained. A STEAM sequence was used for preselection (large box in the 
localizer image) while the small voxels were selected using MRSI localization.  
Bottom: Individual MR spectra from voxels inside the STEAM selection box  
Top right: An enlarged spectrum of the indicated voxel shows the same resonances as the 
single voxel spectrum in figure 1.5. 
MR spectra of both brain and skeletal muscle show characteristic signals for specific 
metabolites. In the brain, a wide range of overlapping resonances can be detected and 
although the physiological significance of some metabolites is not exactly known, some 
26 
INTRODUCTION  
general remarks can be made (117). N-acetylaspartate (NAA) (for a review see: (124)) is one 
of the major metabolites visible in the 1H MR spectrum of the brain. It is considered as a 
marker for healthy neurons and is often decreased in neurodegenerative diseases. The 
concentration of NAA may vary between different species (125). Choline compounds (Cho) 
are thought to be markers for cell proliferation and are generally increased in tumors but 
signal changes may also be associated with myelin breakdown. Myo-Inositol is normally 
elevated in fetal brain where it may play a role in brain development, and it possibly acts as a 
cerebral osmolite (117, 126). The role of taurine (Tau) is largely unknown, it has been 
proposed as osmolite and recently also as a protector of inflammation (127). Lactate (Lac) is 
one of the end products of glycolysis and is present at relatively high concentrations in mouse 
brain compared to human and rat brain (fig. 1.6; (128)). Together, these metabolites provide 
an extensive ‘metabolic fingerprint’ of brain tissue.  
In 1H MR spectra of mouse skeletal muscle signals for Cr and overlapping signals for 
Tau and trimethylammonium (TMA) compounds are present, of which only Cr is of interest 
when monitoring energy metabolism. Preferentially, the skeletal muscle is set at an angle of 
55° with the main magnetic field to reduce dipolar interactions which will split up the signals 
making quantification difficult (129).  
 
1.2.4 In vivo 31P MR spectroscopy of brain and muscle 
31P has a natural abundance of 100%, but the sensitivity is lower than that of protons 
(6-7 % of proton sensitivity). Although CSI or ISIS localization is possible with 31P MRS, it 
sometimes is sufficient to use a pulse-acquire experiment, for instance in hind leg muscle, 
because the surrounding tissues do not contain large enough concentrations of metabolites 
measured with 31P MRS to significantly contribute to the acquired 31P MR signal. 
 Phosphorous MR spectroscopy gives an overview of the levels of phosphates 
involved in energy metabolism like phosphocreatine (PCr), inorganic phosphate (Pi), and 
ATP. During special conditions like ischemia in muscle, or in basal spectra of the brain, 
signals for phosphomonoesters (PME) at approximately 6 ppm are also observed. 
Phosphodiester (PDE) signals are found in the brain and, for instance, in tumors. Besides the 
phosphorous metabolites, tissue pH can be calculated from the shift in resonance position 
between the Pi and PCr signal (130) and the [Mg2+] from positions of the different ATP 
signals (131). 
A typical 31P MR spectrum of the mouse hind leg muscle is shown in figure 1.7. A 
pulse acquire sequence was applied yielding signal mainly from the GPS complex, in which 
the gastrocnemius is the largest muscle. 
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Figure 1.7: 31P MR spectrum under resting conditions using a 3-turn solenoid coil and a 
pulse-acquire sequence (TR=7000 ms, 64 averages). 
31P MR measurements of the mouse brain in this thesis are performed using two 
surface coils, tuned to the 31P frequency and working in quadrature mode (132, 133). 
Contamination of signals from the brain with signals from the masseter muscles could be 
severe since PCr signals are relatively high in muscle compared to brain. Therefore, a 
localization technique, e.g. an ISIS sequence (134), has to be used. Typical voxel sizes 
achieved are 6.5x6.5x4.5 mm3 (190 µl).  
Measurement times for the acquisition of 31P MR spectra are in the order of minutes 
for muscle and even longer for brain. Because metabolic changes may appear much faster, 
these chances will average out and therefore remain undetected in the MR spectrum. One way 
to avoid this is to use a gated approach which allows a spatial resolution for detecting the PCr 
signal changes of a few seconds. This time resolution is sufficient to detect differences in PCr 
levels between wild-type (wt) and M-CK deficient (M-CK-/-) mice immediately after a burst 
of twitch contractions (135). 
 
1.2.5 In vivo 13C MR spectroscopy of brain 
13C MR spectroscopy has a low sensitivity (1.8 · 10-2 of that of protons) and differs 
fundamentally from 1H and 31P MRS in the fact that the 13C isotope has a natural abundance 
of only 1.1%. Therefore, generally only a few molecules present at high concentrations in the 
body, like long chain fatty acids and glycogen in muscle, show a natural abundance signal. 
Recent experiments showed that also signals for neurotransmitters can be detected when 
acquiring signal over a long period of time (3.5 hours) (136). 
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Because of this low natural abundance, infusion of 13C labeled compounds, e.g. 
glucose labeled at the C1 position, enables detection of other molecules by uptake of this 
labeled compound and transfer of the 13C label to other metabolites dynamically (see also 
section 1.1.8). After a certain period, the 13C label of glucose is transferred to several carbon 
positions in Glu, Gln, Lac, alanine (Ala), Aspartate (Asp), NAA and GABA (figure 1.8). 
 
 
Figure 1.8: Difference spectrum of 30 minutes of the mouse brain, one hour after infusion of 
99% enriched 1-[13C] glucose. The number in subscript denotes the carbon position of the 13C 
label in the molecule. 
Two major challenges are present when performing 13C MRS on the mouse brain. 
Firstly, the low sensitivity of the 13C nucleus compared to protons together with the small size 
of the mouse brain yield a low 13C MR signal. Therefore, a sensitive 13C coil is needed. In our 
experiments, a 13C surface coil was used. Secondly, the spins of protons connected to the 13C 
atom split up the energy levels which causes the signal to divide up into multiplets. By using a 
decoupling scheme, magnetization of protons is randomized making the multiplets collapse 
into a singlet with higher signal to noise ratio (SNR). One has to be careful in applying 
decoupling power, however, because too much power could lead to tissue heating (137, 138).  
 
1.2.6 Data processing 
In an MR spectrum, the surface area under the signal reflects the amount of resonating 
nuclei. Therefore, the easiest way to quantify a signal is by integrating the signal area. 
However, low SNR, overlapping signals, and baseline distortions, which are commonly 
observed in MR spectra acquired in vivo, may affect proper quantification. This problem is 
commonly circumvented by introducing prior knowledge (139). 
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The first way this can be performed is by fitting each single resonance by a Lorentzian 
or a Gaussian line shape function. From MR theory in liquids, only Lorentzian lineshapes are 
expected. In practice, however, Gaussian lineshapes may provide a better fit to signals 
obtained in vivo. This fitting procedure can be performed in the time domain using the 
software package MRUI (140) by a so called VARPRO (141) or AMARES (142) technique. 
Further prior knowledge can be enforced on the linewidths and resonance positions making 
the fitting procedure more robust. 
While fitting of single line shapes works well in spectra which consist of a few 
resolved resonances (31P spectra of brain and muscle, 1H spectra of skeletal muscle, 13C 
subtraction spectra), for MR spectra with multiple overlapping resonances, like in 1H MR 
spectra of the brain, another approach is more favorable. For instance, LCModel is a software 
package that fits complete spectra recorded from several metabolites in solution (143). Every 
metabolite that is expected to be found in vivo has to be measured separately in solution. 
These solution spectra are then taken together in a so called basis set, of which a linear 
combination is fitted to the in vivo data. In this way optimal prior knowledge is employed. By 
setting the proper parameter values for the metabolite concentration in solution and some 
other parameters like a transmitter reference amplitude, absolute values for the tissue content 
of the metabolites can be obtained. The new java version of MRUI (jMRUI, (144)) can fit a 
modeled or measured basis set to the in vivo data through an algorithm named QUEST (145). 
Absolute quantification is possible in several ways. As described above, LCModel can 
directly compare the in vivo data to 1H MR spectra of solutions with known concentration. 
Care has to be taken to correct for differences in transmitter amplitude between the acquired 
metabolite spectrum and the water spectrum. An alternative approach is to compare 
metabolite signals to the water signal in an MR spectrum acquired without water suppression. 
Assuming a fixed tissue concentration of water, absolute values for the metabolites can be 
calculated. When measuring with relatively short repetition time (TR), a correction for T1 
saturation needs to be applied, just as a correction for T2 decay when acquiring an echo (e.g. 
when using STEAM). In 31P MRS, the 1H water signal observed by a separate coil may also 
be used for quantification but this requires a somewhat complicated approach. A separate 
measurement performed with equal MR conditions of a phantom filled with a known 
phosphate containing solution can be used as reference. Alternatively, ATP is often used as an 
internal reference. It is then assumed to have a constant value for a particular tissue 
independent of small fluctuations in energetic state of that tissue. Therefore, in 31P MR 
metabolic concentration values are often calculated assuming a constant ATP pool or are 
presented as ratio to ATP. In both cases, possible T1 saturation has to be taken into account.  
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1.3 Outline of this thesis 
MRS is a powerful technique to study transgenic animals in vivo, in particular when 
substrates of the enzymes involved show signals in the MR spectra. In the last decade, several 
new transgenic mouse models and approaches to generate these models have become 
available that provide exiting opportunities to study metabolism and metabolic pathways in 
healthy and pathological conditions. This thesis focuses on the role of CK and AK in a 
number of strongly interconnected energetics pathways, i.e. the Cr-CK system, the AK 
system, glycolysis, the mitochondrial TCA cycle and oxidative phosphorylation (OXPHOS). 
Disabling one or more enzymes may lead to rerouting of fluxes through the remaining energy 
pathways. Although various approaches with use of pharmacological inhibition or siRNA- or 
antibody-based interference strategies are now available to ablate enzyme activity, the use of 
conventional gene knock-out methodology is still the only 100% reliable procedure to achieve 
complete and specific deficiency. Before turning to the in depth studies of the above 
mentioned systems, a review will be given in chapter 2 on the current status of in vivo MRS 
of transgenic mouse models that have a genomic phenotype which affect high-energy 
phosphoryl transfer. 
In the work of this thesis, the following specific issues were addressed. First, a study 
on postnatal development of mice lacking both CK isoforms in muscle was performed 
(chapter 3) to gain insight into the origin of the PCr signal that was somewhat unexpectedly 
observed in earlier studies of mice with complete CK deficiency (146). By combining cell-
biological, biochemical and biophysical approaches, the fate of PCr, and its relation to 
specific levels of CK isoenzymes, during maturation and ageing of muscle was examined. 
Furthermore, in this chapter we address the question whether all Cr is visible in 1H MRS, an 
issue that has been a topic of debate for some years, by performing both biochemical and 1H 
MR spectral analyses.  
One of the reasons that single CK and AK1 knock-out mice display a rather mild 
phenotype is that there is (partial) overlap and redundancy in function of enzymes in the ~P 
transfer network, including the CK, AK and glycolytic systems. Previous work had 
demonstrated that both M-CK and AK single knock-out mice were well capable of handling 
ischemic stress to the hind leg. The question that remained was whether combined knock-out 
of the cytosolic enzymes M-CK and AK1, in so called MAK--/-- mice (61), could provide 
further clues on the interchangeability of both systems in vivo. In chapter 4 we studied 
whether energy provision in MAK-/- muscle during an ischemic challenge and upon recovery 
becomes solely dependent on glycolysis, since no other high-energy sources are available. 
Comparing the results of this study with similar studies in M-CK-/- and AK-/- single knock-
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out mice gives a new perspective on the interaction between the CK and AK enzyme systems 
in vivo. 
The metabolic systems that  provide energy for proper brain functioning are currently 
intensely studied. Much emphasis is aimed at a better understanding of the close interaction 
between neurons and glial cells (81, 82). How B-CK and UbCKmit, the only CK isoforms 
occurring in brain, are integrated into this complex network is not very well understood. First, 
to obtain a better picture and make an inventory of anatomical and metabolic consequences of 
knock-out brains of mice lacking B-CK, UbCKmit, or both enzymes (B-CK/UbCKmit--/--), 
were investigated with 31P and 1H MRS in chapter 5. To study whether CK absence in brain 
also results in an up-regulation of glycolysis, similar to the situation in muscle, 13C MRS 
techniques were developed on a 7 T MR animal system which were applied to  
B-CK/UbCKmit--/-- mice (chapter 6). Although this technique was already used in rat brain, 
the much smaller size of the mouse brain imposes considerable technical challenges which 
have not been solved thus far, despite the great interest to study metabolic adaptation in 
transgenic mice. Using 13C MRS, we compared conversion of glucose, formation of lactate 
and synthesis of other substances including several neurotransmitters between  
B-CK/UbCKmit--/-- and wt animals with high temporal resolution. 
In chapter 7, mice are investigated which lack guanidinoacetate methyltransferase 
(GAMT) and, as a result, lack creatine. These animals serve as a faithful model for GAMT 
deficiency in humans, but were also expected to provide important information on the role of 
Cr/CK circuit, additional to the data obtained from CK deficient mice. As MRS plays a 
crucial role in the diagnosis of these patients, MRS of these mice is performed to see whether 
they show similar metabolic characteristics as patients with GAMT deficiency. Furthermore, 
additional experiments were performed to get a better fundamental understanding of the 
mechanisms involved in Cr deficiency. 
The last chapter, chapter 8, deals with the visibility of Cr in human 1H MRS. In rat 
and mice tissues it has already been observed that the proton invisible pool of Cr is very small 
(147-150). In humans, however, due to technical limitations of clinical MR scanners this was 
thus far not reliably studied. We retrofitted a clinical MR scanner, and measured the pool size 
of the MR invisible Cr fraction in human gastrocnemius muscle. In chapter 9 all findings are 
integrated in a general summary. 
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CHAPTER 2 
2.1 Introduction 
The ability to generate and use genetically altered mice has opened up a broad range 
of new possibilities for the study of the biological role of specific enzymes or even complete 
pathways involved in cell signaling, metabolism, or structural assembly of organismal form 
and function. For a complete appreciation of this work, several types of alterations that can be 
introduced in the mouse genome must be distinguished. At the one end of the spectrum there 
are the spontaneous genetic changes that result as an effect of naturally occurring DNA-
replication/repair errors or spontaneous (retroviral) transposon (re)integrations, or are induced 
by radiation or genotoxic agents. A broad range of mice with these types of changes have 
been identified during the last 2-3 decades and exploited as model systems for various human 
disorders (1), including inheritable neuro-muscular diseases (e.g. the mdx mice (2)), 
immunodeficiencies (e.g. the NOD mouse model (3, 4)), diabetes (5, 6) and cancer (7, 8).  
To date, various centers in the world have started entirely new efforts to produce this 
type of mice at high rate, by using huge cohorts of animals and biological (random insertion), 
chemical or physical (radiation) procedures for forced induction of ‘spontaneous’ mutations. 
Because mutations produced are random and can occur anywhere in the genome, massive 
breeding and elaborate high-throughput screening programs are needed to identify recessive 
or dominant-mutant animals with a potentially interesting phenotype or a hit in the particular 
gene of interest (9, 10).  
At the opposite end of the spectrum, we have transgenesis or targeted mutagenesis that 
can be used to create pre-designed alterations into the mouse genome. A transgenic mouse, or 
in fact any transgenic animal, is one in which there has been a deliberate and stable 
modification of the genome via artificial DNA introduction into one or more of its cells. The 
transgene is thereby randomly integrated or precisely targeted into the chromosomal DNA 
and may be inherited through the germ line upon breeding. Random integration is usually 
achieved upon injection of the transgene construct (as a recombinant DNA insert grown in 
bacterial vectors in vitro) into the male pronucleus of a fertilized mouse egg, followed by 
intra-oviduct transplantation of the zygote into a foster mother and maturation to term. Also 
viral transduction procedures, for example with lentiviral vectors containing a transgene 
insert, can be used. This approach has been applied in many studies where mouse models for 
human dominant genetic disorders were developed (11, 12). Excellent reviews, describing the 
different procedures for introducing the transgene as well as the fate of the injected DNA and 
the genetic consequences of this ‘classic’ transgenic route, have appeared in literature and we 
here refer the reader to those papers (13, 14).  
Use of yet another strategy, homologous DNA recombination in in vitro cultured 
mouse embryonic stem (ES) cells in order to precisely engineer a pre-designed mutation into 
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one of the parental genes of interest, offers one of the most elegant approaches for mimicking 
human mutations in a mouse model. By following this route, changes can be engineered very 
precisely. Strategies used regularly involve replacement of endogenous allele segments of the 
mouse genome by cognate segments of another organism, usually human, with or without 
mutation. Functional knock-out of genes is achieved by replacing an essential gene region 
(usually a coding segment, or essential promoter or RNA-processing signals) by a (selectable) 
cassette. Gene knock-in may involve replacement of genomic DNA domains by para- or 
orthologous domains from other organisms of by cDNA segments. Finally, by applying so-
called knock-in-knock-out procedures, very subtle alterations, even changes of only one DNA 
base-pair, can be introduced. The identity of the mutation is usually already verified and 
studied when still at the ES cell stage, in cell culture. Only if the mutation is genuine and no 
other undesired alterations have been introduced, the ES cells will be used for reintroduction 
in vivo, by injection into blastocysts ex vivo followed by intra-uterine implantation into foster 
mothers and growth of the embryos to term. A high level of sophistication is possible, with 
build-in features to render expression of the transgene conditionally or specifically restricted 
to particular cell types or tissues (15-17).  
Already quickly after the principle of ES-cell transgenesis was developed by Capecchi 
and co-workers, and other procedural groundwork was published, a virtual explosion of 
activity emerged. There are now excellent reviews and commentaries on the topic (18-20) and 
long lists of knock-out and knock-in mice that have been generated via ES cells. 
Unfortunately, application of homologous DNA targeting in ES cells for use in transgenesis 
with other mammals than mouse, is much less well established or often even completely 
impossible, mainly due to lack of pluripotent ES cell lines amenable for manipulation (21, 22) 
or lack of sophistication in embryo manipulation procedures for other species.  
 
Various non invasive bioimaging techniques are available to study tissue of living 
transgenic mice (23), including fluorescence imaging, optical or near infrared spectroscopy 
(24), radionuclei techniques (e.g. PET) (25) and magnetic resonance (MR) methods. One of 
the many branches of MR is MR Spectroscopy (MRS) which provides a unique tool to 
investigate metabolism in vivo and in vitro. MRS can be performed on several MR sensitive 
nuclei, e.g. 31P, 1H and 13C, each offering specific information on distinct metabolic and 
physiologic processes or conditions. When the genetic modification of interest has a effect on 
enzymes that interact directly with MR-visible metabolites (e.g. in case of the creatine kinase 
(CK) knockout mice), MRS is most powerful. Phosphorus MRS, i.e. 31P MRS, enables one to 
monitor the energetic status of the tissue under normal or artificial physiological challenges. 
From 31P MR data fluxes through some phosphotransfer reactions in cellular energetic 
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pathways and other physiological relevant parameters like intracellular tissue pH can be 
inferred (26, 27). Proton MRS offers information on metabolite concentrations of a larger and 
different set of metabolites (28-30) at higher relative sensitivity. Carbon MRS gained more 
momentum recently (see for instance the special issue on 13C MRS in NMR Biomed, vol 16, 
2003) and opened up the possibility to assess several metabolic fluxes simultaneously. For 
example, fluxes through glycolysis and the Krebs cycle were determined by following the 
flow of label in 13C glucose into the metabolic network (31). Natural abundance 13C MR 
spectroscopy was already applied to a spontaneous rat model in 1982 (32). In general, MRS is 
now also regarded a tool that can offer new opportunities in the area of metabolomics, the 
generation of complete metabolite profiles of animal and plant tissues. In this context, MRS 
will become integrated in future multidisciplinary approaches, together with genomics and 
proteomics studies, to obtain a third level of understanding of integral physiology.    
One of the first MRS studies on genetically altered mice – in this case a spontaneous 
model - was performed on the ReJ 129 dy/dy strain, a model for human myopathy (33). Since 
then, MRS studies were published that were conducted with classical transgenic mice (34) 
and finally also in metabolic knock-out mice with a mutation in muscle CK created with the 
ES cell technology (35)). Use of transgenesis for metabolic studies, including effects on 
glucose transport and CK -mediated phosphotransfer, has already been reviewed by Koretsky 
(36). Since then, however, several new studies on transgenic mice and MR spectroscopy 
techniques have appeared. We focus here on animal models with alterations in high-energy 
phosphoryl (~P) metabolism or associated metabolic pathways, like the Cr-PCr circuits, ADP-
ATP exchange reactions and glycolytic and mitochondrial pathways. It has been shown that 
distinct enzymes involved in the ~P transfer pathways corroborate closely (see e.g. (37, 38)) 
First, a brief outline of practical aspects of in vivo NMR in mice will be presented, 
followed by a review of MRS studies on mouse models with altered cellular energetics. 
Furthermore, quantitative and qualitative information on findings from in vivo MRS studies 
of mouse skeletal muscle, heart, liver and brain will be provided.  
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2.2 Equipment for MRS of mice 
In MR spectroscopy of small animals two practical issues are of primary interest: 
sensitivity and field homogeneity. Therefore, much of the MR hardware components and 
software that is described in this thesis are especially designed for particular applications and 
home build according to our own specifications. Proportional spatial downscaling from rat to 
mice requires approximately a tenfold increase in sensitivity. To a large extent this can be 
achieved by the use of smaller radiofrequency coils, although too small a coil may reduce 
tissue coverage and adequate probe building for mice requires skilled miniaturization. In 
principle, sensitivity can also be increased by going to higher magnetic fields. Common field 
strengths for mice studies range from 4.7 to 9.4 T (39). 
Proper imaging and localization requires a sufficiently strong magnetic field gradient 
set. For high spectral resolution, the optimization of the field homogeneity is needed by shim 
coils of sufficient strength (40). Especially in the mouse, field in-homogeneities may be 
relatively severe since most tissue is in close vicinity of air due the small size of the animal. 
Therefore strong shim coils including 2nd order terms are desirable (41). 
For reliable measurement of the anatomical structures of interest in the mouse, they 
have to be ‘immobilized’ without suppressing respiratory motion or other basal physiological 
functions. Commonly, the animal is kept under anesthesia using inhalation or injection 
anesthetics. Possible ways of securing the mouse head, for instance, are the use of stereotactic 
earbars, teethbars and tight attachment of a surface coil on top of the head. As mice are not 
able to maintain body temperature when under anesthetics a warming device, like a warm 
water bed, is needed. Furthermore, temperature has to be monitored continuously, just as 
breathing frequency, to adjust the depth of the narcosis when needed since this can influence 
the MR results.  
For measurements of a clean and distortion free signal, radio frequencies (RF; i.e. 
noise) from outside the MR scanner has to be prevented to interfere with the MR signal. At 
our MR facility, we use copper disks on the front and rear ends of the perspex MR tube 
containing the mouse, which close the cage of Faraday when the tube is slit into the magnet. 
Perspex tune and match sticks, just as tubes for the warm water bed, the optical thermometer, 
and the devise for monitoring the breathing frequency are fed through long cylindrical copper 
pipes of specific length which function as an RF filter. The RF signal enters directly through 
connectors in the copper disks. A proton coil was always present for shimming, imaging and, 
in case of 1H MRS, for transmitting or receiving the RF signal for the MR spectroscopy. For 
the analysis of other nuclei, however, a second coil was employed orthogonal to the proton 
coil such that both coils did not interact with each other.  
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As an example, the experimental setup of 13C measurements of the mouse brain is 
shown. In this case, 13C MR signal was acquired using a surface coil, while imaging, 
shimming and decoupling were performed using a birdcage 1H coil (figure 2.1). 
 
 
Figure 2.1: Setup of a 13C MR measurement of the mouse brain. Top: mouse in basic setup on 
warm water bed, only the 13C surface coil present. Bottom: Final setup when the basic setup 
is slit inside the 1H birdcage coil and fixed in the perspex MR tube. 
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2.3 Genetic alterations of high-energy phosphoryl transfer systems 
The next section reviews MRS studies on mice with genetic alterations that influence 
one or more of the ~P transfer pathways. It starts with a short introduction on Cr/CK and AK 
systems to place the further subsections into context. For a more detailed description, the 
reader is referred to chapter 1.  
 
2.3.1 Key enzymes in phosphoryl transfer 
Creatine is a small metabolite that fulfills a central role in energy metabolism. The 
enzyme guanidinoacetate methyltransferase (GAMT) plays a key role in the biosynthesis of 
Cr, by catalyzing the methylation of guanidinoacetate to form Cr. Phosphorylation of Cr to 
phosphocreatine (PCr) in the reaction catalyzed by CK: Cr + ATP ↔ PCr + ADP + H+ buffers 
the levels of high energy phosphates and balances local ATP/ADP ratios (for more 
comprehensive reviews see (42-45)). In vertebrate tissues, four genes of CK are identified 
coding for altogether five different isoenzymes. M-CK and B-CK subunits can form the 
hetero- and homodimeric isoenzymes MM-CK, MB-CK and BB-CK which are present in the 
cytosol. MM-CK is expressed at high levels in muscle, representing between 85% and 95% of 
total CK activity depending on fiber type (42), and stage of development. In embryonic or 
young skeletal muscle, trace amounts of BB-CK also appear (46). MB-CK is a transitional 
isoform which is present in immature stages of skeletal muscle. In heart, this isoform is 
permanently expressed at rather low amounts. BB-CK is expressed at high concentrations in 
brain and various other tissues in adults. Expression of the other class of CKs, ubiquitous CK 
(UbCKmit) and sarcomeric CK (ScCKmit), is also cell type dependent. UbCKmit is mostly 
found in tissues where also BB-CK occurs. Recent studies indicate that in the brain B-CK is 
preferentially expressed in astrocytes and inhibitory neurons, while mitochondrial CK nearly 
only occurs in neurons (47). The expression of ScCKmit is confined to muscle. UbCKmit and 
ScCKmit isoforms occur as dimeric or octameric enzymes and reside between the inner and 
outer membranes of mitochondria (42).  
Another ~P transfer reaction, catalyzed by adenylate kinase (AK), serves to balance 
ADP/ATP ratios by catalyzing the reaction 2ADP ↔ ATP + AMP. Several isoforms of AK 
exist, labeled AK1 to AK5, all expressed in specific tissues (48-51). In skeletal muscle, AK1 
is the major isoform expressing 99% of AK activity while in heart besides AK1 as major 
isoform also minor isoforms like AK2 and AK3 are present (48). Finally, also glycolytic 
enzymes and enzyme systems in the mitochondrial network in the cell can be considered 
distinct ~P transfer networks. For a schematic overview of cellular ~P transfer systems see 
figure 1.2 in chapter 1. 
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2.3.2 Mice lacking one or more CK isoenzymes in skeletal muscle 
Research on high energy phosphoryl transfer in skeletal muscle benefited enormously 
from the availability of mice with null mutations in the M-CK gene (M-CK-/-) (35), ScCKmit 
gene (ScCKmit-/-) (52), both CK genes (M-CK/ScCKmit--/--) (53) and animals with a leaky 
mutation in the M-CK gene (and graded levels of MM-CK activity) (54). Surprisingly, 31P 
MRS studies in skeletal muscle of mice with reduced or absent M-CK expression revealed no 
significant difference in PCr-, inorganic phosphate (Pi)- or ATP levels, nor in tissue pH, 
compared to control mice (table 2.1) (35, 54). The method of measurement appeared to be of 
influence on the measured PCr levels: chemically determined PCr/ATP ratios were somewhat 
lower than PCr/ATP ratios determined by in vivo MRS (35). Furthermore, chemical 
determination also demonstrated that absolute PCr levels were significantly higher in  
M-CK-/- mice than in control mice. Discrepancy between in vivo MR and in vitro chemical 
measurements is commonly observed and can be ascribed to hydrolysis effects that will occur 
during the isolation and freezing of tissues or generation of cell extracts (55, 56). In M-CK-/- 
mice this hydrolysis of PCr during the freezing procedure was partially blocked, further 
illustrating that CK activity is a difficult to control parameter in invasive approaches where 
tissue fractionation or extraction is used. Results may also be clouded, if the measurement 
time frame does not match properly with the physiological event that is studied. Contractile 
experiments unequivocally demonstrated lack of burst activity in M-CK-/- muscles, however, 
MRS analysis with stimulation with 1 or 5 Hz (35) or challenge by ischemia reperfusion (57) 
did not show differences in M-CK-/- mice compared to wt mice in breakdown of PCr and 
accumulation of Pi within the time resolution of the experiments (~140 s per spectrum). It is 
of note here, that the residual CK activity in these animals was contributed by remaining 
mitochondrial CK activity. If the time interval of measurement was shortened, however, like 
in case of gated 31P MRS experiments, an initial decrease of PCr in CK mutants was found 
during the first few seconds of 5 Hz stimulation in wt (58). This decrease is also observed in 
M-CK-/- mice, but of smaller magnitude which is in good agreement with the lack of burst 
activity in the latter mice (35). The impaired capacity of the CK system in M-CK-/- mice was 
demonstrated already during resting conditions by inversion transfer (35) and saturation 
transfer (59) experiments which revealed that, in M-CK-/- mice, no high energy phosphates 
transfer from PCr to ATP or visa versa was detectable. In fact, transfer from ATP to PCr 
appeared already blocked in mice expressing 34% or less MM-CK activity (54) indicating 
that either this amount of CK activity is necessary to maintain enzymatic kinetics in skeletal 
muscle or that the transfer rate was below the detection threshold of the MR experiment.
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Notes on table 2.1: 
Concentrations are expressed in mmol / (l tissue), except [ADP] which is expressed as mmol / 
(l intracellular water). Values that are expressed per l tissue can be converted to values per l 
intracellular water by using a factor of 0.73 for the intracellular water fraction (60, 61) 
* significantly different from wt animals; § significantly different from value before 
supplementation 
a Ratios are determined from fully relaxed MR spectra. Studies which use not fully relaxed 
spectra to compare wt and transgenic animals are not included in this table for comparability 
reasons. 
b Unless stated otherwise, ratio’s are with respect to β-ATP 
c concentrations are determined by chemical methods in µmol/(g wet weight) and calculated 
to mM by assuming a tissue density of 1.06, unless stated otherwise 
d concentrations derived from in vivo MR spectra 
e equilibrium condition necessary for calculation of ADP may not be valid in this knockout 
mouse 
f after 1 month of Cr supplementation 
g Calculated from other values 
h concentrations are determined by chemical methods in µmol/(g dry weight) and calculated 
to mM by assuming the fraction dw:ww to be 0.3:0.7 (which appears correct since tCr values 
are in accordance to in vivo measurements in the same mouse model) and a tissue density of 
1.06 (62) 
i Cr + PCr were in this study normalized over all muscles. 
 
After an ischemic period of 20 minutes, a somewhat larger acidification was observed 
in M-CK-/- compared to wt muscle (57), which may be due to diminished proton buffering. A 
striking observation in studies of M-CK-/- mice was the disability to phosphorylate β-GPA in 
vivo. This finding suggested that cytosolic MM-CK is the only CK isoform which is able to 
phosphorylate this Cr analogue (63) in muscle. Similar findings from in vitro study had been 
reported (64, 65). 
Just as with M-CK-/- mice, ScCKmit-/- mice showed no difference in PCr, Pi and pH 
levels compared to wild-type mice during resting conditions. Both inversion transfer (52) and 
saturation transfer (66) revealed no difference in the flux trough the CK reaction. Small 
differences compared to wt animals were observed in ischemia experiments: recovery of PCr 
and Pi levels were faster than in wt animals and the hydrolysis of PCr was not completely 
compensated for by Pi and PME increases. This may be related to changes in the 
mitochondrial membrane microenvironment (57).  
Inbreeding of M-CK-/- and ScCkmit-/- resulted in mice lacking both isoenzymes:  
M-CK/ScCKmit--/-- double knockout mice, which have virtually no CK activity in skeletal 
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muscle (53). Total Cr (tCr) level (i.e. the addition of Cr and PCr levels) rose in parallel during 
aging in M-CK/ScCKmit--/-- and wt mice as was shown by 1H MRS and biochemical 
methods (46), both yielding the same concentrations. This latter finding convincingly 
demonstrated that virtually all Cr is MR visible in 1H MR spectra if measured under the 
proper conditions (46, 67). Remarkably, the postnatal increase of PCr levels in these knockout 
mice was the same as in wt animals, which is likely due to the residual BB-CK activity 
present in muscle of M-CK/ScCKmit--/-- mice the first weeks postnatal (46). In muscle of 
mature M-CK/ScCKmit--/-- mice, PCr /ATP ratio’s decreased with age. When  
M-CK/ScCKmit--/-- mice were three weeks old they still were able to fully hydrolyze PCr 
(46). At older age this CK activity decreased to an undetectable low level and as a 
consequence, conversion through the CK reaction became gradually very low (46) until in 
adult mice the MR detectable flux through the CK reaction was fully absent (53, 66). The 
silencing of the CK reaction was reflected by a decrease of ATP levels and a profound decline 
of tissue pH during 20 minutes of ischemia (57). 
By using 13C MRS and 13C-4 labeled creatine, simultaneous observation of Cr and PCr 
became possible. Injection with 13C labeled Cr in adult M-CK/ScCKmit--/-- mice showed 
uptake and phosphorylation of Cr demonstrating that very low CK activity is sufficient for 
this process (46). Using this 13C MR data it was possible to calculate PCr/total Cr (tCr) ratios. 
This PCr/tCr ratio, together with the absolute tCr value yielded from the 1H MR spectra and 
the metabolite ratios determined from the 31P MR spectra, enabled determination of the tissue 
concentrations of ATP and PCr in vivo (table 2.1) (46). 
In general, it appears that CK in normal mouse muscle is abundantly present. 
Reducing CK content does not affect the concentrations of ~P metabolites, and muscles of 
mice with less CK perform reasonably well during metabolic challenges if at least a small 
amount of CK remains present. However, disruption of local ~P equilibrium or sudden 
changes in ~P metabolites on a short time scale are very well possible in mice with less CK 
activity, but may be averaged out in the signals acquired during an MR experiment. 
Furthermore, more challenging conditions may uncover further defects. 
 
2.3.3 Over-expression of phosphoryl transfer enzymes in skeletal muscle 
Converse experiments, with overexpression of CK, were also performed. Ectopic 
over-expression of the B-CK isoform in muscle of transgenic mice resulted in the formation 
of the stable dimers MB-CK and BB-CK, and increased total muscle CK activity as assessed 
under maximal velocity conditions in tissue extract (up to 150% of that of controls) (68, 69). 
Using saturation transfer techniques, the in vivo CK activity appeared to be up regulated by a 
factor of two (69). Interestingly, this up-regulation of CK had no effect on PCr/ATP or 
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Pi/ATP ratios as measured by 31P MRS, or the ATP or Cr concentration as measured by 
HPLC. This provided further evidence for the contention that the CK reaction is at 
equilibrium under resting conditions. The above studies were initially performed in animals 
that were heterozygous for the transgene, but subsequent analysis of homozygous transgenics 
showed similar effects (70). The only difference between wt and these homozygous 
transgenic mice was a decrease in the rise time of force of a 5 s tetanic stimulation, which 
showed that only during severe metabolic demand extra CK may increase performance (70). 
Besides an up-regulation in CK activity, AK activity appeared to be decreased by 9% (70), 
which may reflect the close harmony in which CK and AK work. 
To test whether the proposed specific localization of MM-CK in muscle, close to the 
M line and the sarcoplasmic reticulum, is important, M-CK-/- mice (35) were mated with 
mice expressing B-CK in muscle (69) to generate mice in which M-CK has been ‘replaced’ 
by B-CK although now the cytosolic CK has no specific localization (71). In vivo, 31P 
saturation transfer experiments showed a decrease of CK activity at rest to only 58% of that of 
wt animals (71). Together with the observation that the contractile phenotype of M-CK-/- 
mice returned to normal in the mice containing only B-CK, these results indicated that 
compartmentation of CK to the myofibril is not an (absolutely) essential condition for proper 
contractile function. Another implication of these results is that the CK shuttle, as originally 
proposed by Bessman and coworkers (72, 73), may be beneficial to skeletal muscle but it is 
not of vital importance.  
Besides CK, also other phosphotransfer enzymes can be expressed intentionally in 
skeletal muscle. Using the method of adenoviral transduction, arginine kinase (ArgK), which 
works analogous to CK but with arginine instead of Cr, was expressed in hind leg muscle of 
mice (74). The phosphorylated arginine (PArg) was detected in vivo using 31P MRS, at a 
resonance position of 0.49 ppm upfield of PCr up to 8 months after injection. PArg was 
observed as a singlet of equal linewidth compared to the signal of PCr, where (PArg +PCr)/γ-
ATP in the injected leg was equal to PCr/γ-ATP in the control leg with Parg:PCr of 
approximately 1:1. Using an ischemia reperfusion protocol it was shown that PArg is used 
during energy demand, although the decrease in PArg was less and slower compared to PCr. 
This study is of particular interest as it demonstrated elegantly that an MR spectroscopy signal 
can be exploited as a non-invasive detectable marker of transgene expression and can be used 
to investigate the role of other ~P transfer systems in corroboration with the traditional ones. 
 
2.3.4 Mice lacking one or more CK isoenzymes in brain  
Mice lacking either the cytosolic B-CK (B-CK-/- mice) (75), the mitochondrial 
ubiquitous isoenzyme (UbCKmit -/- mice) (76) or both enzymes (B-CK/UbCKmit--/-- mice) 
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(30) have been generated to study the role of the CK reaction in other tissues than muscle, 
notably in brain. B-CK-/- mice had normal PCr, Pi, ATP and pH levels, but the flux of ~P 
transfer through the CK reaction measured by saturation transfer experiments was 
dramatically lowered, although still measurable (75). Because the brain is an oxidative organ, 
the mitochondrial content and fractional contribution of the mitochondrial CK activity (up to 
30% of total CK activity, unpublished result Wieringa et al.) is much higher than in muscle. 
Unlike in muscle, the mitochondrial CK in brain may therefore be present at large enough 
quantities to mediate a visible exchange between the high energy phosphates of γ-ATP and 
PCr. Direct comparison of the relevance of the cytosolic and mitochondrial end points of the 
CK shuttle in brain and muscle is therefore difficult. Comparison is also difficult because the 
cellular infrastructure and anatomy of these tissues differ profoundly. Brain is composed of a 
very heterogeneous mixture of cell types, and not much is known about the cell-type 
distribution and co-expression of B-CK and UbCKmit isoforms in glial and neuronal cells 
over various brain regions. Recent evidence showed close metabolic collaboration between 
glial and neuronal systems for brain energetics (77, 78), in an arrangement that is very much 
different from the communication between individual myofibers in muscle. This makes it 
intrinsically difficult to know how the PCr shuttle – if any – is integrated into the energetic 
network of brain. Recently, creatine and the CK reaction have been proposed for a neuron-
glial shuttle (47).  
In our own studies, UbCKmit -/- mice appeared to have rather normal basal PCr, Pi, 
ATP and pH levels (30), although Kekelidze and coworkers report a significant lower 
PCr/ATP ratio in homozygous UbCKmit -/- mice (76). During seizure induction by PTZ 
injection, UbCKmit -/- mice showed a more pronounced decrease in PCr and β-ATP signals 
while the PCr/ β-ATP remained always lower than in wt mice (76).  
PCr in brains of double mutant B-CK/UbCKmit--/-- mice appeared to be fully 
depleted, while Pi, ATP and pH levels were virtually normal (30). In addition, a decrease in 
total creatine (tCr) was observed (30) in contrast to muscle, where it remained constant upon 
near depletion of CK. In this respect it may be of interest that the brain is able to synthesize 
(part of) its own Cr (79, 80) and that the blood-brain barrier may not be fully permeable for 
Cr (43). In addition to decreased tCr levels, increased levels of N-acetyl aspartate (NAA) and 
glutamate were observed in B-CK/UbCKmit--/-- mice (table 2.2) (30) which points to 
physiological or morphological adaptations (81) that could be the result of the lack of CK 
during brain development. 
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2.3.5 Mice lacking one or more CK isoenzymes in heart 
Cardiac muscle cells possess a relatively high mitochondrial capacity compared to 
skeletal muscle cells, and therefore have a more oxidative character with smaller diffusion 
distances between energy producing and energy consuming sites. Although the total CK 
activity (activity units per mg tissue) is only between 10-30% of that in skeletal muscle, the 
relative contribution by mitochondrial ScCKmit activity is much higher. Moreover, a small 
fraction of cytosolic CK activity stems from MB-CK (82).  
31P MRS has revealed that M-CK-/- hearts displayed normal PCr/ATP ratios as well as 
normal absolute PCr and ATP levels, thus keeping phosphorylation potential high (83, 84). 
During different workloads (i.e. at different pacing frequencies), changes in PCr and other 31P 
MRS detectable metabolites appeared to be equal in M-CK-/- and wt mice, however, 
differences in very fast events may have been missed in these studies as rather long 
acquisition times were used. Free ADP levels were also equal or somewhat higher in 
transgenic mice at a workload of 600 beats per minute (83, 84). In contrast to skeletal muscle 
without M-CK, saturation transfer clearly demonstrated phosphoryl transfer from PCr to ATP. 
Again, this is most easily explained by the presence of relatively large amounts of 
mitochondrial CK (59, 84). At higher workloads, however, CK flux could not keep up and 
increased less than the CK flux in wt mice (84). From these studies it was concluded that 
mitochondrial CK activity is sufficient to maintain most of the CK functions. The authors 
hypothesized that mitochondrial CK, although quantitatively present at lower concentrations 
than cytosolic CK, has a contribution to the total measured CK flux that is higher than that in 
skeletal muscle (84). This conclusion was further corroborated by 31P MR experiments 
performed on ScCKmit-/- hearts which showed that mitochondrial CK was necessary to 
maintain normal high energy phosphate levels (85). Mice lacking only mitochondrial CK 
showed 20-30% lower PCr-levels (85, 86), which is in contrast to the situation in skeletal 
muscle, where PCr levels remained unaltered (52). Furthermore, ScCKmit-/- hearts showed 
elevated ADP levels by a factor of two while Pi and ATP levels appeared normal (85). This 
latter finding is rather remarkable, and underlines the role of ScCKmit in maintaining (local) 
ADP concentrations. During increased workload the mice were still able to break down PCr, 
although hydrolysis of PCr was somewhat less in ScCkmit -/- mice (24%) than in wt mice 
(37%). When recovering from this higher workload, ScCKmit-/- mice resynthesized PCr. 
Therefore it was concluded that ~P transfer is maintained even if CK is lacking from the inter-
membrane compartment of mitochondria (85). A similar conclusion had already been drawn 
from study of skeletal muscle without ScCKmit earlier (57).  
The basal PCr level was also lower in intact hearts of M-CK/ScCKmit--/-- mice, as 
was demonstrated by 31P MRS. In sharp contrast to skeletal muscle, hearts of double knockout 
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M-CK/ScCKmit--/-- mice are able to hydrolyze PCr even better than in M-CK-/- or wt hearts 
during increased cardiac work (83, 87). Since the [PCr] is a balance between Cr 
phosphorylation and PCr breakdown, this is attributed to impaired synthesis (normally 
primarily mediated by ScCKmit) during cardiac work. In addition, the presence of BB-CK in 
cardiac muscle may contribute to this conversion, although this remaining CK activity is only 
~2 times higher than that in muscle of CK double knockouts (1.9 mMs-1 vs. 0.5-1.0 mMs-1). 
Localization of the enzyme and substrates in different muscle compartments may also play a 
role here (46, 83). [ADP], as calculated using the CK reaction equilibrium constant (88), was 
increased by 95% in hearts of M-CK/ScCKmit--/-- mice, which may also be the result of the 
disrupted functioning of mitochondrial CK in balancing ADP/ATP levels.  
 
2.3.6 Transgenic expression of CK in liver 
Liver is an ideal model to study creatine metabolism and CK function in a null 
background, since it normally does not express CK. Transgenic expression of CK in liver can 
therefore be used as a marker for successful expression (89). When CK is ectopically 
expressed from a transgene, differences with the normal situation in liver can provide direct 
information on the working mechanisms and importance of CK. Moreover, as the CK reaction 
in equilibrium enables to calculate free ADP levels, its presence opens up a possibility to 
study free ADP in liver. 
One of the first genetic manipulations involving the CK system was by expressing the 
B subunit of CK in liver (34). Livers were measured using an 31P RF probe adjacent to a 
surgically exposed liver. The ability to phosphorylate Cr was only observed after Cr feeding 
and the concentration of PCr measured correlated with the quantity of Cr ingested (90). ADP 
levels were calculated to remain constant with different CK activities and Cr concentrations 
(68, 90). In studies of the perfused liver during an ischemia protocol, 31P MRS showed that 
the introduced CK system prevented a dramatic decrease in ATP and pH (91), thus rescuing 
the liver tissue from the adverse effects of the ischemic challenge. This role has striking 
parallels with the role in muscle, where also hydrolysis of ATP and a severe decline of pH 
was observed when both isoforms of CK were knocked out (57). Later, the pH of the 
perfusate was also shown to have a large influence on the amount and rate of PCr formed with 
several Cr concentrations in the buffer (92). Tissue pH levels decreased immediately upon 
application of ischemia in wt livers, while in CK containing livers tissue pH remained 
constant during the initial period of ischemia. Again this confirmed our own observations in 
the muscle studies (57, 93, 94). Pi was increasing more during ischemia in CK expressing 
livers than in wt livers. After reperfusion, the CK expressing livers appeared to have gained 
the ability return to pre-ischemia values of ~P within 80 minutes (91). Besides protecting the 
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liver from ischemia, the CK system could also protect the liver from anoxia, depending on the 
amount of PCr present (91).  
A fructose load is a severe challenge of energy metabolism in the liver due to the 
consumption of ATP and Pi in the conversion to fructose-1-phosphate. When fructose was 
injected intraperitonially, 31P MRS revealed that PME levels rose two-three fold, and Pi and 
ATP levels decreased by 60% and 50%, respectively, similarly in wt type mice and in 
transgenic mice not fed Cr. Pi returned to resting levels in approximately 30 minutes, while 
ATP and PME were not back at these levels after one hour. Upon feeding of Cr, the fall in 
ATP levels was prevented and only a small decrease of ATP was observed for relatively low 
PCr values (PCr/ATP =1 - 1.5) (95). Both Pi decrease and PME increase were diminished in 
the presence of PCr. ADP levels as calculated from MR spectra, however, changed 
independently of Cr feeding (95). The authors concluded that prevention of decline in ATP 
must be due to the new available source of high energy phosphates of PCr (95). Interestingly, 
these results also demonstrate that only small amounts of PCr are sufficient to play a 
significant role in the buffering of high energy phosphates, a finding that was confirmed in 
later studies on Cr deficient mice (see below). 
In addition to mice expressing cytosolic CK, mice have been generated that express 
the mitochondrial UbCKmit isoenzyme in liver (96). These mice were able to synthesize PCr 
upon Cr feeding, and during ischemia of perfused livers PCr decreased, indicating that it is 
utilized (96). Furthermore, mice were generated which express both cytosolic and 
mitochondrial CK in liver, in this way providing a series of mice expressing a range of CK 
activities (B-CK, UbCKmit or both, ranging in activity from 28 – 1635 µmol·g wet wt-1·min-1) 
(97). Saturation transfer experiments on perfused livers showed a linear relation between the 
CK rate in vivo and the biochemically determined CK activity. Furthermore, it was 
demonstrated that the forward and backward flux through the CK reaction were similar 
because the kfor/krev is equal to [ATP]/[PCr], even in mouse liver expressing only 
mitochondrial CK. Expression of CK also had a large effect on ADP levels: only in the mice 
expressing very low levels of CK ADP levels were relatively high. When a certain threshold 
in CK activity was reached, apparent ADP levels dropped significantly. The authors attributed 
this effect to functional incorporation of the mitochondrial CK isoform in the livers of these 
transgenic mice. (97). 
 
2.3.7 Mice lacking guanidinoacetate methyltransferase (GAMT) 
Recently, mice lacking GAMT were generated (98) as a model for human Cr 
deficiency (99). As these animals were not able to synthesize their own Cr, they were 
completely deprived of Cr unless Cr was orally ingested.  
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Localized proton MRS of GAMT-/- mice showed reduced levels of Cr in muscle and 
brain although residual Cr may still be present due to oral intake (29). In skeletal muscle, a 
broad signal of guanidinoacetate (Gua) was observed, however this signal was only present in 
cases when Cr was decreased to almost complete depletion. Gua was shown to be 
phosphorylated and metabolic active in skeletal muscle (29). In ischemia-reperfusion 31P MR 
experiments PGua decrease showed similar time evolution as the PCr signal. The recovery of 
the PGua signal, however, was significantly reduced and because recovery rate did not change 
upon Cr feeding, it was concluded that this may be a result from the lower affinity of CK to 
Gua (100). Accordingly, saturation transfer experiments on the γ-ATP showed negligible 
transfer of ATP to PGua indicating slower enzymatic kinetics (100).  
Brain and heart, just as skeletal muscle, showed a phosphorylated Gua (PGua) signal 
(29, 98). The PGua signal from brain had much lower intensities than in skeletal muscle and, 
since in skeletal muscle the PGua signal showed striking fluctuations, oral ingestion of Cr 
appeared to be an important factor (29, 100). In mice with no detectable PCr, after a few days 
of Cr feeding the PCr signal in muscle already exceeded the PGua signal (100). In contrast, 
large fluctuations of the PGua signal were not observed in brain, suggesting limited 
permeability of the blood brain barrier, which was already suspected from the slow recovery 
of the Cr signal after long term feeding of high amounts of Cr to GAMT deficient patients 
(43, 101). Feeding of Cr to GAMT-/- mice could in the future elucidate the extent of 
permeability of the blood brain barrier for Cr. 
Another interesting phenotype of GAMT--/-- mice was an increased Pi signal which 
was similar as observed in M-CK/ScCKmit--/-- mice (table 2.1) (100). This increased Pi was 
only detected when PCr was fully absent for a longer time period. Upon (intentional) Cr 
feeding the Pi signal normalized (100). Despite the lower affinity of CK for PGua, it functions 
surprisingly well in vivo to match moderate energy demands. Only small amounts of PCr 
were necessary to prevent elevated levels of Pi, and increased levels of Pi itself may also be a 
adaptation to stimulate glycolysis, yet another pathway for relatively fast energy production. 
Taken combined, these findings confirm a model with cooperativity in function between 
various ~P pathways. 
 
2.3.8 Knock-outs of the AK system  
Parallel to these studies also the role of yet another ~P pathway, the AK-mediated 
ADP↔ATP exchange reaction, was assessed in mice lacking the cytosolic isoform AK1  
(AK-/- mice). In these mice the cytosolic capacity to maintain local ADP/ATP ratios (94) was 
changed. Ischemia reperfusion experiments showed no difference in PCr breakdown and 
restoration, which was not surprising because CK activity was not changed. PME, however, 
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accumulated more during the ischemic period. This was explained by an increased glycolytic 
flux accompanied by higher glucose 6-phospate levels, as measured by 18O labeling studies in 
AK-/- mice (94). The lower tissue pH measured at the end of the ischemic period may also be 
a result thereof (94). 
Double knock-out mice lacking both AK1 and cytosolic M-CK enzymes (MAK--/-- 
mice) had a severely impaired cytosolic phosphoryl transfer capacity (102). This was evident 
from the much delayed recovery of both PCr and Pi after an ischemic challenge compared to 
wt animals (93). This delayed recovery of high energy phosphoryls appeared, at first sight, 
similar to the response of GAMT-/- mice to an ischemic challenge (100), but probably has a 
different origin. In MAK--/-- mice, it could be attributed to re-establishment of mitochondrial 
~P metabolism which may be accompanied by local unfavourable ADP concentrations, while 
in GAMT-/- mice the reduced enzyme kinetics were the most likely explanation for the 
reduced recovery rate. 
  
2.4 Concluding remarks 
The use of MRS methodology in combination with new procedures for the generation 
of transgenic mice have opened up entirely new opportunities to study metabolism under 
normal (i.e. healthy) and pathological conditions in vivo. Especially when the genetic 
modification has a effect on enzymes that interact directly with MR visible metabolites, or on 
the presence of MR visible metabolites, the tools that different MRS techniques offer to study 
these mice in vivo are very potent. Mario Capecchi’s statement ‘if you give me a gene, I 
could knock it out and tell you what its function is’ (20), however, appeared to be overly 
optimistic, since in a complex biological system the functions of a protein may not be 
straightforward (103) due to partial redundancy or overlap with functions of other proteins. 
Knockout mice show a remarkable plasticity in coping with the effects of gene 
deficiency. For CK, which was long considered essential in tissues with high energy demand, 
it has now been demonstrated that it is not absolutely indispensable under laboratory 
conditions since CK knockout mice are viable. As was shown in several studies altering CK, 
AK or any related pathway, metabolic intervention in energy metabolism will always result in 
a global response, preventing a direct or expected alteration in metabolism. Therefore, 
changes may be subtle and remain unnoticed. When the metabolic system is sufficiently 
stressed, however, alterations may become apparent.  
When making a phenotypic comparison between a knockout and control mouse, care 
should be taken in selecting the proper strain for reference. Differences may be large between 
strains with different genetic backgrounds, obscuring small changes resulting from the genetic 
alteration of interest. Furthermore, cellular heterogeneity in tissues may be an issue of 
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concern, especially when the tissue composition changes due to the mutation. Moreover, 
unexpected secondary adaptations may occur, which may have a larger influence on the 
metabolism than the direct (primary) effect of knockout itself. This was shown for example in 
muscle CK double knock-out mice, which showed a shift in fibertype and up-regulation of 
glycolytic and oxidative potential (104). 
Another important consideration is that the phenotypic consequences may also not be 
100% penetrant, as was shown in imaging of ventricles of HD and B-CK mice (30, 105). 
Although detectable in MRI, when this occurs in MRS studies in which only average values 
are presented, changes may remain unnoticed. Despite these challenges, in vivo MRS has 
proven to be a valuable and powerful tool in the study of mice with genetic alterations in the 
high energy phosphoryl transfer systems. 
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ABSTRACT  
We assessed the relationship between phosphocreatine (PCr) and creatine (Cr) content 
and creatine kinase (CK) activity in skeletal muscle of mice. Therefore, PCr and total Cr (tCr) 
concentration as well as CK activity in hind-limb muscles of mice with or without the 
cytosolic and mitochondrial isoforms of muscle creatine kinase (wild-type and  
M-CK/ScCKmit--/-- mice) were determined by in vivo MR spectroscopy and by biochemical 
means during postnatal growth and adulthood. In wild-type muscle [tCr], the PCr/ATP ratio 
and CK activity increased rapidly in the first 4 - 7 weeks of age. Remarkably, M-
CK/ScCKmit--/-- mice showed a similar increase in the PCr/ATP ratio during the first month 
of age in the presence of only minor brain-type BB-CK activity. Uptake of Cr in muscle was 
seemingly unrelated to CK activity as tCr increased in the same way in the muscles of both 
mice types. At older age the PCr/ATP ratio decreased in M-CK/ScCKmit--/-- muscles in 
contrast to wild-type where it still slowly increased, whereas [tCr] was similar for muscle of 
both mice. Using a new in vivo MR approach with application of 13C-4 labeled Cr, also a 
lower PCr/tCr ratio was observed in M-CK/ScCKmit--/-- muscle. From these data it followed 
that in vivo global ATP levels at rest are similar in presence or absence of CK. Although Cr 
could still be converted to PCr in mature M-CK/ScCKmit--/-- muscle, the immediate 
availability of PCr decreased, and PCr became partly inconvertible at older age. Apparently 
catalysis of the CK reaction by BB-CK, although significant in muscles of newborn mice, 
gradually declines to very low levels in adulthood. Part or all of this BB-CK may arise from 
satellite cells fusing with myotubes, a process which is most active during the first months of 
life. Finally, our observation that the MR and the chemical assessment of muscle [tCr] and 
PCr/tCr ratio were similar for all mice does not support the existence of a significant MR-
invisible or immobile pool of Cr, with a role of CK in this phenomenon.  
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INTRODUCTION 
Creatine kinases (CKs; EC 2.7.3.2) form a small family of isoenzymes which catalyze 
the reaction Creatine (Cr) + MgATP2- ↔ Phosphocreatine (PCr2-) + MgADP- + H+. These 
proteins play a key role in the energetics of excitable tissues, such as muscle and brain, by 
keeping ATP/ADP ratios balanced and the adenylate pool highly charged (1, 2). Apart from 
forming a temporal energy buffer, the CK circuit may also act as an intermediate in spatial 
energy networks (3). Other roles of the CK system, which follow from the presence of other 
CK reactants, are intracellular regulation of pH (1, 4) and inorganic phosphate (Pi) levels (5).  
To study the overall physiological significance of the CK/PCr-system in muscle, we 
have generated mice with null mutations in the muscle-specific cytosolic M-CK and 
mitochondrial ScCKmit genes (6-8). Apart from specific functional losses, also some 
remarkable metabolic adaptations were observed in muscles of CK lacking animals (e.g. (7, 9, 
10)). Early in life a significant part of total skeletal muscle CK activity comes from the  
BB-CK isoform and it has been shown for some species that the expression of this isoform 
becomes gradually suppressed during maturation of skeletal muscle, leaving only trace 
amounts at adulthood (11, 12). Skeletal muscle of adult mice with combined null mutations 
for M-CK and ScCKmit (M-CK/ScCKmit--/--) showed no up-regulation of BB-CK activity. 
Nevertheless, substantial amounts of PCr were found in these muscles. However, this pool 
was not accessible for energy buffering (8, 13) and moreover, the exchange-flux of phosphate 
between the PCr and ATP pools measured in MR transfer experiments had dropped to below 
detection levels in adult animals (9, 13). 
The main purpose of the present study was to obtain a more precise characterization of 
the origin and fate of the PCr pool in muscle without muscle-type CKs as compared to PCr in 
muscle of wild-type mice. It is of particular interest to know what happens with the muscle 
PCr content in relation to CK activity and total Cr levels. These key parameters in the setting 
of PCr tissue levels are expected to change in skeletal muscle of mice during postnatal 
development and aging. To address how they relate to PCr levels in wild-type and  
M-CK/ScCKmit--/-- mice the total content of Cr (tCr) and PCr in hind-limb muscle was 
assessed by in vivo MR spectroscopy in parallel with biochemical determinations of muscle 
Cr levels and CK activity as a function of age. To identify whether uptake and 
phosphorylation of creatine indeed occur in muscle of adult M-CK/ScCKmit--/-- mice we 
introduce a new approach involving the administration of 13C-4 labeled Cr to monitor its 
phosphorylation in vivo by 13C MR spectroscopy. From this approach also the muscle 
[PCr]/[tCr] ratio can be determined which, together with tCr content and [PCr]/[ATP] ratios, 
allows for an assessment of in vivo ATP levels in a novel way. Finally, we also compared the 
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potential to de-phosphorylate PCr in muscle of wild-type and of double knock-out mice as a 
function of age. The results provided further clues on the presence of PCr in (developing) 
skeletal muscle of wild-type mice and of mice without cytosolic MM-CK and mitochondrial 
ScCKmit. Moreover, the particular results of this study on metabolite levels also have 
interesting implications for views on Cr mobility and visibility as seen by MR spectroscopy in 
skeletal muscle. 
 
MATERIALS AND METHODS 
Animals 
In this study a comparison was made between mice lacking cytosolic M-CK and 
sarcomeric mitochondrial ScCKmit (i.e. M-CK/ScCKmit--/--) and wild-type C57Bl/6 
controls. All procedures were approved by the Animal Care Committee of the University of 
Nijmegen and conformed to the Dutch Council for Animal Care. Animals were anesthetized 
with 1.2% isoflurane in a gas mixture of 50% O2/ 50% N2O delivered through a facemask. 
Their body temperature was monitored using a fluoroptic thermometer (Luxtron 712, 
California, USA) and was maintained at 36.8 ± 0.5°C using a warm water circuit.  
 
Magnetic Resonance (MR) equipment 
The MR experiments were performed on a horizontal 7.0 T magnet (Magnex 
Scientific, Abingdon, UK), which was equipped with 150 mT/m shielded gradients, and 
interfaced to a SMIS (Surrey Medical Imaging Systems, Surrey, UK) spectrometer, operating 
at 300.22 MHz for 1H, at 121.53 MHz for 31P and at 75.49 MHz for 13C. The receiver channel 
was slightly modified by using home-built ultra-low noise preamplifiers and a low-loss active 
transmit/receive switch. 
 
Phosphorus (31P) MR study of postnatal development 
For non-localized 31P MR measurements, a three-turn solenoid coil with a diameter of 
8 mm was used with an Alderman-Grant type 1H coil surrounding it (14). For young mice (7 – 
14 days of age), a special plastic insert was used to ensure that only the hind limb muscles 
were measured. After the shimming procedure, a scout image was obtained in three 
perpendicular directions to ensure that only the hind limb was situated in the radiofrequency 
(RF) field of the coil. Experiments on a phantom (100 mM inorganic phosphate solution) 
showed that the field of view of the 1H coil corresponded to that of the 31P coil. This was 
verified by the combined application of localized 31P MR spectroscopy (15) and 1H MRI 
which showed the absence of 31P MR signals outside the phantom. MR spectra were acquired 
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using a 90° RF pulse of 40 µs with a repetition time of 7 seconds and were obtained from the 
hind limb of mice starting at ages of 7 days up to ages of 300 days (N= 3 – 6 for each data 
point). Additional spectra were obtained with a repetition time of 25 sec from animals at ages 
of 90 and 110 days to obtain metabolite levels under fully relaxed conditions and to assess 
saturation factors (N= 3 for each mouse type).  
 
Post mortem study 
31P MR spectra were acquired from wild-type mice aged 21 days and 12 months (n=2 
each), and M-CK/ScCKmit--/-- mice aged 21 days (n=3) and 6, 9 and 12 months (n=1 per 
time point). The 31P MR spectra (TR=7 s, 128 scans) were acquired using the same coil setup 
as used in the postnatal development study. After the acquisition of a reference spectrum, the 
animal was killed with an overdose of isoflurane and the PCr resonance was monitored until 
its level became constant. 
 
In vivo monitoring of [4-13C] creatine by 13C magnetic resonance spectroscopy (MRS) 
M-CK/ScCKmit--/-- (n=5) and wild-type (n=5) mice between 3 and 6 months of age 
were injected intravenously with 100% 13C-4 labeled Cr (11.25 mg/ml, 200 µl), three times a 
week, for three weeks. The labeled Cr was obtained from Mercachem (Mercachem, 
Nijmegen, The Netherlands) synthesized according to (16). Hind-limb muscles of these mice 
were analyzed weekly by 13C MR spectroscopy, using a 4-turn solenoid 13C coil with a 
diameter of 8 mm surrounded by an Alderman-Grant 1H coil. 13C MR spectra were acquired 
with a 90° RF pulse of 40 µs, a repetition time of 3 seconds, and Waltz-4 1H decoupling  
(40 W, duty cycle 0.7%) to ensure that the resonances of PCr and Cr are maximally resolved. 
Heating caused by decoupling power was evaluated by monitoring the temperature of the hind 
limb and of the body by a two-channel fluoroptic thermometer (Luxtron 712); no warming of 
the animal could be detected during 1.5 hours. 
 
Ischemia protocol 
To make hind-limb muscles ischemic the MR probe was provided with a diaphragm 
plate, which allows reversible and reproducible occlusion of the hind limb (17). Before, 
during and after ischemia sequential 13C MR measurements were made essentially as 
described above, except that the number of scans was reduced to 600 with a repetition time of 
one second. These experiments were performed on mice between 3 and 6 months of age. 
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Quantification of the total Cr pool in muscle using localized 1H MR spectroscopy 
Creatine levels were determined by quantitative localized 1H MRS in gastrocnemius 
muscle, oriented at 550 with respect to the static magnetic field (Bo) direction (magic angle) to 
avoid complications due to dipolar coupling (18). Localized 1H MRS was performed as 
described previously (18). A stimulated echo pulse sequence with an echo time of 10 ms and 
a repetition time of 5 s was used to select a voxel (typical size 2x2x2 mm3) in the 
gastrocnemius muscle, guided by MR images acquired in three oblique, perpendicular 
directions. Localized shimming on this (oblique) voxel was performed until a H2O peak with 
full width at half maximum of less than 22 Hz was reached. Creatine levels were estimated 
from the peak area of its methyl protons using the 1H signal of water as an internal reference 
and assuming a muscle water content of 76% (19). Corrections were made for T2 transverse 
relaxation times. The relaxation time T2 for Cr methyl and water proton spins was estimated 
by the acquisition of 1H MR spectra at different echo times and applying a mono-exponential 
fit to the signal intensities obtained at increasing echo times. At a repetition time of 5 seconds, 
the proton spin system was considered to be fully relaxed and hence no correction for T1 was 
applied. Creatine content was determined in this way at the ages of 60, 120 and 200 days  
(n= 3 each).  
 
Biochemical determination of CK activity and metabolite levels 
Mice were killed by cervical dislocation and hind limb muscles snapshot frozen and 
stored at –80 °C. Muscles were homogenized in a Teflon-glass Potter-Elvehjem using 10 
volumes of an ice-cold buffer containing 200 mM sucrose, 2 mM EDTA, 10 mM TrisHCl 
(pH 7.4), supplemented with heparin (50 Units/ml) and protease inhibitors (Boehringer 
Mannheim, Germany). The suspension was diluted 1:1 in a 30 mM phosphate buffer (pH 7.4), 
with 0.2 mM DTT, 0.05% (v/v) Triton X-100 and protease inhibitors. Extracts were incubated 
at room temperature for 20 minutes and subsequently centrifuged at 14,000 rpm (Eppendorf) 
at 4 °C for 20 minutes. Total CK activity was measured at 37 0C using a CK-NAC activated 
kit (Boehringer) and expressed in mmol . L-1 (intracellular water). s-1 assuming 20% protein 
content in skeletal muscle (20) and 1 g of muscle being equivalent to 0.69 ml intracellular 
water. For zymogram analysis, total protein extracts (5 µg) were resolved on a 0.7% (v/v) 
Seakem ME agarose gel (FMC Bioproducts, Rockland, ME, USA). Enzyme activities were 
visualized by a CK isoenzyme colorimetric detection kit (Sigma Diagnostics, St. Louis, USA, 
(8)). 
For chemical analysis of the Cr content in the gastrocnemius-plantaris-soleus (GPS) 
complex, tissues were extracted by 0.6 M HClO4 and neutralized with 3 M KOH. Total Cr 
levels were assayed via coupled enzymatic reactions using a spectrophotometer operating at 
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340 nm (21). Cr levels were determined in µmol/g wet weight and mmol/l tissue, assuming a 
muscle density of 1.06 g/ml (22). These were converted to mmol/l intracellular water 
assuming a cellular water fraction of 0.73 (19, 23). PCr was determined as described 
previously (8, 9). 
 
MR data analysis 
MRS data was evaluated in the time domain using MR user interface (MRUI) 97.1 
software (24). The processing of 1H MR spectra was performed as described previously (18). 
The creatine peak at a chemical shift of 3.03 parts per million (ppm) was fitted assuming a 
Gaussian line shape model function. Resonances in 31P MR spectra were also fitted with a 
Gaussian line shape model function. No further prior knowledge was used. For the assessment 
of ATP content only the γATP and the βATP signals were considered. Intracellular pH was 
derived from the chemical shift difference between Pi and PCr peaks (25). 
In 13C MR spectra, all signals originating from carbons in lipids were filtered using 
Hankel Lanczos singular value decomposition (26), leaving Cr and PCr signals around 157 
ppm for further analysis. As prior knowledge, a chemical shift difference of 0.8 ppm (16) and 
equal damping for these resonances was assumed. Differences between mean parameter 
values were analyzed by the Student’s unpaired t-test. 
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Figure 3.1: 31P MRS of hind-limb skeletal muscle as a function of age.  
(a) Spectral changes for a wild-type (a, left panel) and a M-CK/ScCKmit--/-- mouse (a, right 
panel) reflect postnatal development of high-energy phosphate metabolism. Spectra are 
vertically scaled to the ATP content. The age of the animals (days) is indicated at the left. 
Assignments: PME, phosphomonoesters; Pi, inorganic phosphate; PDE, phosphodiesters; 
PCr, phosphocreatine; ATP, adenosine triphosphate. (b) The PCr to ATP signal ratio as a 
function of the age for M-CK/ScCKmit--/-- (o) and control (■) mice. Ratios are not corrected 
for partial signal saturation. Each data point represents the average of at least 3 different 
mice. Standard deviations are indicated when outside the symbol sizes.   
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RESULTS 
Postnatal development of (phospho)creatine levels  
Energy metabolites in developing hind-limb muscles of control and  
M-CK/ScCKmit--/-- mice aged 7-300 days were monitored by 31P MR spectroscopy. All 31P 
MR spectra (figure 3.1a) showed signals for PCr, γ-, α- and β-ATP, inorganic phosphate (Pi) 
and phosphomonoesters (PME). During the first four weeks of life the PCr/ATP signal ratio 
gradually increased to a value of about 2.5 (uncorrected for spin saturation), with a similar 
slope for wild-types and mutants (figure 3.1b). Thereafter, this ratio slightly increased further 
in controls, but gradually declined in M-CK/ScCKmit--/-- mice. 
To assess how the size of the cellular Cr pool determines the ratio of PCr over ATP we 
measured total Cr levels as a function of age, in the same cohort of mice as studied by 31P 
MRS. Using a chemical assay the creatine content appeared to increase similarly in both wild-
type and M-CK/ScCKmit--/-- mice during postnatal development and leveled off after about 7 
weeks of age at values between 27 and 35 mmol/l tissue (see figure 3.2).  
Total creatine was also determined by quantitative localized 1H MRS, with the muscle 
oriented at the so-called magic angle (18, 27), from the peak area of its methyl protons and 
using the water peak as a reference. The T2 relaxation times used for signal correction were 
estimated to be 83 ± 4 ms (n=6) for creatine methyl protons and 21.9 ± 0.1 ms (n=6) for water 
proton spins. At 60 and 120 days of age tCr levels were determined in this way by MRS and 
also chemically, in the same skeletal muscles (n=3). At 60 days of age total creatine 
concentration was 27.9 ± 0.9 mmol/l tissue by MRS, which is not different from the creatine 
tissue content determined chemically (27.3 ± 1.4 mmol/l tissue). Although the average value 
determined by MRS at 120 days (32.5 ± 0.7 mmol/l tissue) is somewhat higher than that 
determined chemically (30.3 ± 0.9 mmol/l tissue) it is within the range of chemically 
determined values between 90 and 160 days of age (see figure 3.2). 1H MRS analysis at 200 
days of age found tCr to be 33.2 ± 1.1 mmol/l tissue in controls (n=3) and 34.5 ± 1.2 mmol/l 
tissue in M-CK/ScCKmit--/-- muscles (n=3). 
 
Postnatal changes in creatine kinase activity  
During postnatal development of mammalian skeletal muscles a gradual repression of 
B-CK gene expression takes place. In order to assess the possible involvement of this  
CK-family member in PCr pool build-up and depletion, we quantified the residual level of 
BB-CK isoenzyme in M-CK/ScCKmit--/-- muscles in relation to normal wild-type CK 
activity over time. The zymogram assay confirmed complete absence of MM-CK and 
ScCKmit in double mutant muscle, whereas the BB-CK isoenzyme was clearly visible in both 
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wild-type and mutant muscle extracts at 7 and 14 days of age (figure 3.3a).  During further 
progression to adulthood, isoenzyme staining on zymograms dropped to undetectable low 
levels, but the corresponding residual BB-CK enzyme activity could still be assessed with 
spectro-photometric analysis of tissue lysates. In wild-type hind-limb skeletal muscle CK 
activity increases during the first month of life from about 75 mM/s at an age of 7 days to a 
value of about 200 mM/s at adulthood (figure 3.3b). In 7-day-old M-CK/ScCKmit--/-- 
muscles this activity was about 2.5 mM/s or 4% of the normal overall CK activity (combined 
BB-CK, MM-CK and ScCKmit activities in wild-type controls) and decreased to values of 
less than 1 mM/s within about 40 days (figure 3.3c).   
 
Figure 3.2.  Creatine levels in hind-limb skeletal muscle as a function of mouse age. 
Data is presented as mmol/l tissue (left axis) and as mmol/l intracellular water (right axis) 
assuming an intracellular water fraction of 0.73 (see materials and methods section). Values 
for M-CK/ScCKmit--/-- mice are indicated by open symbols and for wild-type control mice by 
closed symbols. Data points at 60, 120 and 200 days, indicated by filled circles, were 
obtained by quantitative 1H MRS of wild-type gastrocnemius muscle (n=3) and at 200 days of 
age also in M-CK/ScCKmit--/-- muscle (n=3), indicated by an open circle. The other data 
points have been obtained by biochemical means from the muscle GPS complex. The data 
points at 60 and 120 days (n=3) have been determined from the same leg on which the MRS 
quantification was performed. The data points at 140 and 145 days are averages of 6 and 5 
mice, respectively, varying in age between 120 – 160 days. Each other point represents an 
average of 3 – 6 mice, except at 7 days postpartum, which are single measurements. Standard 
deviations are indicated if extending beyond the symbol size.  
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Figure 3.3: CK isoenzyme and adenylate kinase 1 (AK1) distribution in skeletal muscle as a 
function of mouse age (days) 
(a) Zymogram analysis of extracts from wild-type (left panel) and M-CK/ScCKmit--/-- mouse 
muscle (right panel) reveals low levels of BB-CK activity during the first 2 weeks. Note the 
complete absence of MM-CK activity in M-CK/ScCKmit--/-- animals. AK1 activity staining 
appears different in the right and left panels due to the use of differential staining protocols, 
necessary to avoid overexposure of MM-CK signal and blurring of the AK1 band by the 
presence of vast amounts of MM-CK in wild-type muscles. Staining of (low) ScCKmit activity 
is not visible under the present conditions. (b) CK enzyme activity measured as a function of 
age in wild-type muscle. Activities are given as mmol/l intracellular water /s. (c) CK activity 
in M-CK/ScCKmit--/-- muscle, which is the non-MM-CK/ScCKmit activity, expressed as mmol 
(l intracellular water)-1 s-1. Note the difference  in vertical scaling with respect to b.  
Uptake and phosphorylation of 13C-labeled creatine in muscle of adult mice 
To assess the uptake and phosphorylation of creatine in mature wild-type and  
M-CK/ScCKmit--/-- mice we explored a new approach by which we could assess Cr and PCr 
simultaneously in muscle in vivo using 13C MR spectroscopy after injection of 13C-labeled Cr. 
After one week, this resulted in well-resolved signals in the 13C MR spectrum of wild-type 
muscle for Cr and PCr (figure 3.4a). Strikingly, uptake and phosphorylation of 13C labeled Cr 
were also detectable in M-CK/ScCKmit--/-- mice (figure 3.4b). The phosphorylated fraction  
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Figure 3.4: 13C-MRS of adult hind limb muscle, after administration of 13C-4 labeled Cr.  
13C MR spectra (128 – 180 ppm spectral range) of (a) wild-type control and (b)  
M-CK/ScCKmit--/-- mice. (c) PCr/tCr ratios derived from these spectra assessed over a 3 
week period. (d) Zoomed 13C MR spectra obtained before and during 20 minutes of ischemia 
and recovery. Hydrolysis of PCr and rephosphorylation of Cr are evident in wild-type 
muscles, while in M-CK/ScCKmit--/-- muscles no conversion was detected within the limits 
set by the signal to noise ratio. 
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of the Cr pool remained constant during three weeks of creatine injection in both mouse 
strains (figure 3.4c). The average PCr/tCr ratio as determined by 13C MRS in  
M-CK/ScCKmit--/-- mice (0.56 ± 0.05) is significantly lower than in wild-type muscle (0.74 
± 0.04). In a determination by chemical analysis (8) similar values were found for  
M-CK/ScCKmit--/-- mice (0.55 ± 0.06) and slightly lower values for wild-types (0.66 ± 0.07), 
which likely is due to some PCr breakdown during the extraction procedure because of the 
high CK activity. 
To verify whether the 13C-labeled PCr in muscle is metabolically active, we applied 
ischemia to the hind limb muscle. 13C MR spectra were acquired at a time resolution of 10 
minutes, during a total ischemic period of 20 minutes. In wild-type mice we observed a clear 
conversion of PCr to Cr during this time interval, and full recovery of PCr levels occurred 
after reperfusion (figure 3.4d). In M-CK/ScCKmit--/-- mice, no changes in PCr and Cr levels 
could be observed, within limits set by the signal to noise ratio. 
 
Non-invasive estimation of intracellular ATP and ADP content at rest 
Usually the in vivo levels of compounds in skeletal muscle involved in the CK 
reaction are assessed by 31P MRS by taking the chemically determined contents of ATP and 
total creatine as starting points. The availability in this study of absolute Cr levels and of the 
[PCr]/[tCr] and [PCr]/[ATP] ratios allowed the non-invasive estimation of PCr and ATP 
levels. The average [tCr] for muscle of wild-type mice between 60 and 200 days of age was 
30.5 ± 2.0 mmol/l tissue (see Table 3.1).  
With a PCr/tCr ratio of 0.74 ± 0.04 we calculate an average value for [PCr] of 22.5 ± 
1.9 mmol/l tissue and with a PCr/ATP ratio of 2.90 ± 0.19 we arrive at an average [ATP] of 
7.8 ± 0.8 mmol/l tissue. In previous studies we obtained similar [ATP] values for wild-type 
skeletal muscle (GPS complex) by chemical means: i.e. 8.2 ± 0.8 mmol/l tissue (28) and 8.3 ± 
0.5 mmol/l tissue (7). [ATP] in M-CK/ScCKmit--/-- muscle derived by the MRS approach 
was not different from wild-types, but it was substantially lower in the chemical 
determination. Assuming a fraction of 73% for intracellular water the intracellular 
concentrations of tCr, PCr and ATP were also determined (Table 3.1). Free intracellular ADP 
levels were derived from these concentrations and the CK reaction assuming this reaction to 
be at near-equilibrium with an equilibrium constant of 1.66⋅109 (29) and including 
intracellular pH data from 31P MR spectra of skeletal muscle. The near-equilibrium condition 
generally seems valid for skeletal muscle at rest, e.g. (29). This condition also appears to 
occur in muscle of wild-type mice (7), but may not necessarily be valid for  
M-CK/ScCKmit--/-- muscle.  
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Table 3.1: Average metabolite concentrations, ratios and tissue pH for adult mouse skeletal 
muscle. 
Notes: All the data (± SD) is obtained from measurements of animals between 60 to 200 days 
of age. Metabolite concentrations in mmol/ l tissue (left column for each mouse type) were 
converted to mmol / l intracellular water (right columns) assuming a fraction of 0.73 for 
intracellular water. [PCr] and [ATP]MRS were derived from the PCr/tCr and PCr/ATP ratios 
respectively.  
 * difference comparison between wt and M-CK/ScCKmit--/-- by unpaired t-test:  
two tailed p value < 0.0001. 
(1) tCr = phosphorylated + unphosphorylated creatine. Data from chemical and 1H MRS 
determinations have been taken together. n=24 for WT and 12 for 
 M-CK/ScCKmit--/--. 
(2) Data taken from (28) in µmol/g wet weight and converted to mmol/L intracellular water 
assuming a muscle density of 1.06 and an intracellular water fraction of 0.73. n=5 for 
WT and n=6 for M-CK/ScCKmit--/-- . 
(3) ADP is estimated as described in the text, using the [ATP]MRS values and assuming the 
CK reaction at equilibrium. This may not be valid for M-CK/ScCKmit--/-- 
(4) Ratios obtained from 31P MR spectra measured under relaxed spin conditions (TR > 20 
s) or corrected for spin saturation if obtained at a pulse repetition time of 7 s. n=9 for 
WT and M-CK/ScCKmit--/-- 
(5) Data from 13C MRS of the hind-limb, averaged from measurements obtained 1, 2 and 3 
weeks after the start of 13C-4 creatine administration for 4 WT and 4 M-CK/ScCKmit--/-- 
mice. n= 11 for each mouse species. 
(6) Determined from 31P MRS data. n=6 for WT and n=5 for M-CK/ScCKmit--/--. 
wt  M-CK/ScCKmit--/-- 
 mmol / l 
tissue 
mmol / l 
intracellular water
mmol / l 
tissue 
mmol / l 
intracellular water
[tCr] (1) 30.5 ± 2.0 41.8 ± 2.7 31.4 ± 2.8 43.0 ± 3.8 
[PCr] 22.5 ± 1.9 30.8 ± 2.6 17.6 ± 2.2 24.1 ± 3.0 
[ATP]MRS 7.8 ± 0.8 10.7 ± 1.1 7.5 ± 1.1 10.3 ± 1.5 
[ATP]chem* (2) 8.2 ± 0.8 11.2 ± 1.1 5.7 ±  0.6 7.8 ±  0.8 
[ADP] (3)  0.037  (0.083) 
PCr/ATP * (4)  2.90 ± 0.19  2.36 ± 0.21 
PCr/tCr * (5)  0.74 ± 0.04  0.56 ± 0.05 
pH (6)  7.22 ± 0.03  7.24 ± 0.04 
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Postmortem de-phosphorylation of phosphocreatine as a function of age 
Having demonstrated that Cr phosphorylation can occur in both developing and 
mature muscle of M-CK/ScCKmit--/-- mice at rest, we next investigated to what extent also 
the inverse reaction, i.e. de-phosphorylation of the PCr pool, could still ensue in these 
animals. We therefore quantified this activity as a function of age by measuring the rate of 
PCr signal decay in hind-limbs after a maximal physiological challenge, the onset of death in 
the MR magnet. Post-mortem PCr breakdown occurs at the same rate in 21 day and 12 month 
old wild-type mice (figure. 3.5). In contrast, M-CK/ScCKmit--/-- mice showed delayed 
depletion of PCr at the age of 21 days, while de-phosphorylation of PCr was further slowed 
down at 3, 9 and 12 months of age (figure 3.5). In these latter measurements, the PCr signal 
did not drop to zero, but reached a plateau at about 50% of the initial concentration, indicating 
that on the time scale of the experiment a significant portion of PCr had become metabolically 
inactive.  
 
 
 
Figure 3.5: Postmortem depletion of PCr in mouse skeletal muscle followed by 31P MRS.  
The animals were killed at t=0 as described in the text. Data point symbols for wild-type are  
■ : 21 days (n=2); ● : 12 months (n=3); and for CK--/-  : □ : 21 days (n= 3); ∇: 3 months 
(n=1); ∆: 9 months (n=2); ο: 12 months (n=1). In control mice at 21 days and 12 months of 
age the decay is the same. In M-CK/ScCKmit--/-- muscle, the ability to hydrolyze PCr 
decreases with age. In 21-day-old M-CK/ScCKmit--/-- mice, PCr gets completely depleted, 
but at 3 months or older, PCr appears to decrease only to 50% and at a lower rate. 
 
83 
CHAPTER 3 
DISCUSSION 
Differences in PCr, total Cr content and CK activity during development and at 
adulthood 
The increase of the CK activity and of the PCr/ATP ratio during postnatal 
development of skeletal muscle in wild-type mice confirms results of previous studies in 
rodents (e.g. (20, 25)). In the present study we also observed a postnatal increase for total 
muscle creatine (tCr) content in these mice, which in the first 4 weeks occurs in parallel with 
increasing CK activity and PCr/ATP ratios. In general for different tissues there appears to be 
a positive correlation between CK activity and Cr content (2). However, it is clear that this 
correlation does not hold strictly. An increasing tCr level paralleled a minor and steadily 
decreasing CK activity in the M-CK/ScCKmit--/-- mice, which declined to levels below  
1 mM/s. A decline of BB-CK activity has also been observed for the hearts of these mice 
(30). Interestingly, the PCr/ATP ratio in skeletal muscle of M-CK/ScCKmit--/-- mice 
increased in a very similar fashion to in wild-type mice during the first four weeks after birth, 
despite the fact that the total CK activity differed profoundly between mutants and controls. It 
appears that the initial increase in PCr levels relates to the postnatal increase in the tCr pool, 
which is largely identical in wild-type and M-CK/ScCKmit--/-- mice. While beyond 30 days 
of age the PCr/ATP ratio increased more slowly in wild-type or even decreased in M-
CK/ScCKmit--/-- mice, the increase of the muscle tCr content leveled off somewhat later. 
Resting PCr/ATP ratios are not only determined by the tCr level and CK activity (see below), 
but also by the intracellular energy charge and total adenylate levels which may change 
during the postnatal development of skeletal muscle, e.g. (31). The present study indicates 
that Cr uptake in skeletal muscle is independent from its phosphorylation by CK. This uptake 
is an active process, regulated by specific Na+/Cr co-transporters (2, 32), the activity of which 
is coupled to energy- and Na+-, K+- and Ca2+-homeostasis. Creatine transporter activity shows 
regional and developmental differences (33, 34), but it seems unaffected in CK lacking 
mutants. 
Once M-CK/ScCKmit--/-- mice become older than four weeks, they display lower 
PCr/ATP and PCr/tCr ratios than wild-type mice. To put this in the proper perspective we first 
consider how CK activity, the in vivo flux through the CK reaction and ATPase activity relate 
to each other. The maximum activity (Vmax) of CK from adult wild-type GPS muscle is about 
200 mM/s at 37 0C (see Fig 3B). This is in agreement with other studies on rodent (fast 
twitch) skeletal muscle, e.g. (20, 35, 36), but it is in contrast to the actual resting CK flux in 
vivo as derived from 31P MRS magnetization transfer in our earlier studies (7), which is 
approximately 8 mM/s and thus only about 5% of the in vitro values. Similar discrepancies 
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have been noted previously for skeletal muscle and are explained by specific kinetic behavior 
of CK enzymes under in vivo conditions (35, 37, 38). Still, these fluxes are well above 
maximum values of ATPase activity so that adequate backup during the early phase of muscle 
contraction is ensured. In the cytosolic M-CK single knock-out mice the in vitro CK activity 
at 37 0C drops to about 5 mM/s and the in vivo CK flux to below 0.4 mM/s (7, 36, 39, 40). 
These mice lack muscle burst activity as demonstrated by electrical stimulation at 5 Hz. As 
the rate of ATP breakdown may easily increase above 1 mM/s at such muscle activity 
(calculated from data in (41, 42)), the CK flux cannot follow ATP breakdown during the first 
10 s of contraction when ATP regeneration nearly completely relies on PCr (42). The 
concomitant ADP increase may explain why burst activity is lacking in the muscle of these 
mice (43). In muscle of adult M-CK/ScCKmit--/-- mice the in vitro CK activity is further 
reduced to less than 1 mM/s. These mice not only lack burst activity but in addition showed 
lower muscle force and slower relaxation compared to the single M-CK knock-out mice (8). 
If the in vivo activity is also only 5% of the in vitro value (i.e. ~ 0.02 mM/s) this comes close 
to ATPase flux rates as estimated for resting rat skeletal muscle, which are between about 
0.01 – 0.04 mM/s (35, 37, 41, 44). With similar ATPase fluxes occurring in resting  
M-CK/ScCKmit--/-- muscle the CK reaction might be out of equilibrium upon work 
transitions, which, at comparable total Cr and adenylate pools, would result in an altered 
PCr/ATP ratio. In addition this altered ratio could represent a situation in which the (entire) 
muscle pool of CK substrates no longer is in continuous open contact with the, now only 
sparsely present, CK molecules, for instance due to compartmentalization such as discussed 
for the presumed role of satellite cells below. If, on the other hand, the residual CK activity 
would still be sufficient to keep the overall CK reaction at or near equilibrium in the resting 
state, it follows that the concentration of ADP must differ between wild-type and mutant 
muscle as tissue pH, total creatine and ATP levels are similar. Under equilibrium conditions 
we estimate an increase of resting free ADP levels by a factor of about 2 in  
M-CK/ScCKmit--/-- muscle (see table 3.1). As resting PCr content may vary with fiber type 
(45), the different PCr levels might be related to an overall change in fiber type composition 
in the mutant mouse compared to control. Moreover, postnatal changes in CK activity appear 
to correlate with changes in myosin heavy chain phenotype (46). However, the myosin heavy 
chain distribution did not appear to differ much in skeletal muscle of M-CK/ScCKmit--/-- 
mice, although a shift towards a more oxidative character of mainly the type-II fast-twitch 
glycolytic muscles in M-CK/ScCKmit--/-- mice was identified (9, 10).  
 
85 
CHAPTER 3 
On the origin of the Cr (de)phosphorylation activity in mature muscle of  
M-CK/ScCKmit--/-- mice 
As the 13C MRS experiments showed that even in mature M-CK/ScCKmit--/-- muscle 
older than 3 months, Cr can be converted to PCr the question remains of what the origin of 
this catalytic activity is. It is conceivable that BB-CK activity arises from non-muscle cells, 
such as vascular endothelium, or that some unknown Cr phosphorylating activity is present in 
muscle cells. These possibilities seem rather unlikely, in particular as mice with combined 
deficiency of cytosolic BB-CK and mitochondrial ubiquitous CK (UbCKmit) isoforms 
completely lack PCr in the brain (47). This provides indirect evidence for the supposition that 
Cr ↔ PCr conversion in mammalian tissues becomes fully blocked if activity of all CK 
isoforms is completely ablated. 
If we assume that Na+/Cr co-transporters do not transport PCr, formed elsewhere and 
transported by circulation, into muscle directly, and that the negatively charged PCr (PCr2-) 
will not freely pass the sarcolemma against a concentration gradient, we can only explain our 
results by assuming that trace CK activity in adult CK double mutant muscles causes PCr to 
occur. Two possibilities remain for this residual CK activity. The first is that even in mature 
myotubes the expression of the B-CK gene, although decreasing with age, is still not 
completely blocked. Another interesting explanation for the build-up of a PCr pool in mature 
hind-limb muscle would be the deposition of BB-CK molecules from satellite cells in the 
process of fusion (48). Muscle satellite cells are prominently present and active in the 
growing muscles of young animals, but their population decreases with age (48). Satellite cell 
nuclei are 30% of the total muscle nuclei at birth, 4% at 8 months and 2.4% at 30 months of 
age in mouse soleus muscle. Moreover, at adult age when muscle growth has slowed down 
the remaining satellite cells become quiescent, only being re-activated when myofibers are 
over-challenged. Thus in the adult stage when little satellite fusion is occurring, a 
considerable fraction of myofibers may hardly have any BB-CK left. This view is 
corroborated by the post-mortem data of M-CK/ScCKmit--/-- muscle, which shows that at 
older age the rate of PCr de-phosphorylation is slower and that 50% of the total PCr pool size 
virtually is unaffected during the observation period. If a significant part of the total cellular 
Cr pool has no access to the enzyme, this would indeed explain the lower PCr/tCr ratio in 
adult mutants. In this context M-CK/ScCKmit--/-- mice could become a convenient model to 
study the role of satellite cells, using BB-CK and PCr as sensitive reporters for their fate 
under different physiological conditions.  
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Estimation of in vivo ATP content using 13C-4 PCr/tCr ratios 
From the experiments with 13C labeled creatine the in vivo PCr/tCr ratio was derived 
for skeletal muscle. Because we also have total Cr levels and PCr/ATP ratios available this 
gives the opportunity to estimate in vivo ATP levels in a novel manner. The tissue 
concentration derived in this way (~ 8 mmol/l tissue) is on the order of ATP values for (fast 
twitch) skeletal muscle that have been reported by others, e.g. (44, 45, 49) and conforms with 
ATP tissue concentrations determined by chemical means in wild-type mouse skeletal muscle 
(7, 28). Moreover, in this way we demonstrate that ATP levels in wild-type and  
M-CK/ScCKmit--/-- muscle are similar, and that differences seen previously in chemical 
analysis (8, 28) can be explained by rapid breakdown of ATP during the clamping procedure 
for the extraction (44), which cannot be compensated in M-CK/ScCKmit--/-- muscle, because 
it has a very inefficient CK reaction. In contrast in wild-type muscle PCr is more depleted 
during this procedure, thus sustaining ATP levels, which is reflected in a slightly lower 
PCr/ATP ratio when determined by chemical means (8).  
 
The MR visibility of creatine 
The present results also bear on the issue of MR visibility of the cellular Cr pool, and 
the presumed existence of significant free Cr pools that do not participate in the CK reaction. 
Based on experiments using 14C-labeled Cr in heart muscle (50, 51) and in fast-twitch muscle 
of fish (52) it has been proposed that a significant fraction of Cr (about 30%) is not 
immediately available for the CK reaction in these tissues. MR magnetization transfer 
experiments on skeletal muscle indeed revealed a pool of Cr that may be bound to matrix or 
cellular macromolecules, but this pool is in exchange with “mobile”, MRS visible creatine 
and comprises only about 2% of total creatine (53, 54). The observation in human skeletal 
muscle that the methylene peak of Cr in 1H MR spectra disappears during exercise (55) 
further stimulated the discussion that a significant immobile Cr pool may exist, which is not 
readily accessible to creatine kinase. In another study a decrease in T2 relaxation time of 
creatine methyl proton spins was observed during ischemic fatigue in humans (56), 
suggesting reduced mobility of creatine. In contrast, 1H MRS investigations of mouse skeletal 
muscle indicated that changes in Cr signals, observed immediately after death of the animal, 
mainly result from altered dipolar interactions related to removal of the phosphate moiety of 
this compound and not from changes in its cyto-architectural environment (18). After 
eliminating the spectral appearance of these interactions by orienting the fiber direction of the 
muscle at 55° with the main magnetic field (magic angle), the Cr signal did not change in the 
early postmortem phase. Interestingly, a recent study indicated that the electric charge of 
small molecules and proteins affects dipolar coupling interactions in skeletal muscle (57). 
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Our quantification of total Cr content in adult mouse skeletal muscle, by 1H MRS of 
muscles placed at the magic angle to avoid complications by dipolar interactions (27), yielded 
similar values to those obtained by chemical means. In the GPS complex of animals at an age 
from 2 to about 6 months the intracellular total creatine concentrations were about 40 mM. 
This is close to the values published for type 2a/b muscles in mouse and rat (45), which is 
what can be expected as the gastrocnemius muscle is dominating in this complex. Altogether 
these results do not point to a significant MR invisible Cr pool (i.e. more than the error of the 
measurements, which is less than 10%) in mouse skeletal muscle as was already concluded 
for PCr in these muscles (58). Further support for ‘full MR visibility’ of the total Cr pool 
comes from the observation that PCr/tCr ratios determined by 13C MRS resemble the 
chemically determined values. Ischemia experiments indicate that the MR visible PCr and 
free Cr pools are in direct contact with each other in wild-type mouse skeletal muscle. Finally, 
the similarity of creatine levels in wild-type and mutant muscles as detected by 1H MRS 
indicates that the mere presence of CK itself does not affect the MR visibility at rest of the Cr 
pool and hence its mobility. 
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CHAPTER 4 
ABSTRACT 
Creatine kinases (CK) and adenylate kinases (AK) are high-energy phosphoryl (~P) 
transfer enzymes with a complementary role in the homeostasis and compartmentalization of 
cellular energetics in tissues like muscle and brain. Here we report on the use of 31P MRS at  
7 T to study energy-metabolite behavior in hind-leg muscles of mice lacking both cytosolic 
creatine kinase (M-CK) and Adenylate Kinase (AK1) (MAK--/--) before, during and after an 
ischemic challenge. Data of similar MR experiments in M-CK and AK1 single knockout mice 
were reevaluated and compared to MAK--/-- mice. 
During the ischemic period, both inorganic phosphate (Pi) accumulation and 
phosphocreatine (PCr) depletion in MAK--/-- were faster than in wild-type mice, but total 
[PCr + Pi] remained constant in both types of animals. After ischemia, MAK--/-- mice had a 
significant slower recovery of PCr and Pi than wild-type mice, reflecting a severely 
compromised phosphoryl transfer efficiency. Although basal tissue pH levels were similar, 
upon ischemia pH started to decline immediately in MAK--/-- mice while in wt mice basal 
tissue pH was initially maintained. Therefore, MAK--/-- mice had a lower intracellular pH 
during most of the ischemic period, suggesting earlier turn-on of glycolysis. As ATP levels 
appeared similar and were essentially homeostatic in both types of animals, our results 
suggest that the communication between supply-demand pathways for ~P metabolites, 
reflected by the pool-dynamics thereof, is deviant in MAK--/-- mice.  
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INTRODUCTION 
The enzymes creatine kinase (CK) and adenylate kinase (AK) play important roles in 
tissues with high energy demand by providing an efficient network for high-energy 
phosphoryl (~P) transfer between sites of energy production and consumption (1-5).  
By catalyzing the reaction creatine (Cr) + ATP ↔ phosphocreatine (PCr) + ADP + H+, 
CKs are generally thought to act as a spatial and temporal energy buffer, and as regulator of 
tissue pH (1, 5). Several CK isoforms are tissue specifically expressed and located in distinct 
cellular compartments. In muscle, two major isoforms of CK are present, namely as dimeric 
MM-CK in the cytosol (representing approximately 85%-95% of total CK activity) and 
octameric ScCKmit in the space between the inner and outer membranes of mitochondria 
(representing the remaining 15-5% of CK activity) (5).  
Besides CK, AK also contributes to the energy homeostasis by catalyzing the reaction 
2 ADP ↔ ATP + AMP (6). In skeletal muscle, AK1 is the major isoform representing 
approximately 99% of all AK activity (7) and is present as a soluble molecule in the cytosol 
or as splice variant (designated AK1β) bound to the cell membrane (8, 9). The only other AK 
isoform available in skeletal muscle is AK3. It is present at low activity and is in fact an 
enzyme which uses GTP and AMP as substrates (7). It has been shown in cardiac muscle that 
AK phosphotransfer is involved in regulating the response of KATP channels to metabolic 
changes (10). A more general function of AK may be to increase the efficiency of ATP 
turnover by releasing the energy that is stored in β-phosphoryls (11). 
Our group has generated knockout mice lacking M-CK (M-CK-/- mice) (2), ScCKmit 
(ScCKmit-/- mice) (12) or both CK isoforms (M-CK/ScCKmit--/-- mice) (13) as well as AK1 
deficient mice (AK-/- mice) (3) to study the significance of these individual enzymes in 
cellular energetics. In one series of biochemical and cell biological studies (2, 3, 12, 13) we 
have monitored the role of the enzymes under conditions of rest and contractile force 
production in skeletal muscles. In an independent approach we have applied in vivo 31P MR 
spectroscopy (MRS) to investigate the specific coupling of phosphotransfer reactions to 
ischemic stress conditions in hind-leg muscle. The focus of these studies was on the 
monitoring of effects of CK or AK absence on the levels of PCr, inorganic phosphate (Pi), 
phosphomonoesters (PME) and ATP, and on tissue pH (3, 14, 15).  
Our studies (3, 16, 17) and studies of others (18-23) point to a model for muscle in 
which the proper maintenance of ADP/ATP ratios and transport of ~P is safeguarded by 
concerted action of the CK and AK circuits and enzymes in the glycolytic pathway, with 
partial redundant functions of the separate enzymes. Thus a flexible network is created which 
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provides plasticity and enables muscle to dynamically respond to sudden and highly 
fluctuating metabolic challenges. 
In the current paper we present new data on the effects of ischemia in muscles with 
combined deficiencies of the cytosolic M-CK and AK1 (MAK--/-- mice). Skeletal muscles of 
MAK--/-- mice (24) have only about 8% of the CK activity remaining (attributable to 
ScCKmit activity in mitochondria), whilst β-ATP turnover due to AK has decreased by 85% 
(remaining activity is due to combined activities of AK3 and nucleoside diphosphokinases) 
(24). Based on these observations, phosphotransfer in MAK--/-- muscle was expected to rely 
heavily on glycolytic activity. We demonstrate here that this led to a situation in which 
recovery of PCr and Pi levels upon termination of ischemic stress was dramatically delayed, a 
phenomenon that was never observed in single mutant M-CK-/- or AK-/- mice.  
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MATERIALS AND METHODS 
Animals 
MAK--/-- mice were compared to wild-type (wt) animals of the same mixed genetic 
background (50% C57BL/6 and 50% 129 Ola) and age (3-4 months). All animals were 
anesthetized using 1-2 % isoflurane in a gas mixture of 50% O2 and 50% N2O delivered 
through a facemask, while the breathing frequency was monitored. Rectal temperature was 
monitored during the experiments using a fluoroptic thermometer (Luxtron 712, Santa Clara, 
California, USA) and maintained at 36.8±0.5 °C using a warm water circuit. Experiments 
were in accordance with rules of the local animal ethics committee. 
 
MR equipment and methods 
The experiments were performed on a horizontal 7.0 T magnet (Magnex Scientific, 
Abingdon, England) with a free bore size of 120 mm. The MR probe consisted of two coils: a 
1H Alderman-Grant type of coil (25) for shimming and a 3-turn 9 mm solenoid coil for 31P 
acquisition which were interfaced to a S.M.I.S spectrometer (Surrey Medical Systems, 
Guildford, England) operating at 300 MHz for 1H and at 122 MHz for 31P. All 31P MR spectra 
were obtained using a pulse-acquire sequence. As the gastrocnemius has the largest volume of 
the mouse hind-leg calf muscles, this muscle contributed most to the signal intensity in 31P 
MR spectra. 
Firstly, to get an overview of basal metabolite ratios and tissue pH, 31P MR spectra 
were obtained with low temporal resolution but with a good signal-to-noise ratio (SNR) from 
six MAK--/- and six wt mice during resting conditions (TR=7 s, 128 averages). Furthermore, 
fully relaxed spectra (TR=25 s, 64 averages) and spectra with the same repetition time as 
during ischemia (TR=1400 ms, 512 averages) were acquired in six wt animals to correct PCr 
and Pi metabolite ratios for T1 saturation. Since it is unlikely that T1 values of PCr and Pi will 
be different in MAK--/-- mice compared to wt animals, the T1 correction factors derived in 
this way were applied to both wt and knock-out animals. 
Ischemic occlusion of skeletal muscle was applied in a separate group of eight  
MAK--/-- and eight wt mice by clamping with a diaphragm plate, which allowed reversible 
and reproducible obstruction of blood flow through the hind limb (26, 27). Spectra were 
obtained with high temporal resolution (106 s) using a pulse-acquire sequence (TR=1400ms, 
76 averages). After four reference spectra were acquired, an ischemic period of 25 minutes 
was applied (14 spectra), succeeded by a recovery period of 16 minutes (9 spectra). 
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Data processing 
Data was processed in the time domain using the AMARES method from the MRUI 
software package (28). When processing the basal spectra, no prior knowledge was used. 
Signal intensities were fitted assuming Lorentzian lineshape functions and are presented as 
ratio to the fit of the β-ATP signal. 
For the spectra acquired during the ischemia protocol, Pi and PME were constrained 
during the fit by setting the linewidths of these signals 1.5 times to the linewidth of PCr, 
which was determined empirically from spectra during ischemia which have higher Pi and 
PME signal intensities. The individual fitted signals and residues were evaluated and 
metabolite values from obvious wrong fits (i.e. when the signal could not be fitted or was 
fitted at a wrong frequency), especially from low SNR signals like PME and sometimes Pi, 
were discarded. All metabolite signals measured were normalized per mouse to the mean 
value of the four β-ATP signal integrals measured before applying the ischemic clamp in the 
same mouse (β-ATP0).  
Although our ischemia protocol was designed to induce ischemia without moving the 
hind leg by clamping with a diaphragm plate, small changes in position of the hind leg did 
lead to small alterations in line shape. This, in turn, could lead to errors in the quantification. 
Therefore, changes in lineshape during ischemia were corrected for by using the assumption 
that the total ATP signal during the first 3.5 min. of ischemia did not change from resting 
values.  
In all experiments the tissue pH was calculated from the shift in resonance position (S) 
of the Pi signal compared to the resonance position of PCr (29) using the equation pH=6.75 + 
log((3.27-S)/(S-5.63)). ADP levels were calculated assuming that the CK reaction was at 
equilibrium, with a equilibrium constant of K=1.66⋅109 (30). Previously, tissue ATP values in 
hind-leg skeletal muscle of this wt mouse strain were calculated from in vivo MRS data to be 
7.8 ± 0.08 mM (27), and MAK--/-- mice were assumed to have equal in vivo ATP levels. 
Furthermore, a fraction of 0.73 for intracellular water was assumed to calculate intracellular 
ATP (31, 32). Cr levels, also necessary for the calculation of ADP concentrations, were 
derived from the PCr/ATP levels and the measurement that during resting conditions 74±4 % 
of the total Cr pool is phosphorylated in these wt mice (27). During the ischemia protocol, 
however, the percentage of the phosphorylated Cr pool changes. Therefore, the concentration 
of the total Cr pool (41.8 ± 2.7 mmol per l intracellular water) was used to calculate ADP 
levels in these experiments (27). 
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Analysis of time constants 
A monoexponential function was fitted (15, 33) to the recovery profile of PCr and Pi 
using a non-linear least square method with a Levenberg-Marquardt algorithm (GraphPad 
Prism, San Diego CA, USA). This fit yielded a time constant for signal recovery (τ) for PCr 
(τPCr ) and Pi (τPi ). No constraints were applied other than fixing the begin time of the 
exponential to the start point of recovery. 
 
Reevaluation of M-CK-/- and AK-/- data 
To provide a complete overview of the implications of knocking out M-CK, AK or 
both, data of M-CK -/- (n=6) (15) and AK-/- (n=9) (3) mice, together with wt animals for both 
knockouts (n=6 and n=10 for comparison with M-CK-/- and AK-/-, respectively) were 
reevaluated in light of the current results. Several additional plots were generated, including 
Pi/ATP0 and (PCr + Pi)/ ATP0 in AK-/- mice and Pi/PCr in both M-CK-/- and AK-/- mice. 
Furthermore, τPi and τPCr were calculated in AK-/- mice and recalculated in M-CK-/- mice 
using identical algorithms as in AK-/- and MAK--/-- mice. Because the M-CK-/- mice were 
measured on a MR scanner with a vertical bore magnet and different occlusion system than 
the AK-/- and MAK--/-- mice, time constants of recovery are not compared quantitatively 
between different knockouts. Instead, every knockout is compared to the wt group measured 
in the same study. 
Although temporal resolution in the ischemic experiments of M-CK-/- mice was 
somewhat lower, the ischemic period and the observation period for recovery are of equal 
length in all three experiments (25 min and 16 min, respectively). For easy comparison, t=0 is 
set at the start of ischemia in all time curves at the same vertical position.  
 
Statistics 
A student t-test was used to test differences in metabolite levels between wt and 
MAK--/-- mice for significance before ischemia or at specific time points. Differences in τ 
between wt and knockout mice, but also between the different wt mice used as control for the 
M-CK-/-, AK-/- and MAK--/-- mice, were tested for significance using an F-test (GraphPad 
Prism, San Diego CA, USA). Differences were considered significant when p<0.05. Data is 
presented as mean ± SEM unless stated otherwise. 
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RESULTS  
MAK--/-- and wt mice at resting conditions 
Basal 31P MR spectra of mouse hind-leg muscle at resting conditions (as given for 
MAK--/-- muscle in Figure 1a) showed resonances for PCr, Pi and three resonances for the 
three phosphate groups of ATP. In some cases a signal of very low intensity for PME could 
be distinguished in the reference spectra.  
 
d 
c 
b 
a 
Figure 4.1: representative spectra of MAK-/- hind-leg muscle before (a), during (at 10 min. 
(b) and 25 min. (c)) and at 15 min. after (d) the period of ischemia. 
At a repetition time of 25 seconds, 31P MR spectra were assumed to be fully relaxed at 
7 T. Measurement of the same wt mouse at resting conditions with TR of 1400 ms, 7 s and  
25 s enabled the estimation of T1 saturation factors necessary to correct for partial saturation 
at TR of 1400 ms and 7s. T1 correction factors for PCr/ATP are 1.8 ± 0.1 and 1.09 ± 0.07, and 
for Pi/ATP are 2.3 ± 0.7 and 1.6 ± 0.7 for TR=1400 ms and TR=7 s, respectively.  
The ratio of the PCr and Pi signal to the β-ATP signal, and the Pi / PCr ratio itself, 
appeared to be similar in MAK--/-- and wt mice since t-tests showed no significant 
differences (table 4.1). Also no significant differences could be determined in tissue pH, or 
the ADP concentration (calculated from the CK equilibrium reaction; table 4.1) between these 
mice.  
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Table 4.1: Ratios of integral values of phosphorous metabolite signals. 
 PCr/ATP a Pi/ATP a Pi/PCr a ADP (mmol/l) b pH 
wt 2.9 ± 0.4 0.48 ± 0.11 0.16 ± 0.02 0.040 ± 0.003 7.24 ± 0.04 
MAK--/-- 3.0 ± 0.3 0.50 ± 0.12 0.17 ± 0.04 0.040 ± 0.003 7.24 ± 0.04 
All values are presented as mean ± s.d. 
a T1 corrected values acquired at a repetition time of 7 s. 
b ADP value is expressed as mmol/(l intracellular water), and calculated using the 
equilibrium CK reaction (see materials and methods for details). 
Ischemia of hind-leg muscle 
During ischemia, we observed a pronounced decrease for both mice in the signal of 
PCr. Concomitantly, the signal of Pi increased and shifted slightly towards the PCr signal due 
to a lower pH (figure 4.1). PME levels also increased during the ischemic period, however, 
the SNR remained low in MAK--/-- and wt animals. After the challenge, the signal intensities 
returned to their original values (figure 4.1d). 
Fitting of the PCr and Pi signals at various time points before, during and after 
ischemia revealed remarkable differences between MAK--/-- and wt mice (figures 4.2, 4.3) in 
comparison to previously reported findings in M-CK-/- and AK-/- single knockout mice. 
Towards the end of the ischemic period, PCr levels were significantly lower in MAK--/-- 
mice than in wt animals. Pi levels showed the opposite tendency (figure 4.3c). Differences 
between MAK--/-- and wt animals became even more apparent when looking at the ratio of Pi 
/ PCr (figure 4.4), which is a measure for the energetic status of the muscular tissue (34, 35). 
During the ischemic period, Pi / PCr ratios increased rapidly in MAK--/-- mice and much 
more slowly in wt animals (figure 4.4c) while the total PCr and Pi pool remained constant 
(figure 4.5).  
In wt animals, tissue pH first stayed at basal levels during the first 10 minutes of the 
ischemic interval (figure 4.6c), but declined at a constant rate during the entire period 
thereafter. In MAK--/-- mice, tissue pH started to decline earlier, however, pH subsequently 
decreased during the ischemic period with a slope similar to that in wild-types. This created a 
situation in which, from a fixed time point in the ischemic period onwards (approximately at  
t = 5 min and beyond), tissue pH became significantly lower in MAK--/-- mice (figure 4.6). 
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Figure 4.2: time plots of PCr signal
intensities normalized to the β-ATP signal
before, during and after ischemia in the
hind leg of M-CK-/- (a), AK-/- (b) and
MAK--/-- (c) mice and their wt controls.
Knock-outs are presented by grey dots, wt
mice are presented by black squares. 
Figure 4.3: time plots of Pi signal
intensities normalized to the β-ATP signal
before, during and after ischemia in the
hind leg of M-CK-/- (a), AK-/- (b) and
MAK--/-- (c) mice and their wt controls (for
annotations see figure 4.2). 
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Figure 4.4: time plots of Pi/PCr before,
during and after ischemia in the hind leg
of M-CK-/- (a), AK-/- (b) and MAK--/-- (c) 
mice and their wt controls (for annotations
see figure 4.2). 
. 
 
Figure 4.5: time plots of PCr +Pi intensities 
normalized to the β-ATP signal before, 
during and after ischemia in the hind leg 
of M-CK-/- (a), AK-/- (b) and MAK--/-- (c) 
mice and their wt controls (for annotations 
see figure 4.2). 
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ADP concentrations were calculated from the CK reaction (assuming this reaction to 
be at equilibrium) and, just as PME levels, did not show differences between wt and  
MAK--/-- mice before, during or after ischemia (data not shown). At the end of the ischemic 
period ADP increased to 0.13 ± 0.05 mmol/(l intracellular water) and 0.15 ± 0.03 mmol /  
(l intracellular water) for wt and MAK--/-- mice, respectively. Finally, ATP levels remained, 
as expected, constant in both wt and MAK--/-- mice during ischemia (data not shown).  
 
Recovery of ischemia 
When releasing the ischemic clamp, a pronounced and significantly slower recovery of 
the PCr pool was observed in MAK--/-- mice (figure 4.2c), with time constants of recovery of 
2.7 ± 0.4 min and 4.5 ± 0.7 min in wt and MAK--/-- mice, respectively (table 4.2). The 
recovery of the Pi signal was also significantly slower in MAK--/-- mice (3.2 ± 0.5 min) 
compared to wt mice (1.9 ± 0.2 min). These results are in contrast to PCr and Pi recovery in 
M-CK-/- and AK-/- mice, which show no differences in recovery of PCr with respect to their 
wt controls (Figures 4.2a,b 4.3a,b). Recovery of the Pi / PCr ratios was, like recovery of the Pi 
and PCr levels, slower in MAK--/-- mice. In both M-CK-/- and AK-/- single knockout mice, 
the Pi / PCr ratio was similar to that in wt animals before and during the ischemic period and 
during the recovery thereafter.  
 
Table 4.2: time constants for signal recovery (τ) after ischemia of PCr/ATP0 and Pi/ATP0 
(min). 
Recovery rates are presented as fitted value ± SEM.  
M-CK-/-: mouse lacking cytosolic M-CK; AK-/-: mice lacking AK1 ; MAK--/--: mice lacking 
both M-CK and AK1; wt: wild type animals. 
Note: every knockout mouse has to be compared to wt controls measured in the same 
experiment (see text for details). 
* significantly different (p <0.02) from wt animals. 
** significantly different (p <0.01) from wt animals. 
wt M-CK-/- wt AK-/- wt MAK--/-- 
τPCr 5.3 ± 0.8 5.8 ± 1.7 2.8 ± 0.3 2.3 ± 0.4 2.7 ± 0.4 4.6 ± 0.7 * 
τPi 3.7 ± 0.7 3.4 ± 1.1 2.4 ± 0.5 2.9 ± 1.0 1.9 ± 0.2 3.2 ± 0.5 **
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a 
b 
c 
 
Figure 4.6: profiles of changes in tissue pH before, during and after ischemia in M-CK-/- (a), 
AK-/- (b) and MAK--/-- (c) mice and their wt controls (for annotations see figure 4.2). 
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DISCUSSION  
In the present study we showed that knocking out both cytosolic CK and AK1 
enzymes does not have any influence on the resting levels of high-energy phosphoryl ratios in 
skeletal muscle. Nevertheless, it had a profound effect on the rate of recovery of high-energy 
phosphoryl levels after an ischemic challenge, something that was not observed before in 
MRS studies of single M-CK and AK1 knockout mice. Therefore, the current results confirm 
earlier findings from ex vivo and in vitro studies suggesting that CK and AK can work in 
concert, fulfilling partially redundant overlapping functions in the communication between ~P 
pools.  
 
Muscles of MAK--/-- mice appear normal under resting conditions in vivo 
Our in vivo data presented here are in good agreement with biochemical 
measurements reported elsewhere (24), and showed that hind-leg muscles which lack two of 
the major enzymes involved in balancing high-energy phosphates have fully normal 
phosphate-metabolite ratios (PCr/ATP and Pi/ATP) and intracellular tissue pH when kept 
under conditions where blood circulation is normal and muscle activity is low. Although MR 
spectroscopy does not provide an absolute quantification of the level of ATP, our current 
findings provide strong evidence for global ATP levels being entirely normal in MAK--/-- 
muscle, because Pi/PCr ratios in MAK--/-- and wt mice were also identical.  
 
Metabolic stress by means of ischemia 
Since, during resting conditions, no overt differences were revealed between MR 
spectra of MAK--/-- and wild-type muscles we challenged the phosphotransfer circuit in these 
muscles by means of reversible ischemia of the whole hind-leg. To understand the effect of 
such a challenge on phosphorous metabolites in time, it is important to distinguish two 
distinct phases in the protocol. One phase starts immediately after muscle clamping and 
involves the relatively slow progression towards complete ischemia. Oxygen in the muscles 
rapidly decreases (36) but also entrance of nutrients into the muscle and drainage of waste 
products are blocked. The other relevant phase is that of recovery after the ischemic period 
(see below). Because an ischemia-reperfusion protocol is physiologically different from a 
protocol in which muscles are stimulated to contract, like used in the study of Janssen et al. 
(24), it is difficult to compare our results directly to these previous findings. However, direct 
comparison to other MRS studies on ischemia in M-CK-/- and AK-/- single knockout mice (3, 
15) is possible.  
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Here we observed that the PCr signal dropped to significantly lower values in  
MAK--/-- mice than in wt animals during the ischemic period. Studies of M-CK -/- mice 
already had indicated that in muscle with only ScCKmit the PCr energy buffer can still be 
fully utilized (15). Although knocking out AK itself did not have any effect on the rate of PCr 
depletion during ischemic stress ((3) and figure 4.2), it has an effect if tested in combination 
with M-CK deficiency. This is demonstrated by the higher rate of Pi formation and the 
reciprocal increase in PCr utilization, with unaltered values for the [PCr + Pi] pool (figure 
4.5). Imbalance in ATP levels could theoretically underlie our results as both PCr and Pi 
levels (figures 4.2,4.3) are normalized to ATP. Direct comparison of ATP signal intensities, 
however, showed that ATP values remained essentially constant, whereas the Pi/PCr ratio 
showed significant elevation during the experiment (figure 4.5). This strongly suggests that 
the enhanced rates of [Pi] and [PCr] changes are genuine. The increase in Pi accumulation in 
MAK--/-- mice during the ischemic interval can therefore be best explained by a balanced 
PCr breakdown. Additionally, we cannot rule out differences in mitochondrial and cytosolic 
poolsizes, or differences in coupling between glycolytic and mitochondrial activity, between 
MAK--/-- and wt animals. The fact that ADP levels seem to be homeostatic can be explained 
by a higher glycolytic rate in MAK--/-- animals. 
 
Compromised recovery from ischemic stress in MAK--/-- mice  
Recovery is a relatively fast process compared to events during the phase of ischemia. 
Restoration of blood circulation causes myoglobin saturation to reach pre-ischemia levels 
almost instantaneously (36). PCr recovers quickly, due to mitochondrial ATP production, 
which also contributes to normalizing pH and Pi levels.  
Still, the recovery of PCr and Pi after ischemia was much slower in MAK--/-- mice 
than in single knockout M-CK-/- and AK-/- mice. Both MAK--/-- and M-CK-/- mice fully 
rely for their PCr recovery on the mitochondrial isoform of CK, with a remaining CK activity 
which is low in muscles of both mice (in the order of 2-8% (24, 37)). Thus, the relative slower 
recovery in MAK--/-- mice must be due to an indirect effect of AK1 deficiency on the 
activation of flux through the mitochondrial CK-PCr circuit. The recovery of PCr levels after 
exercise is assumed to be a measure of mitochondrial capacity in skeletal muscle (e.g. Kemp 
et al. (38)). If we may compare effects of ischemia and exercise, these results would imply a 
decreased mitochondrial capacity in MAK--/-- mice. This is in contrast to reported findings in 
isolated skeletal muscle, which suggest the opposite, namely an up-regulation of this capacity 
in MAK--/-- muscles (24) (corroborated by an increase in mitochondrial volume; data not 
shown). An alternative explanation would be that the PCr output by ScCKmit activity 
necessary for reactivation is firstly and primarily directed towards protection of 
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compartmentalized homeostasis of ATP and reactivation of primary mitochondrial functions. 
This, or mitochondrial coupling, may differ in MAK--/-- animals. Therefore, the kinetic and 
qualitative aspects of these reactions would overrule effects of mitochondrial capacity on PCr 
replenishment and would therefore take longer in muscles with the most profoundly 
compromised local ATP/ADP ratios and/or ~P pool distributions, i.e. in MAK--/-- muscles 
which have undergone the most extensive cytoarchitectural adaptations. Although global 
ADP ratios calculated from the CK equilibrium reaction were not different between MAK--/-- 
and wt mice (table 2), local changes in ATP/ADP ratios or cellular ATP gradients across the 
cytosol may go unnoticed in MR spectroscopy. It is therefore very well possible that reaction 
pathway preferences may become only visible as a delayed response in PCr and Pi signal 
recovery upon the sudden release of the ischemic clamp, associated with fast changes in 
oxygen and metabolite supply. Also other explanations are possible. Other factors, like the 
deviant pH at the end of the ischemic period (see below), may also have influenced the 
recovery rate (39, 40). In our previous studies we did, however, not observe similar effects in 
AK-/- mice, which also show a lower pH compared to wt animals at the end of the ischemic 
period. Combined, our previous and present results demonstrate that AK presence affects the 
mitochondrial ScCKmit mediated Cr ↔ PCr reaction and helps in preserving normal ~P 
levels after an metabolic challenge.  
 
The role of AK in maintaining tissue pH 
No differences in basal tissue pH were observed between MAK--/-- and wt mice. This 
is in agreement with the fact that basal lactate concentrations were the same in MAK--/-- mice 
and wt (24), although this does not necessarily imply a similarity in glycolytic flux (41). After 
the onset of ischemia, pH started declining due to an increase in net proton production. This 
acidification started earlier in MAK--/-- than in wt mice, but thereafter occurred at similar rate 
in both animals. Changes in pH can be attributed to anaerobic glycolysis and/or ATPase 
activity, or to PCr hydrolysis, main reactions which produce or consume protons, respectively 
(41, 42). There is no a-priori reason why ATPase activity would differ between wt and  
MAK--/-- mice. We therefore assume that effects of anaerobic glycolysis will become 
dominant and explain the larger decrease in tissue pH during the period of full ischemia. Once 
ischemia is complete, the magnitude of H+- production is most likely solely driven by energy 
demand, explaining why the rate of acidification has similar characteristics in wt and 
knockout muscle, despite the possible differences in glycolytic capacity between MAK--/-- 
and wt muscles (24). Feedback inhibition of [H+] on glycolysis could also result in a similar 
tissue pH course during ischemia, only with a time delay (43).  
 108
IMPAIRED RECOVERY OF STRESS IN M-CK/AK DOUBLE KNOCKOUT MICE 
Study of exercise as a metabolic challenge demonstrated that changes in pH level and 
shifts in glycolytic flux need not always be exactly synchronized, due to interfering effects of 
switches between aerobic-anaerobic glycolysis, and the CK-PCr reaction proper (42). 
Differential initial use of the CK reaction and/or shifts in the flux ratio through CK and 
glycolytic pathways, may therefore explain the earlier onset of acidification in MAK--/-- 
muscle.  
 
In summary, in previous studies we have shown that metabolic and cytoarchitectural 
adaptations, including changes in mitochondrial volume, have a role in masking the effects of 
mutation in AK1 and M-CK mutant mice. Although M-CK-/-, AK1-/- and MAK--/-- mice 
each have a distinctly altered glycolytic and mitochondrial capacity, a systematic comparison 
of how mutation type correlates with the nature and extend of individual macromolecular 
changes has not been done. We conclude here, from the differential metabolic responses 
during the onset of ischemia and the phase of recovery, that also the distribution of 
phoshometabolites ATP, PCr and Pi over subcellular pools and the communication between 
cytosolic and mitochondrial reactions must be distinctly correlated with genotype. Explaining 
how adaptational changes in the “macromolecular world” (i.e. the proteome) and the 
“micromolecular world” (i.e. the metabolome) are reciprocally connected is a challenge for 
future research.  
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CHAPTER 5 
ABSTRACT 
Creatine kinase (CK) catalyzed ATP - phosphocreatine (PCr) exchange is considered 
to play a key role in energy homeostasis of the brain. This study assessed the metabolic and 
anatomical consequences of partial or complete depletion of this system in transgenic mice 
without cytosolic B-CK (B-CK-/-), mitochondrial ubiquitous CK (UbCKmit-/-), or both 
isoenzymes (B-CK/UbCKmit--/--), using non-invasive quantitative magnetic resonance (MR) 
imaging and spectroscopy.  
MR imaging revealed an increase in ventricle size in a subset of B-CK-/- mice, but not 
in animals with UbCKmit or compound CK mutations. Mice lacking single CK isoenzymes 
had normal levels of high-energy metabolites and tissue pH. In the brains of CK double 
knockouts pH and ATP and Pi levels were also normal, even though PCr had become 
completely undetectable. Moreover, a 20 – 30% decrease was observed in the level of total 
creatine and a similar increase in the level of neuronal N-acetyl-aspartate compounds. 
Although CKs themselves are not evenly distributed throughout the CNS, these alterations 
were uniform and concordant across different brain regions. Changes in myo-inositol and 
glutamate peaks did appear mutation-type and brain area specific. Our results challenge 
current models for the biological significance of the PCr/CK energy system and suggest a 
multifaceted role for creatine in the brain.  
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INTRODUCTION 
Creatine kinases (CKs; EC 2.7.3.2) form a set of isoenzymes which catalyze the 
reaction: Creatine (Cr) + MgATP2- ↔ phosphocreatine (PCr2-) + MgADP- + H+. CKs are 
considered to play a key role in the energy homeostasis of muscle and brain cells, by keeping 
ATP/ADP ratios at distinct subcellular locations functionally balanced. In mammals the 
isoforms of CK are distributed in a tissue dependent manner and located in different cellular 
compartments (1, 2). The cytosolic isoforms brain CK (B-CK) and muscle CK (M-CK) are 
enzymatically active as BB-CK and MM-CK homodimers or as BM-CK heterodimers. The 
ubiquitous (Ub) and sarcomeric (Sc) isoforms act as dimers or octamers and are located in the 
intermembrane space of mitochondria.  
Brain tissue, despite its complex structure and cellular heterogeneity, contains mostly 
only B-CK and UbCKmit isoforms. These CK-family members are, however, not uniformly 
co-distributed: B-CK is present in white and gray matter, while UbCKmit is mainly found in 
gray matter, at the sites of highest mitochondrial density (3). B-CK appears to be more 
abundant in astrocytes and oligodendrocytes than in neurons and is highest in the cerebellum 
(4, 5), while UbCKmit expression is predominantly confined to the cell soma of a subset of 
neurons in the cortex and hippocampus (6, 7). The expression of both CK family members is 
regulated in accordance with functional specialization in development, hormonal status, and 
energy demand.  
Knowledge on the functional significance of the CK/PCr system in brain is lagging 
behind that in muscle not only because approaching the CNS in vivo is technically more 
demanding but also due to our limited knowledge of the effects of the blood-brain barrier and 
the extent of energy compartmentalization, such as in organellar networks in cell bodies or in 
axonal-denditric projections. For example, feeding b-guanidinopropionic acid to mice, a 
competitive inhibitor of creatine transport and a poor substrate for CK, results in a complete 
replacement of PCr by phosphorylated β-guanidinopropionic acid in muscle (8), but gives 
only partial replacement in brain (9). Unlike in muscle, severe challenges of the brain energy 
system did not result in total depletion of PCr, pointing to the existence of different pools of 
PCr in brain (e.g. (9)).  
Although the Cr-PCr/CK system is commonly seen as an integral part of the energy 
network in brain, it remains unclear what fractions of oxidative and glycolytic derived ATP 
actually flow through this circuit. Flux direction in this network is probably strongly 
determined by specific ATP demand. To investigate the biological significance of brain CK 
isoenzymes we have generated mice deficient for UbCKmit , referred to as UbCKmit-/- (10, 
11) or for cytosolic B-CK, referred to as B-CK-/- (7). As neither of these genotypes is lethal it 
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seemed that pathways involved in the maintenance of energy homeostasis in brain, like in 
muscle (12, 13), are – at least partial - redundant. However, further studies of mice lacking 
CK isoforms showed behavioral deficits, changes in seizure susceptibility (for B-CK-/-), and 
anatomical abnormalities, indicating that this loss is indeed only partially compensated for by 
other systems (7, 11), leaving a distinct role for the CK circuit in neurodevelopment and in 
synaptic and metabolic connectivity.  
Next from being a high-energy phosphate carrier, creatine also appears to act in brain 
osmoregulation (14-16) or as PCr in other as yet unspecified processes (17, 18). The 
neurological abnormalities of patients suffering from creatine deficiency syndromes indicate 
that adequate (phospho-)creatine levels are important for proper brain function (19-22). In the 
metabolic characterization of these patients magnetic resonance (MR) spectroscopy played a 
crucial role and recently we demonstrated that MR can also identify metabolic abnormalities 
in the brain of a mouse with genetic ablation of a creatine-biosynthetic pathway (23). 
Here we report on the non-invasive morphologic and metabolic comparison of wild-
type, B-CK-/- and UbCKmit-/- single knockout mice, and B-CK/UbCKmit--/-- double 
knockout mice by quantitative 1H and 31P MR. Measurements of specific brain locations in 
animals lacking B-CK and/or UbCKmit revealed distinct changes in their metabolic profiles. 
The brain of mice completely devoid of CK iso-enzymes, the only model in which the entire 
CK system is rendered truly non-functional, showed normal ATP, Pi and pH levels, in spite of 
complete absence of an MR signal for PCr. 
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MATERIALS AND METHODS 
Animals 
The generation and phenotyping of knockout mice with mutations in the gene(s) 
encoding the ubiquitous mitochondrial creatine kinase (UbCKmit-/-) or the cytosolic brain 
specific creatine kinase (B-CK-/-) have been described in detail (7, 10, 11).The breeding and 
phenotyping of double knockout mice lacking both B-CK and UbCKmit has been described 
recently (24). In short, B-CK-/- and UbCKmit-/- mice (both on a mixed genetic background 
of 75% C57BL/6 - 25% 129/Ola) were interbred to obtain heterozygous B-CK/UbCKmit+/- 
offspring. Siblings with only one wild-type CK allele (either B-CK+/-UbCKmit-/- or B-CK-/-
UbCKmit+/-) were mated with double knockout (B-CK-/-UbCKmit-/-) partners resulting in 
the generation of mice lacking both CK isoforms (further referred to as B-CK/UbCKmit--/-- 
double knockout mice) in sufficiently high numbers. Mating between double mutant partner 
animals gave only an occasional litter and a majority of these B-CK/UbCKmit--/-- mice had a 
reduced body weight. 
All mice examined in this study were females at 4-7 months or 2 years of age. Wild-
type littermates were used as controls. As the brain morphology of the two parental 
background strains C57BL/6 and 129/Ola differ significantly (see (25)), mice with the pure 
parental background were also examined. Verification of genotypes was done by PCR 
analysis (7, 10, 11). All animal procedures were approved by the Animal Care Committee of 
the University of Nijmegen, and conformed to the Dutch Council for Animal Care. 
During the MR experiments animals were anesthetized with 1.3% isoflurane in a gas 
mixture of 50% O2 / 50% N2O delivered through a facemask. The rectal temperature was 
monitored using a fluoroptic thermometer (Luxtron 712, California, USA) and maintained at 
36.8±0.5 °C using a warm water circuit. Respiratory frequency and amplitude were monitored 
optically (Sirecust 401/ Siemens).  
 
MR equipment 
The MR experiments were performed on a 7.0 T horizontal magnet (Magnex 
Scientific, Abingdon, England) equipped with 150 mT/m shielded gradients and interfaced to 
a S.M.I.S. spectrometer (Surrey Medical Imaging Systems, Surrey, England) operating at 
300.22 MHz for 1H and at 121.53 MHz for 31P. Details of the RF probes are described below 
and in (26). 
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Localized 1H MR Spectroscopy and Imaging 
An elliptically shaped surface coil (15 x 11 mm) adapted to the geometry of the mouse 
brain was used. Localized 1H MR spectroscopy was performed by the STEAM sequence (27) 
with an echo time (TE) of 10 ms, a mixing time (TM) of 15 ms and a repetition time (TR) of 
5000 ms. The spectral width was 5000 Hz and 512 scans were averaged (43 minutes 
measurement time). Water suppression was achieved using CHESS (28). Voxels of 4 µl 
nominal volume were placed in three locations, i.e. thalamus (with some striatal contribution), 
cortex / hippocampus and cerebellum. The localization of this voxel was guided by T2-
weighted spin echo images acquired in three oblique, perpendicular directions (TE=50 ms, 
TR=2000 ms, slice thickness 0.5 mm, bandwidth 50 kHz, matrix size 512x256, 24 slices). 
Field shimming on this voxel was performed until a line width (FWHM) of typically 12 Hz 
(0.04 ppm) or less was reached.  
 
Localized 31P MR Spectroscopy 
For 31P MRS two slightly overlapping, 16-mm diameter, surface coils operating in 
quadrature mode inside the brain were used (29). Both coils were anatomically shaped to fit 
the mouse brain. This configuration was shifted inside a cylindrical 1H-volume coil with a 
diameter of only 33 mm to maintain good image quality. Localized 31P MR spectroscopy was 
performed with an ISIS sequence (30) (TR=7 s, 512 scans). Voxel selection was guided by 
gradient echo images (FOV 20mm,TE=5ms, TR=500ms, slice thickness 1 mm, bandwidth 
100 kHz, 128x128 matrix, 12 slices) and shimming was performed on this voxel using a 
STEAM sequence (27) until a water line width < 0.12 ppm. The largest possible VOI while 
still excluding unwanted contributions from surrounding skin and muscle tissue was 7x7x5 
mm3 covering most of the brain except the cerebellum. The 6.5 kHz bandwidth adiabatic 
hyperbolic secant RF pulses were sufficiently B1-insensitive. The maximum chemical shift 
displacement for the β-ATP is less than 1 mm when the observe frequency is set at the PCr 
resonance. 
  
Data analysis 
To circumvent problems with automatic segmentation of MR images obtained with the 
inhomogeneous B1-field of the surface coil, the following procedure was applied. All MR 
images of contiguous slices parallel to the RF-coil were edited so that only brain tissue 
remained visible and pixels inside the ventricles were manually selected in each slice and then 
set to a maximum intensity value of 255. Subsequently, using IDL software (RSI, Boulder, 
Co), the ventricle shape was segmented in 3-dimensions and the amount of pixels forming the 
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ventricles was counted. Since the pixel volume is known (3.05x10-3 µl), an absolute value for 
the ventricle volume can be obtained. 
The 1H MR spectra were analyzed in the frequency domain with the LCModel 5.1-7 
software package (31), which uses a linear combination of model metabolite spectra obtained 
under identical experimental conditions. Eddy current correction was performed with 
LCModel and no further fit constraints were used. Direct absolute quantification of metabolite 
levels by LCModel requires the use of a homogeneous RF coil. Since a surface coil was used, 
tissue water was taken as internal reference. The water signal was fitted in the time domain 
using the MRUI 97.1 software package (32) and a factor was determined relating the 
amplitudes calculated in MRUI to those in LCModel. A mean tissue water content of 78% 
was assumed as determined for mouse brain (33, 34). 
The 31P MR spectra were evaluated in the time domain also using the MRUI 97.1 
software package. Peaks were fitted using a Gaussian line shape function with no further prior 
knowledge. Tissue pH was calculated from the Pi-PCr shift and also from the Pi-αNTP shift 
(35). For quantification, the signals were related to the amplitude of the 31P MR signal from a 
100 mM Pi solution acquired under identical experimental conditions including coil loading.  
 
Estimation of the free creatine pool by the combination of 1H and 31P MRS 
The combination of quantitative 31P and 1H MR spectroscopy provided the possibility 
to estimate the free Cr levels by subtracting the PCr pool (31P) from the total Cr pool (1H). 
Although the selected volumes for the 1H and 31P MR measurements were not identical the 
volume selected using 31P MR covers two different voxel locations in which 1H MR found 
identical Cr+PCr levels. Moreover, by chemical means the same Cr + PCr level was derived 
(vide infra).  
 
Chemical analysis of the total creatine pool 
For analysis of the creatine concentration in the mouse brain, mice were anaesthetized 
with Avertine. The mouse brain was removed and quickly frozen in liquid nitrogen. The 
tissue was powdered and extracted with 0.6 M HClO4 and the resulting extract was 
neutralized with 3M KOH. The PCr and free Cr levels in this solution were essayed via 
coupled enzymatic reactions (36). 
 
Statistics  
An unpaired t-test was used to test if metabolite levels were significantly different 
between animal groups. Differences were considered significant when p< 0.05. 
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RESULTS 
Enlarged ventricles in B-CK-/- mice 
To determine possible anatomical differences in mice lacking B-CK, UbCKmit or 
both, high-resolution T2-weighted MR images were acquired in three perpendicular directions 
and compared to similar images of wild-type animals of different genetic backgrounds (figure 
5.1).  
 
Figure 5.1: Morphology of the mouse brain as studied by T2-weighted spin-echo MR images 
in two different horizontal planes.  
Images are shown for the two parental background strains (top row), wild-type (wt), B-CK-/- 
and UbCkmit-/- single knockouts and B-CK/UbCKmit--/-- double knockout. Note the larger 
ventricles in the B-CK-/- panel. 
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Figure 5.2: Ventricle volume size in microliter (µl) for wild-type, B-CK-/-,  
B-CK/UbCKmit--/-- double knockouts and UbCKmit-/- mice, as determined from MR images 
of their brains. 
When compared to the wild-type controls, 3 out of 5 B-CK-/- mice showed an increase 
in ventricle volume by about a factor of 2 to 3 (figure 5.2). We consider the effects on 
ventricle size a serious phenotype although the volume increase was not evident in all  
B-CK-/- animals. This could be due to developmental masking or incomplete penetrance by 
compensating activity of genes that make up the volume regulatory system in brain. To 
analyze this possibility more closely we measured the same five B-CK-/- mice also at an age 
of 7 months, but found no progressive effects on ventricle volume (i.e. the volume of the 
enlarged ventricles remained at 10 to 16 µl, compared to a ventricle volume between 2 to 6 µl 
in wild-type brains). In another group of 2 year old B-CK-/- mutants enlarged ventricles  
(> 8 µl) were found again in 3 out of 6 mice, whereas all 5 wild-type mice of the same age  
had normal sized ventricles (< 8 µl). It is of note here that all UbCKmit-/- and  
B-CK/UbCKmit--/-- double mutants had apparently normal ventricle sizes (figures. 5.1 and 
5.2).  
 
 Lack of PCr in B-CK/UbCKmit--/-- double knockout mouse brain 
To investigate the effects of the lack of one or both brain creatine kinases on the high-
energy phosphor-metabolite profile we performed localized 31P MR spectroscopy. The 
selected voxel of 7x7x5 mm3 covered a large part of the cerebrum, but did not include the 
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cerebellum. In the spectra of wild-types, UbCKmit-/- and B-CK-/- obtained from this voxel 
(figure 5.3), resonances were routinely observed for PCr (resonating at 0 ppm), nucleoside 
triphosphates (NTP), primarily composed of ATP (γ, α and β phosphates resonating at -2.5,  
-7.5 and –16.1 ppm), Pi (5 ppm) and phosphomonoesters (PME; ~6.7 ppm). Usually also 
signals for phosphodiesters (PDE; ~3.1 ppm) were observed.  
 
Figure 5.3: Localized 31P-MR spectroscopy of mouse brain. The spectra were obtained from a 
7 x 7 x 5 mm volume centered on the cerebrum, excluding contributions from cerebellum and 
extracranial tissue. Spectra are shown for wild-type (wt), B-CK-/- and UbCKmit-/- single 
knockouts, and a B-CK/UbCKmit--/-- double knockout mouse. Resonances are visible for 
phosphocreatine (PCr), phosphomonoesters (PME), inorganic phosphate (Pi) and the three 
phosphates of NTP (γ, α and β). Usually signals for phosphodiesters (PDE) could also be 
detected. There are no obvious spectral differences between the groups, except for  
B-CK/UbCKmit--/-- double knockout mice that clearly lack PCr. 
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Strikingly, but not entirely unexpected from genotype and proteome information, the 
PCr signal was clearly below the level of detection in the spectrum of B-CK/UbCKmit--/-- 
mice. Evaluation of the 31P MR data to obtain absolute average metabolite levels and tissue 
pH (calculated from the Pi-PCr resonance shift) revealed that PCr levels and tissue pH in  
B-CK-/- and in UbCKmit-/- mice were not deviant from those in wild-type (table 5.1). 
Interestingly, also NTP and Pi levels were the same in all mice, even in B-CK/UbCKmit--/-- 
brain. As B-CK/UbCKmit--/-- mice have no detectable PCr signal the pH in these mice was 
calculated on basis of the Pi-αNTP resonance shift. This pH in the B-CK/UbCKmit--/-- brain 
was not significantly different from those in other genotypes (table 5.1). 
 
Table 5.1: Brain tissue levels of phosphoryl metabolites and tissue pH for wild-type and 
different CK mutant mice by 31P MR spectroscopy. 
 
Phosphoryl metabolite levels (in mM) and tissue pH values are presented as mean ± SD and 
derived from localized 31P MR spectroscopy measurements from a 7 x7x 5 mm3 brain voxel. 
NTP: nucleoside triphosphate, mostly ATP  
ND: not detectable.  
pH (Pi-PCr): tissue pH derived from shift of Pi signal with respect to that of PCr  
pH (Pi-αNTP): tissue pH derived from shift of Pi signal with respect to that of αNTP.  
 
 
 
 
 
 
 
 
Wild-type 
(n=5) 
B-CK-/- 
(n=5) 
UbCKmit-/- 
(n=4) 
B-CK/UbCKmit--/-- 
(n=3) 
NTP 2.3 ± 0.3 2.4 ± 0.5 2.4 ± 0.5 2.3 ± 0.5 
PCr 3.7 ± 0.6 4.4 ± 0.7 4.0 ± 0.3 ND 
Pi 1.9 ± 0.6 2.0 ± 0.7 2.0 ± 0.7 1.9 ± 0.6 
pH (Pi-PCr) 7.14 ± 0.07 7.10 ± 0.10 7.10 ± 0.02 - 
pH (Pi-αNTP) 7.22 ± 0.16 7.18 ± 0.18 7.09 ± 0.06 7.20 ± 0.08 
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Local metabolite levels in mouse brain as assessed by 1H MR spectroscopy 
While 31P MR spectroscopy primarily gives an indication of the bio-energetic state of 
brain tissue, 1H MR spectroscopy can provide a somewhat more diverse picture of brain 
metabolic content. Moreover, because of its higher sensitivity, much smaller volumes of 
interest can be measured. To compare data from areas of the brain with different functionality, 
grey matter and/or CK content, we selected voxels with a nominal volume of 4 µl positioned 
in three distinct regions, i.e. thalamus, cortex/hippocampus and cerebellum (figure 5.4).  
 
Figure 5.4: Spin echo MR images of the mouse brain depicting the projection in three 
perpendicular directions (horizontal, sagital, coronal) of three selected brain tissue voxels 
from which for 1H MR spectra were obtained. Position 1, thalamus; position 2, 
cortex/hippocampus; position 3, cerebellum. Nominal voxel volume: 4 µl. 
The 1H MR spectra acquired from these locations in the brain of a wild-type and a  
B-CK/UbCKmit--/-- double mutant (figure 5.5) show various resonance of which the three 
most prominent ones represent the CH3 protons of total creatine (PCr + Cr) at 3.03 ppm, of  
N-acetyl aspartate (NAA) at 2.03 ppm, and of phosphorylcholine (PC) and glycerol-
phosphorylcholine (GPC) at ≈ 3.2 ppm. Signals for protons of other compounds such as 
glutamate, glutamine, taurine and myo-inositol are also visible (figure 5.5). The results of the 
quantitative spectral analysis for a subset of major metabolites are given in table 5.2. Total 
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NAA (tNAA) is presented as the sum of NAA and NAA-glutamate levels. NAA-glutamate 
content was about 0.5 mM for all mouse strains, mutants and investigated brain regions.  
Wild-type mice showed regional variations for creatine content, which is higher in the 
cerebellum, and for choline compounds, which is lower in the cortex/ hippocampus as 
compared to the other investigated areas. Total NAA levels did not significantly differ 
between the three areas. For a proper comparison of mixed background wild-types with the 
other genotypes also metabolite levels in the parent strains were assessed in the 
cortex/hippocampus/thalamus region. Brain levels of the major metabolites appeared not 
significantly different for C57BL/6, 129/Ola and mixed background wild-type controls, with 
the exception of glutamate that was increased in 129/Ola mice to 9.0 ± 1.9 mM (n=3). 
 
 
Figure 5.5: Proton MR spectra of the three selected locations (see figure 5.4) in the brain of 
wild-type littermate (left) and B-CK/UbCKmit--/-- double knockout mice (right).  
Resonances are indicated for protons of phosphocreatine + creatine (PCr + Cr), glutamate 
(Glu), glutamine (Gln), N-acetyl-aspartic acid (NAA), taurine, glycerophosphorylcholine 
(GPC) and phosphorylcholine (PC) and myo-inositol (Ins). Between wild-type and  
B-CK/UbCKmit--/-- double knockout mice, the differences in NAA levels (higher) and 
creatine levels (lower) are the most prominent. 
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Table 5.2: Metabolite levels at 3 locations in the mouse brain for wild-type and different CK 
mutant mice as determined by 1H MR spectroscopy. 
Metabolite & location 
Littermate 
(n=5) 
B-CK-/- 
(n=5) 
UbCKmit-/- 
(n=6) 
B-CK/UbCKmit--/--
(n=5) 
Total Creatine     
 Thalamus 8.5 ± 0.6 9.1 ± 0.4 8.4 ± 0.9 6.5 ± 0.5# 
 Cortex/hippocampus 8.3 ± 0.5 8.9 ± 0.5 8.8 ± 0.8 6.7 ± 0.5# 
 Cerebellum 10.0 ± 2.1 10.3 ± 3.0 11.2 ± 2.0 7.9 ± 1.5# 
Total NAA     
 Thalamus 7.3 ± 1.0 5.9 ± 0.3# 6.3 ± 0.4 8.8 ± 0.9# 
 Cortex/hippocampus 6.3 ± 1.1 6.5 ± 0.5 6.4 ± 0.7 8.4 ± 1.0# 
 Cerebellum 6.4 ± 0.9 6.2 ± 0.7 7.0 ± 0.7 8.1 ± 0.6# 
GPC + PC     
 Thalamus 2.3 ± 0.4 1.8 ± 0.4 2.2 ± 0.6 2.6 ± 0.7 
 Cortex/hippocampus 0.9 ± 0.4 0.9 ± 0.5 1.4 ± 0.7 0.8 ± 0.4 
 Cerebellum 2.3 ± 1.2 1.4 ± 0.6 3.0 ± 1.1 2.8 ± 1.5 
Myo-inositol     
 Thalamus 4.3 ± 1.2 3.1 ± 0.4 2.9 ± 1.2 2.9 ± 0.6 
 Cortex/hippocampus 2.9 ± 1.0 3.0 ± 0.5 3.0 ± 0.5 2.8 ± 1.3 
 Cerebellum 3.7 ± 0.6 2.0 ± 0.4# 3.8 ± 0.7 2.0 ± 1.1# 
Glutamate     
 Thalamus 6.3 ± 0.4 6.4 ± 0.5 7.9 ± 0.4$ 8.8 ± 1.0$ 
 Cortex/hippocampus 6.6 ± 1.2 6.4 ± 0.4 7.4 ± 0.8 7.3 ± 1.0 
 Cerebellum 6.1 ± 0.7 5.8 ± 0.8 8.3 ± 0.7$ 7.0 ± 0.7 
All values are presented in mM (mean ± SD). The voxel centered at the thalamus had a small 
contribution from the striatum.  
# significantly different (p<0.05) from wild-type and (one of the) single mutant mice 
$ significant different (p<0.05) from wild-type and B-CK-/- mice  
 (i.e., those containing mitochondrial UbCK ) 
Total creatine is PCr + free creatine 
Total NAA is NAA + NAA-glutamate 
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Differences in metabolite levels of creatine kinase deficient brain detected by 1H MR  
 The most obvious changes detected by 1H MR MR spectroscopy, were the significant 
higher tNAA and a lower total creatine levels in the B-CK/UbCKmit--/-- double knockouts 
compared to wild-types (figure 5.5, table 5.2). Although absolute metabolite levels differed 
between genotypes, the relative spatial distribution across brain regions remained unchanged 
for Cr + PCr, choline compounds and tNAA.  
Comparison of glutamate signals between the 3 different CK mutants for all three 
voxel areas (table 5.2), revealed that mice that carried mutations in the mitochondrial 
UbCKmit gene (i.e. either UbCKmit-/- or B-CK/UbCKmit--/-- animals) had significantly 
higher levels of this important metabolite. Glutamate values for all three areas combined in 
UbCK-/- and B-CK/UbCKmit--/-- mice were approximately 25 % higher than in B-CK-/- or 
wild-type animals (p< 0.001). Conversely, in the cerebellum of mice lacking cytosolic B-CK 
(i.e. in either B-CK-/- or B-CK/UbCKmit--/--) the level of myo-inositol was consistently 
decreased by about 40 %. Other metabolites which also have been evaluated (not listed in 
table 5.2) showed no significantly different tissue levels between the three voxel locations and 
between the different mouse genotypes. These included GABA (1-2 mM), glutamine (2-3 
mM) and taurine (about 6 mM).   
In addition, measurements were performed on a cohort of 2 years old wild-type and  
B-CK-/- mice (n= 5 each). Proton MR spectra obtained from the cortex / hippocampus area 
showed no significant differences for any of the metabolites studied, except for tNAA in the 
older B-CK-/- mice (5.2 ± 0.6 mM), which was significantly (p < 0.01) decreased compared 
to tNAA in adult B-CK-/- mice (6.5 ± 0.5 mM), or in adult (see table 5.2) and aged wild-types 
(6.4 ± 0.9 mM). 
 
Abnormal creatine levels in B-CK/UbCKmit--/-- double knockout brain  
Absolute total creatine levels in wild-type and B-CK/UbCKmit--/-- mouse brain 
derived by non-invasive 1H MRS are in good agreement with those obtained by chemical 
analysis (table 5.3). The free Cr pool, estimated from the total creatine and PCr levels, was the 
same in wild-type, B-CK-/- and UbCKmit-/- mice (table 5.3). Interestingly, the total Cr level 
is decreased only by about 25% in B-CK/UbCKmit--/-- double knockouts. Since PCr is 
essentially undetectable in this mouse, we assume that the signal at the PCr + Cr position in 
the 1H MR spectrum represents only Cr. It follows that that the level of free Cr in  
B-CK/UbCKmit--/-- double knockout animals is about 30% higher than that in B-CK-/-, 
UbCK-/- or wild-type mice (6.6 mM vs. ~ 4.6 mM).  
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Table 5.3: Total creatine, phosphocreatine and free creatine tissue levels in the brain of  
wild-type and different CK mutant mice 
 wild-type B-CK-/- UbCKmit-/- B-CK/UbCKmit--/-- 
Chem. anal. → total Cr  8.5 ± 1.0 
(n=4) 
- - 
6.4 ± 0.2# 
(n=3) 
1H MRS → total Cr  8.4 ± 0.4 
(n=5) 
9.0 ± 0.3 
(n=5) 
8.6 ± 0.6 
(n=6) 
6.6 ± 0.4# 
(n=5) 
31P MRS → PCr  3.7 ± 0.6 
(n=5) 
4.4 ± 0.7 
(n=5) 
4.0 ± 0.3 
(n=4) 
0 * 
(n=3) 
free Cr  4.7 ± 0.7 4.6 ± 0.8 4.6 ± 0.7 6.6 ± 0.4# 
All values are presented in mM (mean ± SD). 
Total creatine content was derived by chemical analysis of the brain of wild-type and  
B-CK/UbCKmit--/-- double knockout mice, and by 1H MR spectroscopy, averaging the values 
obtained from thalamus and cortex/hippocampus areas (see table 2)  
Free creatine tissue levels were derived from the total creatine pool (as obtained by 1H-MRS) 
and the PCr levels (as obtained by 31P MRS).  
# Significantly different from all other mouse genotype groups 
* Because no PCr signal is detectable in 31P MR spectra of B-CK/UbCKmit--/-- mice its level 
was set to 0. However, as the detection limit of our 31P MR spectra is estimated to be about 
0.5 mM in principle PCr can be present at any tissue concentration below 0.5 mM.  
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DISCUSSION 
As the creatine kinase reaction is considered to be an integral part of the cellular 
energy network in the brain, facilitating both ATP production and consumption, the ablation 
of any brain isoenzyme (B-CK or UbCKmit) was anticipated to result in a severe phenotype. 
However, earlier we reported that B-CK-/- or UbCKmit-/- mice are overtly normal and rather 
sophisticated analysis and challenging conditions were needed to reveal that these single CK 
mutants showed slower learning, diminished habituation, reduced acoustic startle reflex 
responses and (only tested for B-CK-/-) a different susceptibility to seizures (7, 11). In  
B-CK/UbCKmit--/-- double knockout mice behavioral and learning problems were more 
clearly manifest (24). 
Because changes in metabolite content upon CK depletion are expected to be the cause 
or the consequence of these phenotypes, the main goal of this study was to type metabolic 
effects in CK deficient brains in vivo. Substrates of the CK reaction can be monitored non-
invasively in the living brain by quantitative MR spectroscopy and therefore this method is 
particular attractive to study CK knockout mice, although the application of this approach to 
the mouse brain is still challenging due to its small size. Below, we therefore also emphasize 
the significance of MR spectroscopic findings in wild-type mice, before addressing the effects 
of CK deficiency. As imaging is an inherent part of the applied MR methods also a view on 
brain morphology was obtained complementary to histology, which is discussed first.  
  
Effects on brain morphology and ventricle size 
As variations in genetic background are a known cause of differences in neurological 
properties of mice, e.g. (37, 38) and thus a potential source of errors and confusion in MR 
studies, we validated the “reporter-value” of our MR data by comparing mixed inbred strain 
and parental strains C57BL/6 and 129/Ola. Although ventricles in these animals may vary in 
size, see also (38), the ventricle volume seen in 3 out of 5 adult and in 3 out of 6 aged  
B-CK-/- mice was far outside the range of ventricle sizes seen in any of the other groups with 
mixed and pure inbred background, rendering the finding of enlarged ventricles in these mice 
very significant. Enlarged ventricles have also been observed by MRI in L1 cell adhesion 
molecule knockout mice (39) and in mice with altered copies of the Huntington disease gene 
homolog (40). In two mutant lines about 50% of these latter mice had enlarged ventricles, a 
defect that also did not worsen with age. Apparently this phenomenon is not fully penetrant 
and can be compensated for by other gene functions. The enlargement of ventricles, possibly 
implicating a mild form of hydrocephalus, might result from a defective process of neuronal 
extension or cell loss in specific regions during brain development.  
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Elsewhere we have reported (7) that B-CK-/- brains also show a significantly larger 
intra-infrapyramidal (LIIP) mossy fiber area. It is of particular interest here that our combined 
MRI and histo-anatomical analyses (not shown) did not reveal gross morphological 
abnormalities in the brains of double mutant B-CK/UbCKmit--/-- or single mutant  
UbCKmit-/- mice, except for a 7% reduction in overall brain weight in only the double 
knockouts, suggesting a role of the CK system in neuronal cell differentiation or brain growth. 
 
Absolute levels of metabolites in the in vivo mouse brain 
Quantitative localized in vivo 1H MR spectroscopy to assess metabolite levels in the 
brain has been little applied yet to the mouse. The levels of some metabolites have been 
estimated for a volume in the forebrain of 3 mouse strains (41) and a central brain volume in 
other mouse types (23). The tissue levels of most metabolites in wt mouse brain, as assessed 
in the present study by 1H MRS, are comparable to those for the adult rat brain (42).  
Total creatine content in the cerebrum of mice (7 - 9 mM) is somewhat higher than in 
human cerebrum (5 - 7 mM). There is more Cr in mice cerebellum than in its cerebrum, as 
also observed in humans, e.g. (43, 44), and which is associated with a relative high CK level 
(4).  
Levels of total NAA for wt mouse cerebrum observed in the present study (about 6 - 7 
mM) are comparable to those reported elsewhere for mouse brain (41), but somewhat lower 
than commonly observed for adult human and rat cerebrum (8 - 11 mM). Biochemical 
assessments indicate similar lower values for NAA in the mouse brain: i.e. about 5 - 6 mM 
(45, 46). NAA contributes to the most prominent peak in 1H MR spectra of the CNS and 
because it is primarily synthesized and stored in neurons, the intensity of this peak is widely 
used as a marker for neuronal viability (47). However, NAA can also act as an osmolyte and 
its tissue level may reflect the degree of cellular integration in the CNS (48). Different NAA 
contents in rat and mouse brain may be related to species specific brain organization such as 
reflected in the 2-fold difference in cholinergic neurons per section of equal thickness of 
mouse and rat brain (49).  
Another prominent peak in 1H MR spectra of the brain is that of choline compounds. 
The tissue content of these compounds in the thalamus region is comparable to that reported 
for larger brain volumes (23, 41). The occurrence of lower choline levels in cortical regions is 
generally also observed in rats and humans (42, 43).  
The brain level of the neurotransmitter glutamate in 129/Ola mice is similar to that in 
the rat (42), but is lower in wt littermates and the C57Bl/6 strain, more similar to values found 
for human white matter (43). Brain levels of myo-inositol in wt mice are close to those in rat 
(42). Myo-inositol is considered to be a major cellular osmolyte and a marker for the astrocyte 
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content of brain tissue (e.g. (15, 50, 51)), although it is not exclusively associated with glia 
cells (52, 53).  
Absolute quantification of phosphate metabolites by localized 31P MR spectroscopy 
has not yet been performed for mouse brain to our knowledge. The global NTP amount 
(primarily composed of ATP) estimated in this study (~2.4 mM), is comparable to global ATP 
levels in the brain tissue of adult mice assessed by biochemical means; e.g.(54), and absolute 
PCr levels closely resemble those determined by MRS for rat brain (3.9 mM; (55)).  
  
Creatine kinase deficient mouse brain 
Our regional metabolite profiling revealed that mice with complete brain CK 
deficiency, but not those with only B-CK or UbCKmit mutations, exhibited a higher tNAA 
content across all brain regions, with concentrations clearly outside the range found in mixed 
and pure inbred controls. One could postulate that, in analogy to mice that lack both muscle-
specific CK isoforms, M-CK and ScCKmit (12, 56, 57), B-CK/UbCKmit--/-- double 
knockouts show the most profound adaptations as a result of physiological and developmental 
responses that serve to mask the effects of the genetic lesion. A higher NAA signal most 
likely reflects an increase of this compound in individual neurons or an increase in relative 
neuronal volume (58). NAA is synthesized in mitochondria (47, 59, 60) and implicated in 
lipid synthesis (61) and acetyl-CoA buffering (60, 62). Thus increases in tNAA levels may 
reflect adaptations in any of the intracellular pathways involved (e.g. an up-regulation of 
mitochondrial capacity). The concomitant increase in total NAA and decrease in total creatine 
content may also reflect a redistribution of cerebral osmolites (14, 15). In turn, any shift in 
osmolite levels could promote or block ventricle enlargement. In this respect it is interesting 
to mention that the thalamus of B-CK-/- mice, the only mutant with an enlarged ventricle 
phenotype, shows a “reverse” shift in the levels of tNAA and creatine (Table 5.2). Finally, It 
is also conceivable that changes in cell size or cell-type distribution across brain regions due 
to adaptive neuronal plasticity or neurogenesis, e.g. (63), are the cause of alterations in NAA 
content. Such a generalized effect at the cellular level would corroborate the 7% change in 
brain weight for animals in the B-CK/UbCKmit--/-- cohort (11).  
In this context it is of note that we did observe changes in myo-inositol and glutamate 
content as more localized events in B-CK and UbCKmit single knockouts, respectively. 
Unfortunately, the variation in glutamate level in mice with different genetic backgrounds, 
obfuscates a clear correlation between changes in glutamate concentration and the local 
absence or presence of UbCKmit activity. Our glutamate findings are consistent with both (i) 
simple metabolic alterations in the mitochondrial capacity for glutamate synthesis, as 
mitochondria may have a prominent role in setting the cellular level of glutamate (64) or with 
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(ii) overall changes in cell differentiation and growth. Likewise, the myo-inositol findings in 
B-CK-/- and B-CK/UbCKmit--/-- double knockout mice could be equally well ascribed to (i) 
changes in neuronal physiology such as osmoregulatory adaptations, or to (ii) specific local 
changes in cell type distribution or differentiation, correlated to the unequal distribution of 
CK isoforms across the brain.  
Finally, it is interesting to discuss the role of Cr and PCr proper. In the single knockout 
mice there is little difference in PCr and free Cr content with respect to wild-types, but in  
B-CK/UbCKmit--/-- double knockout brain PCr is undetectable and the level of free creatine 
higher than normal. This renders B-CK/UbCKmit--/-- mice a unique model to study the 
biological significance of Cr in isolation, separated from the role of PCr in brain energetics. In 
muscle we observed that even at very low CK activities the amount of total creatine was not 
affected (65) indicating that the uptake of creatine in muscle cells occurs independent of its 
phosphorylation to PCr or CK activity. In the brain our results show that in the extreme case 
of total CK and PCr absence a response does occur, but it only results in a partial depletion of 
total creatine. Taken combined, these data suggest that the presence of free creatine is 
important in both tissues, but that its uptake is not directly correlated to PCr formation and 
hence, the cellular energy charge. This could point to a role that is independent from that as 
acceptor of high-energy ~P groups in cellular energetics.  
Also the observation that mice without any CK activity in brain were viable, 
corroborated previous findings in other cellular and animal models with CK deficiencies, and 
effectively challenges the proposed energy shuttling role of the CK reaction (66) as absolutely 
vital for life. Instead, a new picture emerges, in which compensatory shifts in associated 
reactions in the whole phosphotransfer network (67) safeguard maintenance of cellular 
energetic homeostasis. What then could be the other possible (i.e. non-energetic) 
physiological roles of Cr proper? All that is known is that Cr may act as an osmolyte, e.g. 
(15), or as co-solvent (in analogy to other amino acid-like compounds (68)). The increased 
level of free Cr may therefore explain the apparent masking of ventricle problems (often 
synonymous with cell volume changes) in B-CK/UbCKmit--/-- mice, but further study is 
needed to clarify this issue.  
The relevance of homeostasis in the entire Cr and PCr system for normal brain 
function has been emphasized by findings in patients lacking (P)Cr due to transporter or 
biosynthetic pathway problems (20, 21). Here the accumulation of neurotoxic precursors, 
such as guanidinoacetate in cases with guanidino-methyltransferase deficiency (69), perhaps 
together with the absence of PCr, but also the lack of free Cr, may have contributed to the 
pathology in these patients.  
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In summary, our data presented here, in combination with the behavioral and 
histological phenotyping reported elsewhere and the clinical findings in humans, point to the 
importance of homeostasis of total and free pools of Cr as an essential factor in the regulation 
of physiological functioning and development of the CNS. Whether we can completely 
separate this from PCr’s role as a buffer for high-energy phosphates during strenuous 
conditions or phases of cell differentiation and maturation during brain growth remains 
subject for further study. 
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CHAPTER 6 
ABSTRACT 
In vivo 13C MRS using 13C labeled compounds is a useful technique to provide a 
window on energy metabolism and neurotransmitter recycling in mammalian brain. Thus far, 
however, the application of 13C MRS was restricted to use in brains of humans or rats, but not 
feasible for mice, due to problems with small brain volume and low SNR.  
Here we present a new experimental framework for MR studies in the mouse brain in 
vivo, with the use of specially designed procedures and dedicated hardware to monitor 
incorporation and transfer of [1-13C] label from glucose into lactate, alanine, and several C-
atom positions in glutamate, glutamine and aspartate with relatively high temporal resolution. 
Using this experimental setup, transfer of label from glucose to other metabolites was 
compared between mice lacking both cytosolic and mitochondrial brain-type creatine kinases 
(B-CK/UbCKmit--/-- mice) and wild-type controls. Direct comparison without calibration of 
glucose input and MR signals revealed that B-CK/UbCKmit--/-- mice displayed an earlier or 
faster conversion of glucose, and less accumulation of label into lactate, suggesting a more 
efficient coupling of aerobic glycolysis and mitochondrial activity in brain energetics. 
Advantages and disadvantages of the current setup and caveats of the experimental protocols 
are discussed. 
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INTRODUCTION 
Creatine kinase (CK) plays an important role in storage and intracellular transfer of 
high-energy phosphoryls (~P) in tissues with high energy demand. By catalyzing the reaction 
creatine (Cr) + ATP ↔ phosphocreatine (PCr) + ADP + H+, CK provides a spatial and 
temporal energy buffer by keeping local ATP/ADP ratios balanced. The same reaction also 
facilitates that this enzyme can act as a regulator of intracellular tissue pH (see e.g. (1-3)). 
Based on these functions, the Cr-CK system was proposed to play an important role in 
neuroprotection in energy failure in brain (2). 
In the brain of mammalian species CK production is developmentally regulated. Only 
two of the four known CK isoform subunit genes are expressed. The B-CK gene encodes the 
B-CK subunit isoform, which assembles into dimers mainly located in the cytosol. The 
ubiquitous CK (UbCKmit) gene specifies the UbCKmit subunit, which forms di- or octameric 
enzymes located between the inner and outer membranes of mitochondria (4, 5). B-CK, which 
represents more than 70-80% of total CK activity in brain, is presumed to work in close 
association with ATPases in the cytosol and cell membranes. There it provides ATPases with 
preferential access to ~P in ATP (from PCr) for work in ion-based electrogenic activity and 
(intra)cellular transport (1), which is important for neuronal communication, morphogenesis 
and plasticity of spines and synapses (6). Conversely, UbCKmit normally tranfers ~P from 
ATP from oxidative phosphorylation (OXPHOS) directly onto PCr before shunting it into the 
cytoplasmic pool; this isoform is mainly present at sites of highest mitochondrial activity. The 
~P flux through the combined B-CK and UbCKmit reactions appears to be higher in gray 
matter than in white matter (7).  
Compared to skeletal muscle, our knowledge on the functional role of CK in brain 
energetics is lagging far behind. The main reason for this discrepancy is that metabolic study 
of the brain, especially in vivo, is technically much more challenging. In contrast to muscle, 
brain tissue consists of a very complex, interwoven, heterogeneous mixture of cell types, each 
with their own metabolic characteristics. Currently, there is intense debate on the design of 
energy metabolism of the brain, both in the field of cellular neurosciences and in the area 
where behavioral neurosciences, psychology and fMRI (functional magnetic resonance 
imaging) meet (see e.g. (8)). Main themes in this ongoing discussion are the cooperation 
between astrocytes and neurons, the relative contribution of glucose, lactate and ketone-
bodies as fuels, cell-type dependence of glycolysis and lactate production, and the role of the 
mitochondrial TCA cycle plus associated pathways in the coupling to OXPHOS (9-11) during 
rest and when the brain is challenged (12). Also the coupling of ATP generation to the Cr-CK 
circuit in brain energetics is still not very well elucidated. Regional distribution and cell-type 
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involvement of Cr import across the blood brain barrier has not been studied in great detail (1) 
and also the contribution of endogenous creatine synthesis (1, 13, 14) is not very well 
understood. At the cellular level, B-CK itself has been found to be present in both glial and 
neuronal cell types, while UbCKmit expression is mainly confined to specific types of 
neurons (15). Unfortunately, details about the distribution profiles are lacking.  
To study the role of CK in the brain we have generated mice deficient in both B-CK 
and UbCKmit (B-CK/UbCKmit--/-- mice) (15-17). Although these mice had a lower body 
and brain weight (18) and displayed abnormal behavioral and cognitive functions (partly also 
seen in single BCK or UbCKmit knock-outs), their basal brain functions were still intact, 
despite the complete absence of PCr (17). Levels of ATP, inorganic phosphate (Pi) and 
intracellular tissue pH were normal, as were most metabolites observed from 1H MR spectra. 
The total creatine pool, however, was lower than in wt animals while NAA and glutamate 
(Glu) were elevated.  
Although 1H and 31P MR measurements yield specific metabolic information, they are 
often not suitable to follow the dynamic process of metabolite import, conversion and 
clearance from brain tissue. To study the routing or adaptation of metabolic fluxes in cellular 
energetics, in vivo 13C MRS with 13C labeled compounds is a more appropriate technique. 
Flux rates for several relevant metabolic pathways in the brain can be investigated 
simultaneously, as has been convincingly demonstrated in studies of coupling of energy 
pathways and the process of neurotransmitter cycling in brains of humans and rats (see e.g. 
(19-24)). 13C MRS studies in mouse brain, however, were thus far limited due to problems 
with the small sample size of tissue and intrinsically lower SNR .  
Here, we present an experimental paradigm to perform in vivo 13C MRS with high 
temporal resolution especially designed for the mouse brain. Experimental monitoring of 
glucose uptake, lactate formation, synthesis and break-down of several neurotransmitters and 
other metabolites in mouse brain was demonstrated for the first time and used to compare flux 
rates through glycolysis and mitochondrial pathways in B-CK/UbCKmit--/-- and wt mice. 
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MATERIALS AND METHODS 
Animals 
B-CK/UbCKmit--/-- mice and wild-type (wt) animals of the same mixed genetic 
background (50% C57Bl/6 and 50% 129/Ola and age (3-4 months) were compared. Directly 
before the MR experiments, the mice were cannulated in the tail vein after which they were 
anaesthetized using isoflurane (1-2%) in a gas mixture of 50% O2 and 50% N2O delivered 
through a facemask. Breathing frequency was monitored, and kept constant during the 
experiment (100 ± 20 min-1). Rectal temperature was monitored during the experiments using 
a fluoroptic thermometer and maintained at 38 ± 1 °C using a warm water circuit. After the 
experiments, animals were killed using cervical dislocation while under anesthesia. All 
experiments were in accordance with rules of the local animal ethics committee. 
 
MR equipment and methods 
The experiments were performed on a 7.0 T magnet (Magnex Scientific, Abingdon, 
England) interfaced to a S.M.I.S spectrometer (Surrey Medical Systems, Surrey, England) 
operating at 300 MHz for 1H and at 75.5 MHz for 13C. The horizontal magnet has a free bore 
size of 120 mm.  
A specially for mouse brain designed 1H birdcage coil (length: 45 mm, ∅ 40 mm) was 
used for shimming, imaging and 1H decoupling, together with a 13C surface coil (∅ 12 mm) 
for 13C excitation and acquisition. Pulse-acquire experiments were performed using a 
WALTZ4 decoupling scheme during acquisition (90° pulse length 13C: 30 ms; 90° pulse 
length 1H: 650 ms; TR=1.2 s).  
Before glucose infusion, a natural abundance 13C MR spectrum was measured in 30 
minutes (5 blocks of 256 averages). Subsequently, 80 spectra with a time resolution of 2.6 
min were acquired (128 averages). After two spectra, [1-13C] labeled glucose (1 M, diluted in 
normal saline) was infused (STC-521, Terumo, Tokyo, Japan) using a protocol adopted from 
Peled-Kamar et al. (25). Infusion speeds were set at 1.2 ml/h for 1 min; 12 ml/h for 45 s;  
3.6 ml/h for 5 min; and 1.2 ml/h for 4 min which in total infused 0.55 mmol in 10 minutes and 
45 seconds.  
 
Data processing 
The glucose 13C-1 signals were fitted directly in the MR spectra obtained with high 
temporal resolution (2.6 min) using the AMARES method, with Lorenzian lineshape 
functions, in the MRUI software package (26). Signals were normalized to the maximum  
β-glucose signal per mouse. To be able to follow label incorporation into glutamate (Glu) and 
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glutamine (Gln), individual spectra were automatically corrected for frequency drifts and 
phase distortions with respect to each other by principal component analysis (27) 
implemented in home build software programmed in IDL (Research Systems inc., Boulder, 
Co, USA). Four spectra were added to enhance SNR, yielding a ten minute temporal 
resolution. The basal spectra, i.e. the spectra recorded before infusion of glucose, were 
averaged and subtracted from spectra obtained during the infusion of glucose. Incorporation 
of 13C label into several metabolites was quantified by fitting signals for the third carbon 
position of lactate (Lac3) and alanine (Ala3), the third and fourth carbon positions of 
glutamate (Glu3 and Glu4) and the third and fourth position of glutamine (Gln3 and Gln4). 
Since the resonance frequencies of 13C label on the second position of Glu and Gln are too 
close to be distinguished in our experiments (about 0.5 ppm; (28)), both signals were fitted 
with a single resonance and denoted as Glx2. Furthermore, signals for 13C label at the second 
and third position of aspartate (Asp2 and Asp3) just as the 3-carbon and 4-carbon position in 
GABA (GABA3, GABA4) could be discerned. All subtracted signals were fitted using a 
Gaussian lineshape function. The linewidths of Glu3 and Gln3 were equalized and the first 
order phase was fixed to an empirically determined value. No other prior knowledge was 
used. The signals fitted in the subtraction spectra were all scaled to the maximum intensity of 
the Glx2 signal per mouse to normalize acquisition parameters.  
 
Statistics 
All data is presented as mean ± SEM unless stated otherwise. Differences in 
metabolite levels were tested for significance using a t-test per time point. Evolution of 
metabolite or neurotransmitter levels during specific time intervals was tested for significant 
differences between wt and B-CK-UbCKmit--/-- using a repeated measures test in SPSS 
(LEAD technologies Inc, Chicago, USA). Using this test, the last time-point in the time series 
(t = 200 min) was excluded to prevent list-wise deletion of animals. In all statistical tests, 
differences were considered to be significant at p < 0.05. 
 
 
RESULTS 
For the duration of the entire experiment, which lasted for over 3.5 hours, the 
experimental setup enabled good physiological control over the mouse as assessed from the 
steady condition of the body temperature and breathing frequency. All signals in the 13C MR 
spectra originated from tissue close to the surface coil, predominantly representing the cortex. 
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Upon infusion of glucose labeled with 99% 13C at the C1 position, two signals for β- and α-
glucose appeared in the 13C MR spectra (figure 6.1a).  
 
a 
 
 
b 
Figure 6.1: 13C labeled glucose infusion and clearance in the mouse brain at different time 
points (a) and the difference of normalized glucose signals between B-CK/UbCKmit--/-- (grey 
dots) and wt (black squares) mice (b). Data is presented as mean ± SEM, asterisks indicate a 
significant difference between wt and B-CK/UbCKmit --/-- mice for that time point. 
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After the infusion, these signals decreased, but were still detectable for more than two 
hours after the infusion was terminated. A difference appeared in the time dependent curves 
of the β-glucose signal between wt and B-CK/UbCKmit--/-- mice (figure 6.1b). After the 
maximum of glucose accumulation is reached at the end of the infusion period, glucose values 
per time point were significantly lower in knock-out mice. Towards the end of the 
experiment, i.e. from approximately 100 minutes after glucose infusion until the termination 
of the experiment (t=200 min), glucose values in wt and knock-out animals became identical 
again. 
 
a b
 
c 
 
 
Figure 6.2: 13C spectrum (30 min. average) of the mouse brain before infusion (a), after 
infusion (b) and subtraction spectrum (c). The horizontal and vertical scaling in the difference 
spectrum is enlarged to appreciate all visible resonances.  
Subtraction of a spectrum acquired before infusion (figure 6.2a) from a average 
spectrum acquired over a time period of 30 minutes during infusion (figure 6.2b) revealed 
multiple MR signals of which the large ones were identified as Glu (Glu3, Glu4), Gln (Gln3, 
Gln4), Glx2 and Lac. Furthermore, smaller distinct signals for Asp (Asp2, Asp3), GABA 
(GABA2, GABA3, GABA4) and Ala were observed (figure 6.2c). 
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a b 
 
Figure 6.3: Sequential incorporation of 13C label into the fourth and third position of Glu and 
Gln (A) and into the second position of both Glu + Gln (B) in wt mice. All signal intensities 
are scaled to the maximum signal intensity of the Glx2. Data is presented as mean ± SEM. 
Sequential incorporation of 13C label into several positions of Glu and Gln (figure 6.3), 
just as into GABA, Asp, Lac and Ala was followed over time. The signal of the carbon-4 in 
glutamate was the first to appear in the 13C MR spectra, and reached the highest amplitude of 
all metabolites that accumulate 13C label at approximately 60 minutes after the start of 
infusion. Subsequent conversion of glutamate into glutamine by glutamine synthetase is 
reflected by the decrease of the Glu4 signal and the increase of signal originating from 13C-
label at the 4-carbon position of glutamine. If the C4 label is not transferred from α-
ketoglutarate to Glu4, it will remain in the Krebs cycle and be transferred to succinate (29, 
30). Because this molecule is symmetrical of structure, the C4 label has an equal chance to be 
transferred to either the C3 or the C2 position. The signal of Glu3 therefore increased with a 
slower pace (maximum at approx. t=100 min.) than Glu4 as this compound is generated 
during the second turn of the Krebs cycle. Label of Glu3 is then transferred to Gln3 (maximum 
at approx. t=115 min.) by glutamine synthetase. Incorporation of label at the second carbon 
position of the combined glutamate and glutamine pool (figure 6.3b) occurred also more 
slowly than incorporation of Glu4 label, with a maximum at approximately 110 minutes. 
Comparing label incorporation into several metabolites between wt and  
B-CK/UbCKmit--/-- mice revealed interesting differences and similarities. Incorporation of 
13C label from glucose into lactate was significantly decreased in B-CK/UbCKmit--/-- mice 
(figure 6.4). Similar results were observed for the temporal incorporation of label into Ala 
(figure 6.4b), with a clear trend to higher accumulation in wt animals.  
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a  b
 
Figure 6.4: Comparison of sequential build-in of 13C label in Lac3 (a) and Ala3 (b) between 
wt (black squares) and B-CK/UbCKmit --/-- (grey dots) mice. All signal intensities are scaled 
to the maximum signal intensity of the Glx2 . Data is presented as mean ± SEM; asterisks 
indicate a significant difference between wt and B-CK/UbCKmit --/-- mice for that time point. 
Temporal evolutions of several 13C labeled Glu and Gln pools were monitored and 
compared between wt and knock-out animals (figure 6.5). The total amount of signal 
measured in each pool, e.g. of Glu4, is the summed result of both incorporation of new 13C 
label into Glu and breakdown of Glu4 to Gln4. During the measurement period, both processes 
will simultaneously contribute to the temporal evolution of the total Glu4 signal. At 55 
minutes after the start of the infusion period, Glu4 breakdown is larger than the generation of 
newly formed Glu4 signal resulting in a decrease in the total Glu4 pool (figure 6.5a). The 
evolution of this decrease was significantly faster in B-CK/UbCKmit--/-- mice. Besides this 
observation, no distinct differences in the time courses of transfer of label into several 
positions in Glu and Gln were detected (figure 6.5).  
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a b
c d
e 
Figure 6.5: Profiles of incorporation of sequential build-in of 13C label incorporation in  
Glu4 (a), Gln4 (b), Glu3 (c), Gln3 (d) and Glx2 (e) between wt (black squares) and  
B-CK/UbCKmit --/-- (grey dots) mice. All signal intensities are scaled to the maximum signal 
intensity of Glx2. Data is presented as mean ± SEM. 
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DISCUSSION 
The present study is the first demonstration that 13C MRS can be used as a tool to 
study metabolic conversions in (transgenic) mouse brain in vivo. Both glucose uptake and 
amino acid formation were analyzed in one experiment with high temporal resolution using 
dedicated home-made equipment for signal acquisition. A broad range of signals for 
metabolites involved in oxidative metabolism and neurotransmitter recycling could be 
identified in the 13C MR spectra. These results open up new prospects for the study of existing 
and new mouse models for brain disease.  
The temporal resolution of 13C label detection in amino acid signals achieved in the 
present study attained the temporal resolution obtained in other studies with larger animals 
and humans (28, 31, 32). Still, in the rat and human studies more metabolites could be 
discerned at this resolution as larger brain volumes can be selected resulting in a better SNR. 
In addition, less tissue-air transitions occur close to the selected volume providing a more 
optimal magnetic homogeneity within the volume of interest. Clearly, the small brain size of 
the mouse will remain an inherent challenge for future studies and a problem that can only be 
tackled with further sophistication of hard- and software and experimental procedures.  
 
Limitations of the current infusion- and data processing protocols 
Since the main goal of the current work is to optimize the technical feasibility of 13C 
MRS in the mouse brain, we first address this aspect of our study. The current experimental 
approach yielded reproducible spectral profiles with clear peaks for relevant carbohydrates 
(glucose, lactate) in the glycolytic pathway and mitochondrial TCA-cycle. Furthermore, 
signals for amino acids (and derivatives) providing information on the TCA-cylce and the 
Glu/Gln neurotransmitter cycle were easily detected. The infusion protocol for the 13C 
glucose label was adopted from a 13C MRS study on glucose uptake in mice (25). Both the 
total amount of glucose infused in this study and the infusion rate appears to be rather high; 
other non-MRS studies on glucose metabolism in mice report values which are lower (see e.g. 
(33-36)). Assuming a blood plasma glucose concentration of approximately 7 mM (34, 37) 
and a blood volume in the mouse of about 2 ml (38), the total glucose in the blood can be 
calculated to be in the order of 14 µmol. Infusion of 0.55 mmol glucose in 11 minutes will 
therefore give a severe rise in blood glucose concentration causing a significant metabolic 
challenge. To approach conditions in which the glucose concentrations are closer to 
physiological levels, it is important to further optimize the infusion protocol.  
During the measurement of 13C labeled glucose it is not possible to discriminate 
between glucose signal originating from the brain and glucose signals originating from the 
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blood vessels in the brain. Although there appears to be a linear relationship between blood 
and brain glucose as was shown in rat (39), this relation may very well be altered during 
infusion in genetically modified mice (25). Unlike can be done for humans and rats, for mice 
it is difficult to acquire blood samples while the animal is inside the magnet during an MR 
protocol as the blood volume is too low compared to the volume of the connecting infusion 
lines. Therefore, separate parallel experiments under identical conditions have to be 
performed in order to obtain reliable 13C/12C ratios and glucose concentrations. Also future 
use of an external phantom of known concentration as a reference may add to a better 
comparison of absolute metabolite levels in wt and knock-out mice. 
 
Larger glycolytic capacity in B-CK/UbCKmit--/-- mice 
In the absence of absolute values for glucose uptake and conversion, we now took the 
approach to normalize all signals for one mouse to the maximum intensity of the glucose 
signal observed in that same animal. Using this approach, relative differences in 13C label 
incorporation between B-CK/UbCKmit--/-- and wt animals were observed.  
The significant lower glucose values per time point suggest a faster or earlier 
clearance rate of glucose in B-CK/UbCKmit--/-- mice. As glucose clearance from the brain 
reflects the rate of glycolysis (25), this points to an earlier onset of glycolysis or a larger 
glycolytic capacity, possibly by transcriptional or post-translational up-regulation of specific 
enzymes in the glycolytic pathway. Although this picture matches the results found in CK 
deficient muscle (40-42), also other physiological parameters - including altered 
mitochondrial function in brain or altered lipid and carbohydrate metabolism in other organs 
in the body - have to be considered. It has been shown, for instance, that B-CK/UbCKmit--/-- 
mice have a lower average body weight than wt animals (18) and show size adaptations in fat 
pads and in liver (Streijger, unpublished results). Furthermore, basal glucose levels in  
B-CK/UbCKmit--/-- mice appear to be decreased and the levels of metabolic hormones have 
changed (Streijger, unpublished result). Infusion of identical quantities of glucose may 
therefore not necessarily yield similar blood glucose concentrations in wild-type and knock-
out animals. The extend to which these changes in other tissues affect glucose levels in 
circulation and in brain is not known. 
Besides direct measurement of the total 13C labeled glucose pool, i.e. of signal 
originating both from blood and brain glucose, indirect determination of incorporation of 
label in the brain glucose pool only is also possible. Pfeuffer and coworkers showed that the 
incorporation of 13C label from glucose into lactate mirrors the kinetics of the incorporation of 
label in brain glucose (43). The reduced accumulation of lactate would therefore point to 
lower brain glucose levels - or lower glucose uptake - in knock-out mice. It is also feasible, 
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however, that changes in mitochondrial Krebs cycle turnover rate augmented lactate demand 
and that increased uptake of pyruvate coupled to more intense mitochondrial activity explains 
the lower glucose signal for the B-CK/UbCKmit--/-- mice. 
 
Adaptations in oxidative metabolism in B-CK/UbCKmit--/-- mice 
In the subtraction spectra, signals were normalized per mouse to the maximum of the 
Glx2 signal. This normalization was preferred over normalizing to the maximum of the 
glucose signal, as was done in the processing of the glucose data itself, because glucose 
signals likely do not originate only from within the cell. Glx2 was chosen for this 
normalization because it has a relatively large signal with no other large signal in the spectral 
neighborhood which makes it ideal for a robust fit. It represents a summed signal of the 2-
carbon positions in both glutamate and glutamine, each mainly originating from a different 
compartment because glutamate is mainly present in neurons while glutamine is mainly 
present in glial cells (see e.g. (29, 30)). Normalizing to this signal therefore appears more 
robust and reliable than normalizing to one of the Glu or Gln signals alone. 
The only significant difference when comparing Glu neurotransmitter generation and 
breakdown in B-CK/UbCKmit--/-- mice to that in control animals, is in the faster decrease of 
the Glu4 signal. Indeed, the most likely position to find differences when looking at the 
oxidative side of the metabolism is in Glu4, since this compound is the first MR visible 
metabolite to be generated after 13C label has entered the Krebs cycle. Generation of all other 
metabolites takes longer, and differences in generation rate or breakdown may therefore be 
obscured by dilution of label both in time and to other compounds.  
Taken together, both our findings of an earlier onset of glycolysis or an increased  
flux through glycolysis and a reduced accumulation of 13C label into lactate in  
B-CK/UbCKmit--/-- mice suggest a faster transfer of label into the Krebs cycle. Although no 
differences could be observed in the generation of Glu4, its breakdown was significantly faster 
in knock-out mice. Also this observation can be explained by altered mitochondrial activity. 
To avoid that evidence remains merely circumstantial and indirect, future experiments need to 
be designed that will enable us to follow 13C label transfer into several amino acid pools in 
such a way that dilution of label is maximally prevented. This can be accomplished by 
adapting infusion protocols and optimizing measurement protocols to obtain quantitative 
values of MR signal intensities and chemical concentrations of all relevant metabolites. 
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CHAPTER 7 
ABSTRACT 
As a model for guanidinoacetate methyltransferase (GAMT) deficiency in humans, a 
gene knock-out mouse model was generated. Here we report on several metabolic 
abnormalities in these mice, observed by in vivo and in vitro MR spectroscopy. 
In 1H MR spectra of brain and hind-leg muscle a clearly reduced signal of creatine 
(Cr) was observed in GAMT deficient (GAMT-/-) animals. Analysis of the 1H MR spectra of 
GAMT-/- brain indicated little or no increase of a signal for guanidinoacetate (Gua). In proton 
MR spectra of muscle, a broad signal of low intensity was observed for Gua. However, 
substantial Gua accumulation in intact muscle tissue was unequivocally confirmed in high 
resolution magic angle spinning spectra, in which the Gua signal was resolved as one clear 
sharp singlet. 
In 31P MR analysis of brain and hind-leg muscle a strongly reduced phosphocreatine 
(PCr) content was shown. In addition, a signal of phosphorylated Gua at 0.5 ppm up-field of 
PCr was observed, with much higher intensity in muscle than in brain. This signal decreased 
when ischemia was applied to the muscle and recovered after ischemia was released. Overall 
the in vivo 31P and 1H MR spectroscopy of GAMT-/- mice is similar to that of human GAMT 
deficiency. This opens up new avenues for the fundamental study of tissue-type dependence 
of creatine synthesis and transport, and for diagnostic and therapeutic aspects of creatine 
deficiencies in humans. 
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INTRODUCTION 
Guanidinoacetate methyltransferase (GAMT) is a key enzyme in the biosynthesis of 
creatine (Cr), a process that mainly occurs in pancreas and liver (1). The first step on this 
synthetic route involves transfer of the amidino group of arginine to glycine, to yield ornithine 
and guanidinoacetate (Gua). Subsequently, GAMT facilitates the methylation of Gua to Cr.  
Cr is a central compound in the energy metabolism of tissues such as muscle and 
brain. In these tissues it can be phosphorylated to phosphocreatine (PCr) using one of the five 
isoenzymes of Creatine Kinase (CK). Finally, Cr and PCr are catabolized to creatinine (Crn), 
which is excreted through the urine. To maintain a constant body pool of Cr, its breakdown 
and build-up via dietary intake and endogenous synthesis must be balanced and its transport 
across membranes of cells in various tissues must be tightly regulated (2). 
GAMT deficiency was described for the first time as a new inborn error of metabolism 
(3) in an infant with extrapyramidal movement disorder, who had low Crn in serum and urine 
(3-6). Up to now, several cases of GAMT deficiency have been reported (7-11). Patients show 
symptoms in a wide range of severity (12) including developmental retardation (4, 7-9, 11), 
muscle hypotonia (3, 5, 8, 11), extrapyramidal movement abnormalities (3-5, 7) and epileptic 
seizures (7, 8, 11).  
Localized MR spectroscopy (MRS) of the brain of young patients has played a 
decisive role in the elucidation of the pathophysiology of GAMT deficiency. A strongly 
reduced Cr signal was revealed by 1H MRS (3, 4, 7-11, 13). In 31P MR spectra PCr was 
decreased and a new resonance appeared, which was assigned to phosphorylated Gua (PGua) 
(7, 10, 13). This assignment was confirmed by an additional resonance in the 1H MR 
spectrum at 3.8 ppm, which is likely to arise from Gua protons (3, 9, 10, 13).  
Oral intake of arginine resulted in an increase of the Gua signal intensity in the proton 
MR spectra (3, 13), while intake of Cr led to a partial restoration of the Cr signal (3, 4, 7, 9-
13), decrease of the Gua signal (3, 7, 10, 13) and improvement of clinical symptoms (3-13). 
To our knowledge, in only two patients with GAMT-deficiency MRS of muscle was 
performed. The first case study reported on a considerable signal for creatine in 1H MR 
spectra of muscle but not in brain, and no peak at 3.8 ppm (10). In the 31P MR spectrum only 
one peak was observed around 0 ppm, which was assigned to PCr. The second case study 
showed both PCr and PGua in 31P MR spectra of muscle while no 1H Cr resonance was 
observed in brain (14). 
Detailed study of the pathophysiology of GAMT deficiency and possible treatment 
strategies is difficult in humans, as the disease is very rare. Therefore, GAMT deficient 
knock-out mice (GAMT-/-) were generated (15). This article presents the first results of 31P 
and 1H MRS of hind-leg muscle and brain in these mice. The purpose of this work was to 
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validate the GAMT-/- mice as useful model for creatine deficiency in human patients and to 
initiate a study into tissue-type and dietary-composition dependent accumulation of Gua 
derivatives. 
 
METHODS 
Animals 
GAMT-/- mice were generated by homologous recombination in embryonic stem cells 
(15). As a reference, heterozygous (+/-) and homozygous (+/+) wild-type-like (wt) littermates 
of the GAMT-/- animals were used. In previous studies (not published), Isbrandt et al. showed 
that no differences could be observed between these groups and that animals of both 
genotypes can serve as control. For the determination of the T2 of water and methyl Cr 
protons in hind-leg muscle, six wild-type-like mice with a randomly inbred mixed 
background of C57Bl/6 and 129/Ola were used. During the MR experiments, all animals were 
anaesthetized using 1% isoflurane in a gas mixture of 50% O2 and 50% N2O delivered 
through a facemask. Breathing frequency was monitored and a warm waterbed was used to 
keep the animals at normal body temperature. All experiments were approved by the local 
animal ethics committee.  
 
MR equipment 
The in vivo MR experiments were performed on a 7.0 T magnet (Magnex Scientific, 
Abingdon, England) interfaced to a S.M.I.S. spectrometer (Surrey Medical Systems, Surrey, 
England) operating at 300.22 MHz for 1H and at 121.53 MHz for 31P. The horizontal magnet 
was equipped with a 150 mT/m shielded gradient set and had a free bore size of 120 mm. 
High resolution magic angle spinning (HRMAS) spectroscopy experiments were 
performed on muscular tissues using a Bruker DRX 500 MHz spectrometer. 
 
MR spectroscopy studies 
To get a good overview of the phenotype of the GAMT-/- mice, 1H and 31P MR 
spectroscopy studies of both hind-leg muscle and of brain were performed. In the 1H MR 
experiments Cr refers to the sum of Cr and PCr.  
For the 1H MR studies on the mouse brain, a 12 mm surface coil anatomically shaped 
for mouse brain was used. Additional perspex earbars provided stereotactic fixation. 
Localized spectroscopy was performed using a STEAM sequence (TE=10 ms, TM=15 ms, 
TR=5000 ms, 64 averages) with VAPOR water suppression (16) and outer volume 
suppression. A 3x3x3 mm3 (27µl) voxel was positioned in the center of the brain guided by 
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gradient echo images. In this study, measurements were performed in seven GAMT-/- and 
five wt animals.  
The 31P MR brain measurements were done using two surface coils, tuned to the 31P 
frequency and working in quadrature mode. A large 1H surface coil was utilized for 
shimming, imaging and localization. To prevent contamination with signal from the masseter 
muscles, an ISIS sequence (17) was used (TR=7000 ms, 8 step phase cycle, 512 averages), 
consisting of a 6.5 kHz adiabatic hyperbolic secant pulse for inversion, together with a 50 µs 
rectangular 90° RF pulse for excitation. A voxel with size 6.5x6.5x4.5 mm3 (190 µl) was 
positioned in the brain guided by gradient echo images. The mouse head was fixated using the 
quadrature surface coil and earbars.  
1H MR measurements on the mouse hind leg were done using an Alderman-Grant type 
of coil (18), oriented at the magic angle (55°) with respect to the main magnetic field to 
reduce dipolar interactions (19). The same STEAM sequence was used as in the 1H brain 
measurements (voxel size 1.8x1.8x3.4 mm3, TR=5 s, 128 averages). For absolute 
quantification, the T2 for water and Cr protons was determined by acquiring a suppressed and 
water suppressed 1H spectra at six different echo times in a separate experiment.  
31P MR pulse acquire experiments (TR=7000 ms, 64 averages) on the hind leg were 
done using a three-turn solenoid coil, together with a proton Alderman-Grant type of coil for 
shimming. 31P MR experiments on hind-leg muscle and brain, and 1H MR experiments on 
hind-leg muscle were performed in seven GAMT-/- and seven wt animals. Ischemic occlusion 
of skeletal muscle was applied to two GAMT-/- animals by clamping with a diaphragm plate, 
which allowed reversible and reproducible obstruction of blood flow through the hind limb 
(20). 31P MR spectra were obtained using a pulse-acquire sequence (TR=1400 ms, 76 
averages). After four reference spectra an ischemic period of 25 minutes was applied (14 
spectra), followed by a recovery period of 16 minutes (9 spectra). 
Three GAMT-/- and three wt animals were sacrificed, their hind-leg muscles were 
removed and snapshot frozen in liquid nitrogen. The intact tissue was measured in a 12 µl 
rotor using HRMAS spectroscopy at 4 °C with a spinning rate of 5 kHz. Residual rotor space 
was filled with a PBS-buffer/D2O mixture (30/70). For 1-D 1H MR a CPMG pulse sequence 
was employed with a 90° pulse of 7.2 µs, while the time between the 180° pulses was one 
rotor period. Water was suppressed by presaturation and a T2 filter of 50 ms was applied. 
 
Chemical analysis of total Cr pool 
To serve as a reference to the 1H MR spectroscopy brain metabolite values, the size of 
the total Cr pool (i.e. Cr plus PCr) was determined by chemical analysis. Five C57Bl/6 mice 
and five mice with a randomly inbred mixed background of C57Bl/6 and 129/Ola were 
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sacrificed after which their brains were snapshot frozen in liquid nitrogen. These frozen brains 
were crushed and extracted with 0.6 M HClO4. The extracts were neutralized with 3 M KOH, 
and the PCr and Cr were essayed via coupled enzymatic reactions (21). PCr and Cr 
concentrations were added to yield the total Cr pool size. 
 
Data processing 
The 1H MR data of brain were analyzed using the LCModel 5.2-2 software package 
(22). The unsuppressed water signal was used for eddy current correction, phasing and 
normalization. The chemically determined Cr value was used to scale the MR determined 
metabolite values of the wt mice such that Cr values agreed. This scaling factor was also 
applied to the MR spectra of the GAMT mice yielding absolute quantitative levels for all 
metabolites in the 1H MR brain spectra. 
The 31P MR data of brain and muscle and the 1H MR data of hind-leg muscle were 
analyzed using the MRUI software package (23). In the data processing of 31P MR brain 
spectra, the first order phase was constrained. In GAMT -/- animals the damping of the PGua 
signal was set equal to the damping of the PCr signal. All signals were fitted assuming a 
Lorentzian line shape model function, and normalized to the γ-NTP signal since the β-NTP 
signal was affected by a chemical shift artefact caused by the 6.5 kHz excitation pulse. 
For the 1H MR spectra of muscle, the first order phase was constrained to zero because 
the first acquired data point was obtained at the top of the echo. Signals were eddy current 
corrected using the unsuppressed water signal. The ratio of the linewidths of taurine and Cr 
was determined in wt animals. Cr linewidths were constrained to this ratio in both GAMT-/- 
and wt animals. All signals were fitted assuming a Gaussian line shape model function. 
Absolute quantification of the Cr concentration in muscle was performed using the 
unsuppressed water signal. To correct for T2 relaxation, the obtained water and methyl Cr 
spectra at six different echo times were fitted using MRUI (23), and the results at different 
echo times were fitted using a mono exponential curve. The protons signals in hind leg 
muscle are considered to be fully relaxed at a TR of 5 s, and hence no T1 corrections needed 
to be applied. Tissue water content was assumed to be 77% (24).  
In the fitting procedure of the 31P MR spectra data of hind-leg muscle, the first order 
phase was constrained. No other prior knowledge was used. Signals were fitted assuming a 
Lorentzian line shape model function and normalized to the β-NTP signal. For brain and 
muscle, the pH was calculated from the shift in resonance position (S) of the inorganic 
phosphate (Pi) signal compared to the resonance position of PCr (25) using the equation 
pH=6.75 + log((3.27-S)/(S-5.63)). A two-tailed Mann-Whitney test was used to test if 
GAMT-/- from wt metabolite levels were significantly different (p < 0.05).  
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RESULTS 
Muscle 
The 31P MR spectra of GAMT-/- animals showed striking differences with respect to 
wt spectra: PCr was significantly reduced and a new resonance appeared 0.5 ppm up-field of 
PCr (figure 7.1), which was assigned to PGua (13). Signal intensities of the residual PCr and 
newly formed PGua showed large fluctuations between animals. However, in all individual 
mice the ratio PGua / PCr was larger than 1, ranging from 1.4 to 8.8 (mean 3.4 ± 3). We 
observed that with higher PGua levels PCr levels tended to be equally lower, however, 
significance was not reached for this observation. Other metabolite levels (normalized to the 
β-NTP signal) and tissue pH were not significantly different between GAMT-/- animals and 
their littermates (table 7.1).  
 a
 
b
 
Figure 7.1: 31P MRS of hind-leg muscle of wt (a) and GAMT-/- mice (b) in vivo. Peak 
assignments: inorganic phosphate (Pi); phosphocreatine (PCr); phosphorylated 
guanidinoacetate (PGua) 
. 
 163
CHAPTER 7 
Table 7.1: Ratios of integral values of phosphorous metabolite signals and pH in muscle and 
brain. 
All values are presented as mean ± s.d. PME: phosphomonoesters. 
Muscle metabolite signal values are normalized to the resonance of β-NTP, brain metabolite 
signals to γ-NTP (see materials and methods section for details). 
In order to find out whether PGua was metabolically active, ischemia of hind-leg 
muscle was applied, and monitored by 31P MRS (figure 7.2). The spectrum before ischemia 
showed hardly any PCr signal, but a large PGua signal was apparent, especially in animals 
that were completely deprived of Cr. During ischemia the PGua signal decreased while Pi 
signals increased. After ischemia PGua increased again to its initial value. The time course of 
PGua depletion and recovery was of similar order as that of PCr in wt animals during and 
after ischemia (20). 
The mono exponential fits of the water and Cr signals at different echo times yielded 
T2 values for water and Cr proton spins of 21.9 ± 0.1 ms and 83 ± 4 ms respectively. Those 
values were used to calculate absolute Cr concentrations. Cr was significantly reduced in 
hind-leg muscle of GAMT-/- animals (8.9 ± 3.8 mM) compared to wt animals (28.4 ± 2.6 
mM) (figure 7.3). Despite the presence of PGua in the 31P spectra, we observed hardly any 
signal for Gua in the 1H MR spectra. Even though the spectra were obtained at the magic 
angle (55°) to reduce dipolar interactions, the Gua signal appeared at best as a broad line 
(figure 7.3c) in the spectra where Cr was largely reduced. It is of note that, although we did 
not explicitly study the relation between Cr content of the food and (P)Cr and PGua signals in 
muscle, the muscle 1H MR spectrum showing largely reduced Cr (figure 7.3c) was taken in 
the same period, i.e. in mice eating the same batch of chow, as the 31P MR spectrum which 
shows hardly any PCr (figure 7.2a). 
 
 PME/NTP Pi/NTP PCr/NTP PGua/NTP PGua/PCr pH 
Muscle       
wt - 0.40 ± 0.06 2.66 ± 0.11 - - 7.24 ± 0.09
GAMT-/- - 0.40 ± 0.08 0.76 ± 0.33 1.78 ± 0.42 3.4 ± 3 7.18 ± 0.06
Brain       
wt 1.1 ± 0.5 0.59 ± 0.16 1.36 ± 0.46 - - 7.03 ± 0.08
GAMT-/- 1.4 ± 0.7 0.71 ± 0.26 0.31 ± 0.10 0.28 ± 0.07 0.90 ± 0.2 7.11 ± 0.04
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d 
c 
b 
a 
 
Figure 7.2: in vivo 31P MRS of hind-leg muscle of GAMT deficient mouse before (a) ischemia, 
after 5 minutes (b) and 25 minutes (c) of ischemia, and 5 minutes after releasing the ischemic 
clamp (d). A vertical line is positioned at 0 ppm to show that the large resonance is not PCr 
but PGua at -0.5 ppm 
In an attempt to clarify the apparent discrepancy of the broad Gua signal, HRMAS 
experiments on muscular tissue of GAMT-/- and wt animals were performed. This approach 
yielded again a clearly reduced Cr signal, but now at 3.78 ppm a clear signal for Gua appeared 
as a distinct singlet (figure 7.4). 
. 
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a 
 
b 
c 
 
Figure 7.3: localized 1H MRS of wt mice (a) and two GAMT-/- mice (b,c) hind-leg muscle in 
vivo.  
Peak assignments: total creatine (Cr); taurine (Tau) guanidinoacetate (Gua). Gua is not 
observed in all GAMT-/- mice, only when Cr levels are very low (c). 
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a 
b 
 
 
Figure 7.4: proton HRMAS MR spectra of intact GAMT-/- (a) and wt (b) muscle tissue in 
vitro. Peak assignments: methyl (3.0 ppm) and methylene (3.9 ppm) signals of total creatine 
(Cr); methylene signal of guanidinoacetate (Gua). 
Brain 
Next we used 1H and 31P MRS to establish whether the brains of GAMT-/- animals 
show the same metabolic features as brains of GAMT deficient patients. 
The chemical determined values of the total Cr pool were 8.7 ± 1.0 and 8.6 ± 1.4 
µmol/g wet weight for C57Bl/6 and mice with a randomly inbred mixed background of 
C57Bl/6 and 129/Ola, respectively. Using a brain density of 1.05 g/cm3 (26), this could be 
converted to tissue concentrations of 8.3 ± 1.0 and 8.2 ± 1.3 mM respectively.  
Compared to wt, the Cr signal was significantly reduced in brain of GAMT-/- mice 
although some broad signals remained present at 3.0 and 3.9 ppm (figure 7.5). No other 
metabolites analyzed from the 1H MR brain spectra were significantly different between wt 
and GAMT-/- animals (table 7.2). In addition, no significant increase could be observed at 3.8 
ppm, where Gua resonates. Other metabolites resonate around this position and might obscure 
the Gua signal. However, in some wt and GAMT-/- animals there was a residual signal 
present at approximately 3.8 ppm after fitting the spectra. This residue was of low SNR and 
could not be quantified properly.  
To see whether the residual Cr in GAMT-/- animals could result from intake via the 
mother milk of heterozygous mother animals, 1H MR spectra of brain of GAMT-/- animals 
born to GAMT-/- mothers were also obtained. 
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a 
 
b 
Figure 5: localized in vivo 1H MR brain spectra of wt (a) and GAMT-/- (b) mice. Peak 
assignments: total creatine (Cr); choline (Cho); taurine (Tau); glutamate (Glu); glutamine 
and glutamate (Glx); myo-inositol (Ins); N-acetylaspartate (NAA). 
There was no distinction between 1H MR spectra from GAMT-/- animals nourished by 
heterozygous or homozygous mutant females (data not shown), indicating that the genotype 
of the mother is not an important parameter for the metabolic profile of the offspring. 
In 31P MR spectra of the brain of GAMT-/- animals, a strongly reduced PCr signal was 
evident compared to the 31P MR spectra of brain of wt animals (figure 7.6). In addition, a 
signal for PGua was observed 0.5 ppm up-field of PCr in GAMT-/- animals, at a much lower 
intensity than in muscle. The mean ratio of PGua / PCr in brain was smaller than 1 (0.9 ± 0.2). 
Other metabolite levels, normalized to γ-NTP, did not differ between GAMT-/- and wt 
animals in brain (table 7.2). 
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a 
b 
 
Figure 7.6: localized 31P MRS of brain of wt (a) and GAMT-/- mice (b) in vivo. Peak 
assignments: phosphomonoesters (PME); inorganic phosphate (Pi); phosphocreatine (PCr); 
phosphorylated guanidinoacetate (PGua). Vertical scaling is arbitrary. 
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Table 7.2: Tissue concentrations of brain metabolites. 
All values are determined by 1H MRS and scaled to biochemically determined Cr values  
(see material and methods) and presented as mean ± s.d. 
a phosphocholine + glycerol- phosphocholine 
b creatine + phosphocreatine 
* significantly different from wt (p<0.05) 
DISCUSSION 
In this study we showed that combined use of in vivo and in vitro MR spectroscopy is 
a valuable tool in elucidating the metabolic status of tissues of animal models for creatine 
deficiency. In combination with the introduction of the new GAMT knock-out mouse model 
this opens up many possibilities for studying the integral-physiological fate of precursors and 
products at various steps in the Cr-biosynthetic pathway, in much more detail than is possible 
in human patients.  
 
MR spectra of brain and muscle of GAMT deficient mice 
1H MR spectra of both brain and muscle of GAMT-/- mice showed reduced levels 
compared to wt animals, but no complete absence of Cr. The Cr concentration in the food of 
the mice likely accounts for the continued presence of Cr. There is evidence that the 
permeability of the blood-brain barrier for Cr is limited and that the brain partially relies on its 
own Cr synthesis (1, 27, 28). Therefore it is interesting to note that the reduction of Cr in 
GAMT-/- mice relatively to the signal in wt animals appeared to be larger in brain than in 
muscle, which could be explained by a slower uptake of orally ingested Cr in the brain. 
As absolute concentration data from proton MR spectroscopy of mouse brain 
metabolites have, to our knowledge, not been published, we compared our inferred values to 
metabolite concentrations measured in rat brain (16). Cr concentrations found in wt animals 
are almost similar to those found in rat. Strikingly, NAA and glutamate values are 
 wt (mM) GAMT-/- (mM) Rat (mM) (16) 
taurine 5.8 ± 1.3 5.7 ± 1.6 6.0 
total choline a 1.9 ± 0.4 1.9 ± 0.4 0.5 
NAA 5.3 ± 1.3 5.4 ± 0.8 8.9 
total creatine b 8.2 ± 1.2 1.4 ± 0.4 * 8.5 
myo-inositol 2.2 ± 1.7 2.7 ± 0.9 4.4 
Glutamate 3.9 ± 0.3 4.4 ± 0.6 8.3 
Glutamine 1.8 ± 0.5 2.4 ± 0.7 2.7 
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significantly lower in mouse brain than in rat brain. NAA is considered to be a neuronal 
marker (29) and the observed concentration is in agreement with other biochemical studies 
done in mice (29). The difference in rat and mouse NAA levels corresponds well with the 
factor of about two-fold difference in cholinergic neurons per section of equal thickness in 
mouse and rat brain (30). Glutamate, important for synaptic signaling activity in brain, is 
stored mainly in neurons (31, and references therein) which explains the lower concentration 
found in mouse brain compared to rat brain. Although the concentration of choline 
compounds is in good agreement with values found in the human brain (32), it is higher than 
the concentration observed in rat brain. Why the concentration of choline compounds occurs 
at higher levels in mouse brain than in rat brain is currently not known. 
A remarkable observation from MR spectra of GAMT-/- compared to wt was that the 
PGua content in muscle was much higher than in brain, although in brain we observed a more 
constant level of PGua and PCr. GAMT transcript and protein was found to be present in 
several normal human and mouse tissues, including in muscle at high levels (15). In muscle 
also the enzyme AGAT, involved in synthesis of Gua, occurs at high levels (33). However, 
since the GAMT enzyme is lacking in GAMT-/- mice this does not necessarily mean that Gua 
will accumulate. Altered transport or change in feedback control of metabolic steps may also 
affect the rate of accumulation of precursors, and these factors may vary between tissues. 
Currently, we lack proper explanations for the differences in PGua and PCr levels between 
tissues. It has been suggested that brain is relatively self-sufficient in terms of Cr biosynthesis 
(34), whereas muscle is not. However, no data are available about the relative capacities of 
the different biosynthetic steps leading to the formation of Gua (and the conversion to Cr) or 
for the relative import capacities for Cr in different tissues. The permeability of the blood-
brain barrier is suggested to be limited for creatine (1) and throughout the brain, creatine 
transporters are not equally distributed. Cr uptake capacity almost surely differs between 
neural and glial cell types (28). In muscle fibers Cr transporters may be more equally 
distributed. 
  
Visibility of guanidinoacetate 
If brain tissue ATP concentration is assumed to be approximately 3 mM (35) also in 
GAMT mice, PGua levels in brain can be estimated from the observed signal ratios (table 7.1) 
to be around 1 mM. Assuming that about 75% of the total pool is phosphorylated, as is the 
case for Cr, the total Gua pool in the brain would be in the order of 1.3 mM. At this low 
concentration the signal of Gua may be hard to detect especially as it occurs at 3.8 ppm in a 
spectral area with several other overlapping resonances.  
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In muscle, by using analogous reasoning, Gua levels can be estimated to be 
approximately 19 mM, based on an assumed ATP concentration of 8 mM (36) and a 
phosphorylated fraction of 75%. Despite this high Gua tissue concentration, hardly any signal 
could be observed at the resonance position of Gua in our in vivo 1H muscle spectra. In cases 
where a signal for Gua was observed, this signal appeared at best as a broad line. Because the 
muscle 1H spectra of the GAMT-/- animals were obtained at the magic angle, dipolar 
interactions cannot account for the large linewidth (19). However, HRMAS spectra of intact 
muscle of GAMT-/- animals showed a clear singlet for Gua at 3.78 ppm. As HRMAS spectra 
were obtained at a temperature of 4 °C, the difference could possibly be due to 
conformational or environmental changes in vivo. 
Remarkably, the Gua signal appeared to be more distinct in the 1H MR spectra of 
muscle if a low Cr signal was present, and sometimes very low PCr and high PGua 
concentrations were observed in the 31P spectrum of muscle. Whether the PGua concentration 
decreases on increasing PCr concentration should be investigated further using controlled Cr 
feeding of GAMT-/- animals. 
 
Phosphorylated guanidinoacetate as a substitute for phosphocreatine 
The large variation in the amount of PGua and residual PCr observed in GAMT-/- 
muscle is most likely caused by fluctuations in creatine intake via the food, or fluctuation in 
cellular import capacity, which in muscle is dependent on the feeding status and presumably 
other physiological parameters (2).  
Based on the observation that CK can play a role in the phosphorylation of Cr 
analogues (37-39) it is likely that CK activity is the source of PGua in GAMT-/- animals. The 
utilization of PGua during ischemia was very similar to that of PCr in wt mice (20) despite the 
fact that the conversion rate may be lower as was shown in brain (13). We do not know, 
however, if the cytosolic BB-CK in brain and MM-CK in muscle have equal in vivo capacity 
to convert Gua to PGua. A role of mitochondrial CKs (which also occur at quite different 
concentrations in muscle and CNS) in this process can be excluded. Study of the utilization of 
creatine analogues by mitochondrial CKs in (permeabilized) tissue has demonstrated that 
these isoforms have no role in Gua phosphorylation (37, 38).  
 
Comparison with patient case studies 
The reduction of (P)Cr in the 31P and 1H MR spectra, and the appearance of PGua in 
the 31P MR spectra of the brain in our mouse model revealed a striking similarity to the 
metabolic findings in human patients (3, 4, 7-11, 13). For muscle, however, only two case 
studies have been reported so far to our knowledge (10, 14). In one case, the 31P MR spectrum 
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showed PCr and PGua, as observed in our study in GAMT-/- mice (14). In the other case, 
however, a large signal at about 0 ppm in the 31P MR spectrum was assigned to PCr (10). No 
signal for Gua was found in the human 1H MR spectrum (10). As shown in the present study, 
Gua in muscle gives rise to a broad signal which is hard to detect in vivo even at very low Cr 
concentrations. Brain MRS in GAMT deficient patients showed different levels of Cr after 
oral administration of Cr (3, 4, 7, 9-13). Variable creatine levels were also found in GAMT-/- 
mice and attributed to differences in oral intake of Cr.  
Although different inborn errors of Cr metabolism give rise to a reduction of the Cr 
signal in MR spectra (40-43), the simultaneous observation of reduced Cr signals and new 
signals for PGua is highly indicative for GAMT deficiency and can be diagnostically applied. 
 
In summary, our results indicate that Cr synthesis is blocked in GAMT deficient mice 
providing evidence for the existence of only one biosynthetic pathway for Cr production in 
mammals. We can now use this model for an in-depth study of the effects of oral intake of Cr, 
the pathophysiological thresholds in the Gua levels in different tissues and the monitoring of 
treatment of this disease using MRS. 
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CHAPTER 8 
ABSTRACT  
Transfer of magnetization (MT) between the mobile (MR visible) spin pool and 
immobile (MR invisible) spin pool of creatine (Cr) was studied on a clinical 1.5 T MR 
scanner in human skeletal muscle using continuous wave (CW) pre-irradiation as saturation 
method for the immobile pool. For this purpose, only slight modifications to the MR system 
were made. A specially designed electronic circuit was used to couple a CW amplifier to the 
RF channel of the scanner. CW pulse power (γB2/2π) and pulse length were determined to be 
approximately 550 Hz and 3 s respectively for optimal signal attenuation of the Cr methyl 
signal. The bound Cr fraction in human gastrocnemius muscle was determined to be between 
0.4% and 1.3% using a two-pool exchange model function describing the MT effect. 
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INTRODUCTION 
Magnetization transfer (MT) methods are frequently used in MRI (1) and MR 
spectroscopy (2). Proton spin systems of small metabolites in tissues may show an off-
resonance MT effect: magnetization from an immobile, MR invisible pool is transferred to a 
mobile, MR visible pool. For the first time this was demonstrated in rat brain, where the 
methyl signal of creatine (Cr) showed attenuation after off-resonance irradiation (3). 
Subsequently, several other studies have been published on MT of Cr in rat brain (4-6), rat 
and mice skeletal muscle (7-9) and human brain (10, 11). While 1H spins of some metabolites, 
e.g. Cr and ethanol, showed a clear MT effect in brain (3, 12), for others like  
N-acetylaspartate, glutamine/glutamate, myo-inositol, taurine and alanine only small effects 
were detected (4, 5).  
The exact mechanism of the transfer of magnetization from an immobile to a mobile 
Cr pool is still unknown. It has been demonstrated that both Cr and phosphocreatine (PCr) 
contribute to an MT effect (8). The role of exchangeable protons is negligible (9), even as 
interaction with creatine kinase (8). Using the inversion transfer technique in human brain and 
skeletal muscle, a significant transient reduction in the methyl signal of Cr was found 
indicative of magnetic coupling between protons of water and those of Cr / PCr (13).  
Saturation of the immobile fraction can be achieved by pulsed pre-irradiation, which 
can be applied on or off-resonance, or by off-resonance continuous wave (CW) pre-irradiation 
(14). In theory, these three methods are expected to give similar results as long as the relevant 
experimental parameters are properly optimized (15). However, in practice off-resonance CW 
pre-irradiation offers some advantages, especially for the quantitative analysis of the data in 
terms of an exchange model; the pulse length, saturation power and pulse offset frequency in 
CW pre-irradiation can be calibrated accurately (14). In MT studies in humans, however, no 
CW irradiation has been used so far. In order to obtain full magnetization transfer effects, 
long saturation pulses are required at sufficient strength. Based on earlier CW MT 
experiments in animal muscle and brain, pulse duration and strength of more than 2 seconds 
and γB2/2π of more than 200 Hz respectively should be applied (4, 7, 8). Standard clinical 
MR scanners have an RF pulse-amplifier, which cannot handle these long pulses.  
In the present study, MT of the Cr methyl group was studied in human skeletal muscle 
using CW pre-irradiation for the first time. For this purpose we designed an electronic circuit 
to couple a CW amplifier to the RF channel of the clinical 1.5 T MR scanner, which required 
only slight modifications to the transmit/receive switch on the clinical system. The different 
parameters involved in obtaining maximal signal attenuation, e.g. CW pulse power and pulse 
length, were calibrated. With this approach the bound Cr fraction in human gastrocnemius 
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muscle was determined using a two-pool exchange model function describing the MT effect 
(16). 
 
MATERIALS AND METHODS 
MR equipment and modifications 
A circular polarized 1H coil with a diameter of 15 cm was used for both excitation and 
reception. The coil was interfaced to a Siemens Vision 1.5 T clinical MR scanner (Siemens, 
Erlangen, Germany). The amplifier of the second RF channel was replaced by a 35 W CW 
amplifier (GRF5071-10-100, OPHIR-RF, Los Angeles, USA) and connected to the first 
channel by an electronic switch just before it enters the transmit receive switch. To prevent 
damage to the CW amplifier during transmission with the 15 kW pulse amplifier, a damping 
of at least 26 dB of the switch is required. For this purpose, a Pi-circuit for both amplifiers in 
combination with high power pindiodes (Macom) tuned to a quarter wave at 63.6 MHz was 
implemented (figure 8.1). Because the transmit-receive switch of the 1st channel is by default 
in receive mode and cannot be changed to transmit mode by sequence programming for 
longer than 2 seconds, a trigger signal is added to the driver signal using diodes (figure 8.1).  
 
Figure 8.1: Electronic circuit that switches either the original 15 kW peak amplifier or the  
35 W CW amplifier to the transmit-receive switch. The Pi-circuits are tuned to a quarter 
wavelength at 63.6 MHz and connects or isolates the desired amplifier. A trigger bit from the 
scan gates a circuit that drives the PIN-diodes and sets the transmit-receive switch in transmit 
mode by a diode adder. 
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Calibration of the CW amplifier 
The isolation of the switch to both amplifiers was measured by a network-analyzer 
(8752A, Hewlett-Packard). The function of the switch was first tested by on and off-
resonance irradiation on a phantom containing 50 mM Cr solution. The forward and reflected 
RF power to both coil elements was measured by an RF peak power analyzer (8542B, 
Gigatronics, San Ramon, USA) to calibrate the 2nd channel to the first and to estimate the 
Specific Absorption Ratio (SAR). Since the coil has an inhomogeneous electromagnetic field, 
the RF power was optimized to maximum signal intensity using point resolved spectroscopy 
(PRESS) localization. In this way, the value γB2/2π per square root of power was determined 
at the location of the selected voxel of interest. 
 
MT experiments 
For every volunteer (n=6), the right calf muscle was placed in the coil, after which a 
voxel of interest (27 cc) was selected in the gastrocnemius muscle.  
The magnetization transfer sequence starts with a variable length (1-5 s) CW 
irradiation pulse, followed by a single Gaussian shaped RF pulse for water suppression (25.6 
ms pulse length) and PRESS localization (TE=135 ms; TR=6 s; 12 averages). Since the 
timing in the sequence is sequential, an electronic triggered switch can be included which 
connects either the standard pulse amplifier or the commercially available CW amplifier via 
the transmit-receive switch to the coil. Three series of MT measurements were performed for 
each subject. Firstly, a series consisting of 9 experiments with an MT pulse duration of 3 
seconds and offset frequency of +10 kHz with amplitudes (γB2/2π) ranging from 0 until 900 
Hz. Secondly, 7 experiments with a fixed MT pulse amplitude of 550 Hz and offset frequency 
of +10 kHz with variable duration from 0 until 5 seconds, acquired interleaved to reduce 
maximum SAR. The third series of measurements consisted of 27 experiments with a fixed 
MT pulse duration of 3 seconds and amplitude of 550 Hz with offset frequencies ranging 
from –100 kHz until +100 kHz. Although the estimated maximum local SAR is below 12 
W/kg (17), additional temperature measurements were performed on the leg at the position 
closest to the conductors (18).  
 
Data processing and model fitting 
Trimethylammonium and creatine methyl signals were analyzed using MRUI (19) and 
normalized to the spectra with no MT irradiation. Lorentzian line shapes with constant line-
widths were assumed.  
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The bound Cr fraction was determined from the experimental data series with a fixed 
MT pulse power and duration, at 27 different offset frequencies. The data of all six volunteers 
were averaged, and the mean Cr signal was fitted using a two-pool model function based on 
previous water MT modeling (16, 20, 21) as extensively described by Kruiskamp et al. (7). A 
Lorentzian line shape function for the description of the free Cr signal (pool A), and a 
Gaussian line shape function for the description of the bound pool (pool B) were assumed 
(21). Fitting of the observed Cr signal (MZA), normalized to the Cr intensity without 
irradiation (M0A), involves six parameters and is described by equation 8.1 (21): 
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in which RrfA and RrfB represent the rate of loss of longitudinal magnetization due to saturation 
with a pulse of power ω1 (=γB2/2π) (Hz) at an offset ∆ (Hz): 
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T2A and T2B are the transverse relaxation times of respectively the mobile and immobile Cr 
pool. The six different parameters yielded from the fit of the data to equation 8.1 are the 
longitudinal relaxation rate (=1/T1) of the mobile and immobile pool (RA and RB); T2A and T2B; 
the size of the maximal magnetization of the immobile pool, relatively to the mobile pool M0B 
and a fundamental rate constant R, which describes the rate of exchange between pool A and 
B. Curve-fitting was performed in IDL (Interactive Data Language: RSI, Boulder, Co) using a 
Levenberg-Marquardt algorithm. The normalized mean Cr signals with their standard 
deviations were used as an input for the curve-fitting procedure, which yielded a fitted 
parameter with a one standard deviation confidence interval and correlation coefficients of the 
parameters derived from the covariance matrix. Two evaluation methods for the fitted 
parameters were used. Since the value of the parameter fit appeared to be highly dependent on 
the initial estimate of the parameter, 1000 randomly calculated initial values were used as an 
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initial estimate for each parameter to investigate the influence of the input. Secondly, the 
standard deviation of each parameter was derived from the covariance matrix. The fit was 
performed with none of the six parameters fixed, or with either RA or T2A fixed. The quality of 
the fit was determined by obtaining the root mean square deviation (rmsd) from the fit with 
respect to the experimental data. 
A curve of theoretical spill over was calculated using a theoretical T1 and T2 for Cr of 
1.35 s and 0.18 s respectively (22), and a power of 550 Hz as input parameters (4, 14). All 
data is presented as mean ± standard deviation. 
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a 
 
b 
c 
Figure 8.2 : Total Cr methyl signal measured with a pre-saturation pulse of 3 s. and a power 
of 550 Hz at +100 kHz (a) and +10kHz (b) offset with respect to the Cr methyl resonance and 
the difference spectrum (c). Vertical scaling is equal in all three spectra. Peak annotations: 
total creatine (Cr) and trimethylammonium (TMA). 
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RESULTS 
The efficiency of the circular polarized coil used in these studies was found to be 900 
Hz (γB2/2π) in human gastrocnemius muscle for an input power of 30 W. Power loss due to 
insertion of the Pi-circuit was reduced to only 0.15 dB. The RF power of the pre-irradiation 
pulse was monitored in all experiments and kept within SAR limits; temperature sensors 
showed no tissue heating. A clear MT effect on the methyl resonance of Cr (3.0 ppm) in the 
1H MR spectra of human gastrocnemius muscle was observed after pre-saturation during 3 
seconds at 10 kHz offset (figure 8.2). In addition, an MT effect on the residual water signal 
was observed. 
To optimize the CW power needed for maximal saturation, powers (γB2/2π) ranging 
from 0 to 900 Hz were used for a pre-saturation pulse of 3 s at an offset of +10 kHz (figure 
8.3). It is clearly demonstrated that the relative Cr signal intensity reaches a plateau value at 
approximately 500 Hz. In the same way the optimal pulse length was calibrated using seven 
different pre-saturation pulse lengths (0-5 s) with fixed power (550 Hz) and offset (+10 kHz) 
(figure 8.4). Accordingly, a plateau is reached at a pulse length of approximately 3 seconds. 
 
Figure 8.3: Total Cr methyl signal as a function of saturation pulse power (expressed in 
γB2/2π). The saturation pulse was applied at an offset frequency of +10 kHz with respect to 
the Cr methyl signal with a duration of 3 s. Datapoints are given as mean ± s.d. scaled to the 
fit of the Cr signal without pre-irradiation. 
 
 
. 
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Figure 8.4: Total Cr methyl signal as a function of saturation pulse length. The saturation 
pulse was applied at an offset frequency of +10 kHz with respect to the Cr methyl signal and 
a γB2/2π pulse power of 550 Hz. Datapoints are given as mean ± s.d. scaled to the fit of the 
Cr signal without pre-irradiation 
 
 
Figure 8.5: Total Cr methyl signal as a function of saturation pulse offset with respect to the 
Cr resonance. The saturation pulse was applied with a pulse length of 3 seconds and a γB2/2π 
pulse power of 550 Hz. Datapoints are given as mean ± s.d scaled to the Cr signal without 
pre-irradiation. Solid line is the fitted curve; the dotted line is the theoretical spill over curve. 
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In order to calculate the bound Cr fraction, a frequency sweep was done where a pre-
saturation pulse was swept from an offset of -100 kHz to +100 kHz in 27 steps (see figure 
8.5). For the saturation pulse power and length, the optimized values of 550 Hz and 3 s were 
used. When comparing the Cr signal intensity curve to the curve of theoretical RF spill over 
(figure 8.5, dotted line), a clear MT effect can be observed between an offset of 
approximately 0 and ±40 kHz with respect to the Cr resonance. The mean relative Cr signal 
intensity at different offset frequencies of the pre-irradiation pulse is fitted using equation 8.1. 
When the fit was performed with none of the six parameters fixed, the values yielded for each 
parameter appeared highly dependent on the initial estimate of the parameters used as input 
for the fit. Besides this, the parameters derived were highly correlated and had a very large 
standard deviation; for the immobile fraction, for example, this may be of the order of  
5000 %. In contrast, T2B could be estimated accurately because it is independent of the initial 
parameter estimation, has a small standard deviation and a small correlation coefficient with 
the other parameters. 
To average the influence of the initial estimation of each parameter, 1000 randomly 
calculated initial values were used as an initial estimate for each parameter. The resulting 
parameters of the converging fits (rmsd < 0.016) were averaged and the mean parameter value 
together with the standard deviation of this mean value, caused by differences in initial 
parameter estimation, is given in table 8.1. Because the standard deviation of each parameter 
derived from a single fit was large when six parameters were fitted, RA and T2A were fixed to 
values found in human skeletal tissue by standard relaxation time measurements at 1.5 T (22). 
In these cases, parameter standard deviations were within acceptable ranges (table 8.1) and 
appeared not dependent on the initial estimate of the parameters.  
Overall, the immobile fraction of Cr in human skeletal muscle was determined to be 
small, between 0.4% and 1.3% depending on which parameter is fixed. The value of RB 
appeared to have no influence on the value of the other parameters derived from the fit, but 
could not accurately be estimated as was previously observed in other MT studies (7, 8). 
Therefore, this parameter is not included in table 8.1.  
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Table 8.1: Parameter values obtained by a model fit of the mean Cr signal attenuation due to 
off-resonance irradiation. 
Fitting was performed on the mean MT data using a two-pool model function. The value of RB 
is not shown because it could not be fitted accurately; it did not affect the value of the other 
parameters. 
a Values obtained with none of the six parameters fixed. Data are presented as the mean of 
the fitted parameter with random initial parameter values ± s.d. of the mean fitted value. 
b RA is fixed to 0.74 s-1. Data are presented as the parameter derived from the fit ± s.d. of this 
parameter due to the fit. 
c T2A is fixed to 0.18 s. Data are presented as the parameter derived from the fit ± s.d. of this 
parameter due to the fit.  
d Values for rat skeletal muscle derived from (7). 
e Values for mouse skeletal muscle derived from (8). 
f,g Proton relaxation times of the Cr signal in human skeletal muscle obtained by standard 
relaxation time measurements at 1.5 T obtained from f: (22) and g: (23). 
 present study other studies relaxation studies 
 no fix a fixed RA b fixed T2A c rat d mouse e human f human g 
RA (s-1) 1.7 ± 0.4 0.74 2.4 ± 0.4 1.1 0.83 0.74 0.59-0.83
T2A (s) 0.28 ± 0.08 0.58 ± 0.1 0.18 0.12 0.20 0.18 0.12-0.15
T2B (µs) 11.5 ± 0.0 11.5 ± 1.5 11.5 ± 1.5 12 10   
M0B (%) 0.9 ± 0.2 0.4 ± 0.2 1.3 ± 0.6 2.5 1.3   
R (s-1) 1.4 ± 0.3 0.6 ± 0.4 2.0 ± 1.4 2.3 1.56   
rmsd < 0.016 0.015 0.015 0.011 0.017   
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DISCUSSION 
The present results demonstrate that MT effects can be studied using CW pre-
irradiation on a standard clinical MR machine after a relatively simple modification. Water 
suppression may also lead to an MT effect, however, a CHESS sequence consisting of three 
15 ms Gaussian shaped RF pulses did not show this (4). In the present study, only one 26 ms 
Gaussian shaped RF pulse was used for water suppression and therefore the MT effect 
observed must be solely attributed to the irradiation pulse.  
In the calibration of the pre-irradiation pulse parameters to obtain an MT effect on the 
methyl resonance of Cr we observed plateau vales for the attenuation of this resonance when 
increasing CW pulse length or pulse power. The pre-irradiation pulse length of 3 s used in the 
present study is in good agreement with similar calibrations on rat and mouse skeletal muscle 
(7, 8). The calibration of the γB2/2π pulse power dictated that we had to use somewhat more 
pulse power (550 Hz) than used in animal studies (325 - 400 Hz) (4, 7, 8). Signal attenuation 
due to the MT effect is clearly demonstrated when the CW pre-irradiation pulse is between an 
offset of 0 and ± 50 kHz with respect to the Cr methyl resonance. This frequency range is also 
observed in other MT studies on Cr (4, 7, 8). In both saturation–time and saturation–power 
curves (figure 8.3 and 8.4) the intensity of the Cr signal maximally decreased to a value of 
70% of its original intensity. This is less than found in rat skeletal muscle, where Cr is 
decreased to 60% of its original intensity (7), and it corresponds with a calculated immobile 
Cr fraction of 0.4%-1.3% in our study which is slightly less than observed in the same rat 
study (2.5%). Similar differences in signal attenuation at 10 kHz frequency offset can be 
interpolated from frequency sweep plots to correspond to small changes in calculated bound 
fraction (8, 24). Overall, we conclude from our results that the size of the immobile Cr 
fraction is small in human skeletal muscle and of the same order of magnitude as observed in 
mouse and rat skeletal muscle. This small size of the immobile and therefore MR invisible Cr 
signal indicates that absolute quantification of the Cr content in skeletal muscle by 1H MR 
spectroscopy using the Cr methyl signal is justified. Rat and mouse skeletal muscle are used 
as a reference (table 8.1) because, to our knowledge, no fit of MT data to a two-pool model 
has been performed in humans before. The goodness of the fit, expressed as the rmsd, is 
similar to the fits on rat and mouse Cr data. Until now, no 1H MT by saturation transfer has 
been performed on human muscle although the existence of an MT effect in human muscle 
was demonstrated using 1H inversion transfer experiments (13). 
The parameters describing the mobile Cr pool, RA and T2A, appeared to be somewhat 
higher than values determined by other methods than MT in human muscle at 1.5 T (table 
8.1). The only two parameters that are available from other MR techniques are RA and T2A. 
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When RA is fixed, T2A yields a value that is higher then found in literature. On the other hand, 
if T2A is fixed, RA is higher than expected from literature. These observations suggest that 
further research of the model itself is necessary. 
When none of the parameters were fixed, the parameters are highly correlated, except 
for T2B. . Fixing one of the parameters, the fit to this model resulted in smaller standard 
deviations while the rmsd remained the same. This indicates that this model may consist of 
too many parameters to properly describe this type of data. Combing CW MT experiments 
with other techniques, like pulsed on-resonance pre-irradiation, could improve the ability of 
the mathematical model to derive the relevant parameters (6).  
 
In conclusion, our method of integrating a CW power supply into a clinical scanner 
opens up possibilities to perform detailed studies of the MT effect on various metabolites in 
human muscle and brain and may even be integrated in other MR (imaging) techniques 
involving spin saturation.  
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CHAPTER 9 
 In tissues of all living organisms, energy production and utilization are tightly 
balanced in a dynamic fashion to be able to comply to fluctuating energy demands. In this 
homeostatic process, adenosine triphosphate (ATP) is the most important biochemical energy 
carrier, which fulfills a key role as the main source of fuel for cellular processes. Elaborate 
systems for the production, use and distribution of ATP work in close conjunction with 
specific enzymes, like creatine kinase (CK) and adenylate kinase (AK), for energy buffering 
and transmission. CK stores high-energy phosphoryls (~P) by catalyzing the reaction: creatine 
(Cr) + ATP <-> phosphocreatine (PCr) +ADP + H+ , while AK enables reformation of ATP 
from 2 ADP by catalyzing the reaction: 2 ADP-> ATP + AMP. Together, these circuits 
provide an integrated metabolic network with high flexibility to meet sudden and large 
fluctuations in energy demand in tissues like muscle and brain. Disabling one or more 
enzymes in these circuits, e.g. by genetic knock-out, will promote a re-routing of fluxes 
through the remaining systems to re-establish the balance between energy production and 
utilization.  
Transgenic mice have become a valuable tool to study the (patho)biological 
significance of metabolic conversion by individual enzymes and their role in integral 
physiological pathways. Various tools have been developed to study these mouse models of 
which magnetic resonance spectroscopy (MRS), monitoring 1H, 31P, or 13C nuclei in 
metabolites is now increasingly applied since it enables a unique view on metabolomics of 
tissues such as muscle and brain. In particular when the enzymes that are targeted employ MR 
visible metabolites as substrates, MRS is a very powerful approach. Various MR spectroscopy 
methods are now available for longitudinal and non-invasive measurements to acquire useful 
information about structure and function of metabolic networks, cells and tissues in these 
models. A broad introduction into this theme is presented in chapter 1.  
The general aim of this thesis was to elucidate the role of CK and AK systems in 
energy metabolism of muscle and brain as they function in living animals. The specific 
possibilities and limitations of MR spectroscopy studies on (transgenic) mice with alterations 
in the high-energy phosphoryl transfer systems are reviewed in chapter 2. These first two 
chapters present the basis to understand the remainder of this thesis which addresses the 
following specific issues. 
Insight in postnatal development of (P)Cr in wild-type (wt) mice and mice lacking 
both the cytosolic and mitochondrial isoforms of muscle creatine kinase (M-CK/ScCKmit--/--) 
is of crucial importance in understanding maturation of (P)Cr levels in relation to CK activity. 
Therefore, PCr and total Cr (tCr) concentration in hind-limb muscles of  
M-CK/ScCKmit--/-- and control mice were determined by in vivo MR spectroscopy and by 
biochemical means during postnatal growth and adulthood in chapter 3. Furthermore, in vitro 
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CK activity was determined at different ages for both wt and knock-out mice. In wild-type 
muscle [tCr], the PCr/ATP ratio and CK activity increased rapidly in the first 4 - 7 weeks of 
age. Remarkably, M-CK/ScCKmit--/-- mice showed a similar increase in the PCr/ATP ratio 
during the first month of age in the presence of only minor brain-type BB-CK activity. Uptake 
of Cr in muscle appeared to be unrelated to CK activity as tCr increased in the same way  
in the muscles of both mice types. At older age the PCr/ATP ratio decreased in  
M-CK/ScCKmit--/-- muscles in contrast to wild-type where it still slowly increased, whereas 
[tCr] was similar for muscle of both mice. Using 13C-4 labeled Cr, also a lower PCr/tCr ratio 
was observed in 13C MR spectra of M-CK/ScCKmit--/-- muscle. From these data it followed 
that in vivo global ATP levels at rest are similar in presence or absence of CK. Although Cr 
could still be converted to PCr in mature M-CK/ScCKmit--/-- muscle, the immediate 
availability of PCr decreased, and PCr became partly inconvertible at older age. Apparently 
catalysis of the CK reaction by BB-CK, although significant in muscles of newborn mice, 
gradually declines to very low levels in adulthood. Part or all of this BB-CK may arise from 
satellite cells fusing with myotubes, a process which is most active during the first months of 
life. Finally, our observation that the MR and the chemical assessment of muscle [tCr] and 
PCr/tCr ratio were similar for all mice does not support the existence of a significant MR-
invisible or immobile pool of Cr, with a role of CK in this phenomenon. 
 Because actions of CK are likely concerted with metabolic activity of other enzymes, 
in particular AK, the collaboration between CK and AK was investigated in chapter 4 by 
studying energy-metabolite behavior in hind leg muscles of mice lacking both cytosolic 
creatine kinase (M-CK) and adenylate kinase (AK1) (MAK--/--) before, during and after an 
ischemic challenge. Data of similar MR experiments in M-CK and AK1 single knock-out 
mice were reevaluated and compared to MAK--/-- mice to gain insight in the complementary 
role that these enzyme may have. During the ischemic period, both inorganic phosphate (Pi) 
accumulation and PCr depletion in MAK--/-- were faster than in wild-type mice, but total 
[PCr + Pi] remained constant in both types of animals. After ischemia, MAK--/-- mice had a 
significant slower recovery of PCr and Pi than wild-type mice, reflecting a severely 
compromised phosphoryl transfer efficiency. Although basal tissue pH levels were similar, 
upon ischemia pH started to decline immediately in MAK--/-- mice while in wt mice basal 
tissue pH was initially maintained. Therefore, MAK--/-- mice had a lower intracellular pH 
during most of the ischemic period, suggesting earlier turn-on of glycolysis. As ATP levels 
appeared similar and were essentially homeostatic in both types of animals, our results 
suggest that the communication between supply-demand pathways for ~P metabolites, 
reflected by the pool-dynamics thereof, is deviant in MAK--/-- mice. 
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Cytosolic B-CK and mitochondrial ubiquitous CK (UbCKmit) are the only two 
isoforms of CK present in the brain. Knocking out both these enzymes fully erases the 
possibility to phosphorylate Cr, unlike in muscle where trace amounts of CK remain present 
in double knock-out mice. In light of the current debate in literature on energy metabolism of 
the brain, analysis of mice with a partial or double deletion of CK may add to this discussion 
by highlighting the role of CK in neurometabolic coupling to hemodynamic effects of brain 
activation. To provide a basis for further MR research on the brain of CK deficient mice, 
chapter 5 starts with assessing the metabolic and anatomical consequences of partial or 
complete depletion of this system. Transgenic mice without cytosolic B-CK (B-CK-/-), 
mitochondrial ubiquitous CK (UbCKmit-/-), or both isoenzymes (B-Ck/UbCKmit--/--), were 
studied by non-invasive quantitative MR imaging and spectroscopy. MR imaging revealed an 
increase in ventricle size in a subset of B-CK-/- mice, but not in animals with UbCKmit or 
compound CK mutations. Mice lacking single CK isoenzymes had normal levels of high-
energy metabolites and tissue pH. In the brains of CK double knock-outs pH and ATP and Pi 
levels were also normal, even though PCr had become completely undetectable. Moreover, a 
20 – 30% decrease was observed in the level of total creatine and a similar increase in the 
level of neuronal N-acetyl-aspartate compounds. Although CKs themselves are not evenly 
distributed throughout the CNS, these alterations were uniform and concordant across 
different brain regions. Changes in myo-inositol and glutamate peaks did appear mutation-
type and brain area specific. Our results challenge current models for the biological 
significance of the PCr/CK energy system and suggest a multifaceted role for creatine in the 
brain.  
A method to investigate the dynamics of energy metabolic pathways in vivo is by 13C 
MRS using 13C labeled compounds. It has proven to be a very useful technique in the brain to 
provide a window on both energy metabolism and neurotransmitter recycling in humans and 
rats. Thus far, however, this technique has not been applied yet to the mouse brain to study 
these processes due to lower SNR in these smaller animals, although it could enhance further 
knowledge on whether glycolysis is up-regulated in CK deficient mice. Besides up-regulation 
of glycolysis, also other metabolic adaptation like a faster flux through the Krebs cycle may 
be possible for CK knock-out mice to comply to their energy needs. To answer these and 
other questions, 13C MRS on the mouse brain had to be developed. Chapter 6 demonstrates a 
specifically designed experimental setup to perform in vivo 13C MRS of the mouse brain, 
which enabled monitoring of glucose uptake, lactate and alanine formation, and synthesis of 
several other compounds including some neurotransmitters with high temporal resolution for 
the first time in the mouse brain. Furthermore, build-in of label from [1-13C] labeled glucose 
to lactate, alanine and several positions in glutamate and glutamine was compared between wt 
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mice and mice lacking both B-CK and UbCKmit. It was shown that B-Ck/UbCKmit--/-- mice 
appeared to utilize glucose faster or with an earlier onset than wt animals, although lactate 
production is significantly less pronounced. Since build-in of label into neurotransmitter 
seems to be more rapid, these results may point to an earlier onset or a faster glycolysis and a 
up-regulation of the oxidative processes of energy production in the brain. Although it is still 
too early to fully clarify the role on CK in physiology and energy metabolism of the brain, the 
current results enable further in vivo studies using 13C MRS e.g. under metabolic stress 
situations.  
Instead of deleting one or more CK isoforms, the generation of Cr itself can be 
prevented by knocking out the enzyme that catalyzes the final step in the formation of Cr: 
guanidinoacetate methyltransferase (GAMT). As a model for deficiency of this enzyme as it 
occurs in humans, a gene knock-out mouse model was generated that yielded mice which 
completely lack the ability to synthesize Cr. Both for the research on GAMT deficiency in 
humans as for further exploration on the role of Cr in comparison to role of CK which is 
depicted by CK deficient mice, this new knock-out model could provide new insights. In 
chapter 7, we report on several metabolic abnormalities in these mice, observed by in vivo 
and in vitro MR spectroscopy. 1H MR spectra of brain and hind leg muscle showed a clearly 
reduced signal of Cr in GAMT deficient (GAMT-/-) animals. Analysis of the 1H MR spectra 
of GAMT-/- brain indicated little or no increase of a signal for guanidinoacetate (Gua). In 
proton MR spectra of muscle, a broad signal of low intensity was observed for Gua. However, 
substantial Gua accumulation in intact muscle tissue was unequivocally confirmed in high 
resolution magic angle spinning spectra, in which the Gua signal was resolved as one clear 
sharp singlet. In 31P MR analysis of brain and hind leg muscle a strongly reduced PCr content 
was shown. In addition, a signal of phosphorylated Gua at 0.5 ppm up-field of PCr was 
observed, with much higher intensity in muscle than in brain. This signal decreased when 
ischemia was applied to the muscle and recovered after ischemia was released. Overall the in 
vivo 31P and 1H MR spectroscopy of GAMT-/- mice is similar to that of human GAMT 
deficiency.  
The presentation of experimental data closes with the description of a study in humans 
dealing with the visibility of Cr in 1H MR spectra of human skeletal muscle (chapter 8). In 
rat and mice tissues it has already been demonstrated that the proton invisible pool of Cr is 
very small. In humans, however, due to technical limitations of clinical MR scanners this was 
thus far not possible. We retrofitted a clinical 1.5 T MR scanner, and studied the transfer of 
magnetization (MT) between the mobile (MR visible) spin pool and immobile (MR invisible) 
spin pool of Cr using continuous wave (CW) pre-irradiation as saturation method for the 
immobile pool. For this purpose, only slight modifications to the MR system were made. A 
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specially designed electronic circuit was used to couple a CW amplifier to the RF channel of 
the scanner. CW pulse power (γB2/2π) and pulse length were determined to be approximately 
550 Hz and 3 s respectively for optimal signal attenuation of the Cr methyl signal. The bound 
Cr fraction in human gastrocnemius muscle was determined to be between 0.4% and 1.3% 
using a two-pool exchange model function describing the MT effect. 
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CHAPTER 10 
In weefsels van alle levende organismen is de dynamische balans tussen productie en 
verbruik van metabole energie nauwkeurig gereguleerd. Zo kan goed worden ingespeeld op 
de vaak sterk fluctuerende vraag naar energie. Binnen dit homeostatische proces heeft 
adenosine trifosfaat (ATP) als belangrijkste biochemische energiedrager een sleutelrol. 
Metabole systemen voor de productie, het gebruik en de distributie van ATP werken nauw 
samen met specifieke enzymen, zoals de creatine kinases (CK) en adenylate kinases (AK). 
Deze enzymen zorgen voor de opslag en de verdeling van de energie die verkregen wordt uit 
ATP. CK slaat hoogenergetische fosfaten (~P) op door middel van katalyse van de reactie: 
creatine (Cr) + ATP <-> fosfocreatine (PCr) + ADP + H+. AK hergebruikt 2 ADP moleculen 
om één ATP molecuul te vormen door katalyse van de reactie: 2 ADP -> ATP + AMP. Samen 
vormen deze systemen een integraal metabool netwerk dat een hoge mate van flexibiliteit 
bezit om plotselinge grote fluctuaties in aktiviteit van weefsels, zoals brein en spier, op te 
vangen. Als één of meer enzymen in dit netwerk functioneel onklaar wordt gemaakt - of 
helemaal niet meer wordt aangemaakt - bijvoorbeeld door middel van genetische 
uitschakeling (knock-out), zal dit leiden tot herschikking van de metabole fluxen door de 
resterende systemen. Een nieuw evenwicht tussen energieproductie en -vraag zal zich dan 
instellen. 
Transgene muizen zijn een belangrijk instrument geworden bij de studie van 
omzettingsreacties door individuele enzymen binnen integrale metabole netwerken. Er zijn 
verschillende technieken ontwikkeld om deze muis-modellen te bestuderen. Magnetische 
resonantie spectroscopie (MRS) is hier één van en biedt de mogelijkheid de aanwezigheid van 
bepaalde metabolieten te bestuderen aan de hand van de daarin aanwezige 1H, 31P of 13C 
atoomkernen. Deze techniek wordt steeds vaker gebruikt omdat het een uniek zicht biedt op 
het metabole patroon van weefsels zoals brein en spier terwijl het proefdier geheel intact 
blijft. Met name indien één van de gemodificeerde enzymen MR zichtbare substraten heeft, is 
MRS een zeer krachtige techniek. Verschillende MRS methoden zijn heden ten dage 
beschikbaar voor onderzoek in longitudinale niet-invasieve studies naar structuur en functie 
van metabole netwerken in cellen en weefsels. Een globaal overzicht hiervan wordt gegeven 
in hoofdstuk 1. 
De algemene doelstelling voor de promotiestudie beschreven in dit proefschrift was 
het ophelderen van de rol van het CK en AK systeem in het energie metabolisme van spier en 
brein in levende dieren. De specifieke mogelijkheden - en de beperkingen - van MR 
spectroscopie studie aan (transgene) muizen met een veranderde hoogenergetische fosfaat 
overdracht is beschreven in hoofdstuk 2. Deze eerste twee hoofdstukken vormen daarmee de 
basis om het vervolg van dit proefschrift te kunnen begrijpen. In de daarop volgende 
hoofdstukken komen meer specialistische onderwerpen aan bod. 
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Inzicht in de postnatale ontwikkeling van (P)Cr niveaus in de spieren van normale 
controle muizen en muizen waarbij zowel de cytosolische als de mitochondriële spier 
isovormen van CK ontbreken (M-CK/ScCKmit--/--) is cruciaal voor het begrip van de relatie 
tussen (P)Cr niveaus en CK activiteit tijdens ontwikkeling. Zoals beschreven in hoofdstuk 3 
is daarom in spieren van de achterpoot van M-CK/ScCKmit--/-- en controle muizen zowel het 
PCr gehalte als ook de totale creatine concentratie (tCr) met behulp van een biochemische 
aanpak en met MRS gemeten. Deze metingen werden zowel tijdens postnatale groei als bij 
volwassen muizen uitgevoerd. Daarnaast is bij verschillende leeftijden ook nog de in vitro CK 
activiteit in de spieren van normale en knock-out muizen bepaald. In spieren van normale 
muizen nam de [tCr], de PCr/ATP ratio, en de CK activiteit snel toe tot ongeveer 4 tot 7 
weken na de geboorte. Opmerkelijk was dat tijdens de eerste maand van ontwikkeling in M-
CK/ScCKmit--/-- muizen een vergelijkbare PCr/ATP ontwikkeling werd waargenomen. Dit 
trad op in de afwezigheid van spier-specifieke CKs en vermoedelijk door aanwezigheid van 
zeer kleine hoeveelheden brein-type BB-CK. De opname van Cr in spier bleek niet 
gerelateerd te zijn aan de aanwezige CK activiteit omdat tCr in spieren van beide muis typen 
op een gelijke wijze toenam. In tegenstelling tot de situatie bij normale muizen nam de 
PCr/ATP verhouding af in CK deficiënte muizen naarmate ze ouder werden, terwijl de [tCr] 
gelijk bleef in spieren van beide typen muizen. Door gebruik te maken van 13C-4 gelabelde Cr 
hebben we een lagere PCr/tCr verhouding vast kunnen stellen aan de hand van 13C MR 
spectra van M-CK/ScCKmit--/-- spieren. Hieruit konden we opmaken dat de globale ATP 
niveaus in rust niet veranderde bij afwezigheid van CK. Hoewel Cr in de spieren van 
volwassen CK deficiënte muizen nog steeds kon worden omgezet naar PCr, was de directe 
beschikbaarheid van PCr afgenomen en werd PCr gedeeltelijk onomzetbaar. Katalyse van de 
CK reactie door BB-CK was blijkbaar belangrijk in pasgeboren M-CK/ScCKmit--/-- muizen, 
maar geleidelijk afnemend naar zeer lage waarden bij volwassen muizen. BB-CK in jonge 
spieren zou kunnen worden ingebracht door satelliet cellen, welke tot celfusie kunnen 
overgaan tijdens de vorming van nieuwe spiervezels. Satellietcellen komen in grote aantallen 
voor met name tijdens de eerste levensmaanden. Tot slot kunnen we uit de observatie dat de 
chemische en MRS bepalingen van spier [tCr] dezelfde waarden opleverden voor alle muizen, 
concluderen dat er geen bewijs is voor het bestaan van een MR-onzichtbare (of MR-
immobiele) voorraad van – al dan niet aan CK gebonden - creatine. 
Omdat CK aktiviteit zeer waarschijnlijk nauw verweven is met de activiteit van andere 
enzymen, in het bijzonder met AK, is de metabole samenwerking tussen CK en AK 
onderzocht in hoofdstuk 4. Daartoe hebben wij voor, tijdens, en na een ischemische proef 
energie metabolieten bestudeerd in spieren van de achterpoot van muizen die zowel de 
cytosolische CK isovorm (M-CK) als adenylaat kinase (AK) (MAK--/--) misten. Eerder hier 
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gegenereerde data van soortgelijke experimenten in M-CK en AK1 ‘enkelvoudige’ knock-out 
muizen werden geheranalyseerd om meer inzicht te krijgen in de aanvullende rol die deze 
enzymen kunnen hebben. Tijdens een ischemische periode bleek de toename van zowel 
inorganisch fosfaat (Pi) als de afname van PCr in MAK--/-- muizen sneller te verlopen dan in 
controle muizen, maar de totale voorraad Pi en PCr bleef in beide constant. Na afloop van de 
ischemie periode hadden MAK--/-- muizen een significant langzamer herstel van PCr en Pi 
waarden, wat een weerspiegeling is van een ernstig verstoorde efficiëntie van fosforyl 
overdracht. Hoewel de basale pH uitgangswaarden gelijk waren, bleek de pH in MAK--/-- 
muizen tijdens de ischemische periode direkt te dalen, terwijl deze bij normale muizen eerst 
tijdelijk op het beginniveau bleef na inzet van de ischemie. Hierdoor hadden MAK--/-- 
muizen een lagere intracellulaire pH gedurende het grootste deel van de ischemische periode, 
wat een sneller aktivering van de glycolyse suggereert. Omdat de ATP niveaus gelijk waren 
en niet veranderden in beide groepen muizen lijken onze resultaten te wijzen op een 
veranderde communicatie tussen de aanmaak en het verbruik van ~P metaboliten in MAK--/-- 
muizen. 
Cytosolische B-CK en één van de twee mitochondriële isovormen van CK, het 
zogenaamde ubiquitous CK (UbCKmit), zijn de enige twee isovormen van CK die in het 
brein voorkomen. Met het genetisch uitschakelen van deze twee enzymen is de mogelijkheid 
om Cr te fosforyleren volledig weggenomen. Dit is dus anders dan in de spier, waar immers 
kleine hoeveelheden niet-spier CK (B-CK) achterblijven in CK ‘dubbel knock-out’ muizen. 
Muizen met een gedeeltelijke of totale verwijdering van het CK systeem uit het brein zijn 
interessant in het licht van een heden ten dage bij voortduring gevoerde discussie over het 
karakter van het energie metabolisme van het brein. Met name de mogelijke rol van CK in 
neurometabole koppeling met hemodynamische effecten in het brein is hierbij interessant. 
Hoofdstuk 5 start met de beschrijving van de metabole en anatomische consequenties van 
een gedeeltelijke of volledige depletie van CK als basis voor verder MR onderzoek. 
Transgene muizen zonder cytosolische B-CK (B-CK-/-), zonder mitochondriële CK 
(UbCKmit-/-) of zonder beide enzymen (B-CK/UbCKmit--/--) werden bestudeerd met niet-
invasieve quantitative MRI en MR spectroscopie. MRI liet een toename zien in het volume 
van de hersenventrikels in een subpopulatie van de B-CK-/- muizen, terwijl in muizen met 
UbCKmit of een samengestelde CK mutatie dergelijke afwijkingen niet werden gevonden. 
Muizen zonder B-CK of zonder UbCKmit hadden normale niveaus van hoog-energetische 
metabolieten en een normale intracellulaire pH. Het brein van muizen met een dubbele CK 
knock-out hadden ook normale ATP en Pi niveaus, evenals een normale pH, maar hier was 
het PCr niveau zo laag geworden dat deze niet meer te detecteren viel. Daarnaast werd een 
20-30% afname in de totale creatine concentratie gedetecteerd, welke samenging met een 
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soortgelijke toename in componenten die N-acetyl-aspartaat bevatten. Hoewel CK’s zelf niet 
uniform verdeeld zijn over de cellen van het centrale zenuwstelsel waren deze veranderingen 
wel uniform over de verschillende breinregio’s. Veranderingen in myo-inositol en glutamaat 
waren mutatie en breinregio specifiek. Onze resultaten plaatsen een kritische noot bij de 
huidige modellen voor de biologische betekenis van het PCr/CK energie systeem en 
suggereren dat Cr in het brein meerdere functies heeft. 
 13C MRS met infusie van 13C gelabelde substraten is een methode die de mogelijkheid 
biedt om de dynamiek van metabole paden te onderzoeken welke te maken hebben met de 
energievoorziening in vivo. Het is bewezen zeer nuttig te zijn bij onderzoek naar het humane 
brein en het brein van ratten, waar het een licht werpt op zowel het energie metabolisme als 
ook op de kringloop van neurotransmitters. Tot op heden is deze techniek echter nog niet 
toegepast voor studie van het muizenbrein. Hoewel juist deze aanpak ons dus informatie kan 
verschaffen over de toename van glycolysesnelheid in CK deficiënte muizen blijft het 
verkrijgen van spectra met een goede gevoeligheid een groot probleem, met name omdat de 
hersenen van muizen heel klein zijn. Om de mogelijkheid te onderzoeken of naast toename 
van de glycolyse snelheid ook andere metabole aanpassingen optreden, zoals bijvoorbeeld een 
verhoogde flux door de Krebs cyclus, moest een verbeterde aanpak van 13C MRS voor het 
muizenbrein worden ontwikkeld. Hoofdstuk 6 beschrijft een hiervoor speciaal ontwikkelde 
opstelling. Hierbij werd het mogelijk om met een hoge tijdsresolutie te kijken naar glucose 
opname en naar lactaat en alanine productie, en de synthese van verscheidene andere 
substraten waaronder een aantal neurotransmitters. Overdracht van 13C label van glucose naar 
lactaat, alanine, en verschillende posities in het glutamaat en glutaminemolecuul werd 
vergeleken tussen normale muizen en muizen zonder B-CK en UbCKmit. Er bleek dat B-
CK/UbCKmit--/-- muizen glucose sneller of eerder na de start van de infusie gebruikten dan 
normale muizen, maar dat de lactaat productie in deze muizen minder was. Omdat ook de 
inbouw van label in neurotransmitters sneller leek te verlopen, duiden deze voorlopige 
resultaten op een snellere of eerdere aanschakeling van glycolyse samen met een hogere 
snelheid van oxidatieve processen in het brein van CK deficiënte muizen. Hoewel het nog te 
vroeg is om de rol van CK in de fysiologie en het energie metabolisme van het brein volledig 
inzichtelijk te kunnen maken, bieden de huidige resultaten aanknopingspunten voor verdere in 
vivo studies met 13C MRS, bijvoorbeeld in situaties met metabole stress.  
In plaats van het genetisch uitschakelen van één of meerdere CK isovormen is het ook 
mogelijk om de vorming van Cr zelf te verhinderen. Dit blijkt mogelijk in muizen waar het 
enzym dat de laatste stap in de Cr synthese katalyseert, guanidinoacetaat methyltransferase 
(GAMT), is uitgeschakeld. Deze muizen dienen als model voor humane GAMT deficiëntie en 
kunnen een bijdrage leveren aan het verkrijgen van nieuwe inzichten in humane GAMT 
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deficiëntie en de verdere verkenning van de functie van Cr. In hoofdstuk 7 wordt een verslag 
gegeven van verscheidene abnormaliteiten die in deze muizen zijn gevonden met in vivo en in 
vitro MR spectroscopie. 1H MR spectra van het brein en van spieren uit de achterpoot lieten 
duidelijk verlaagde Cr signalen zien in GAMT deficiënte (GAMT-/-) muizen. Bij analyse van 
de 1H MR spectra van het brein van GAMT-/- muizen werd weinig tot geen toename van 
guanidinoacetaat (Gua), het initiële substraat van de GAMT reactie, gevonden. In proton MR 
spectra van de skeletspier daarentegen werd wel een Gua signaal met grote lijnbreedte 
aangetroffen, maar dit signaal had een kleine amplitude. Duidelijke Gua stapeling werd 
bevestigd in hoge resolutie ‘magic angle spinning’ spectroscopie van intacte GAMT spieren. 
In deze spectra verscheen een Gua signaal als een duidelijk en scherp enkelvoudig signaal. 31P 
MRS van GAMT brein en skelet spier lieten een duidelijk verlaagde aanwezigheid van PCr 
zien. Daarnaast was - 0.5 ppm verschoven in de richting van het signaal voor γ-ATP - een 
signaal van gefosforyleerde Gua verschenen. Dit signaal had een duidelijk hogere intensiteit 
in de skeletspier dan in het brein en nam in skeletspier af op het moment dat de spier 
ischemisch werd gemaakt. Het signaal nam weer toe nadat de ischemie was opgeheven. In het 
algemeen lieten de 1H en 31P MR spectra in GAMT-/- muizen een beeld zien dat overeenkomt 
met het beeld van patiënten met GAMT deficiëntie. 
De presentatie van onze experimentele data eindigt met een beschrijving van een 
studie naar de zichtbaarheid van Cr in 1H MR spectra van menselijke skeletspieren 
(hoofdstuk 8). In ratten en muizen was al aangetoond dat de fractie van de totale Cr 
hoeveelheid die onzichtbaar is in proton MR spectra klein is. Bij mensen was een soortgelijke 
studie door technische beperkingen van klinische scanners echter niet mogelijk. Wij hebben 
daarom een klinische 1.5T MR scanner aangepast zodat we overdracht van magnetisatie (MT) 
van spins van de immobiele Cr fractie (MR onzichtbaar) naar de mobiele fractie (MR 
zichtbaar) konden volgen. Hierbij hebben we gebruik gemaakt van continue (CW) instraling 
als verzadigingsmethode van de immobiele fractie. Om dit te bereiken moesten een aantal 
aanpassingen aan de MR scanner worden verricht. Een speciaal ontwikkeld elektronisch 
schema werd gebruikt om de CW versterker te koppelen met het RF kanaal van de scanner. 
De CW pulslengte en het CW vermogen (γB2/2π) werden geoptimaliseerd (naar een waarde 
van ongeveer 3 s en 550 Hz respectievelijk) voor een maximale verzwakking van het creatine 
methyl signaal. De gebonden fractie van de Cr in de humane gastrocnemius spier werd 
bepaald middels een uitwisselingsmodel met twee compartimenten dat de overdracht van 
magnetisatie beschrijft. Een waarde tussen de 0.4% en 1.3% werd gevonden, in 
overeenstemming met de proefdierstudies.  
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Het schrijven van een goed dankwoord is misschien wel één van de lastigste 
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de verschillende onderwerpen binnen mijn promotie waren zeer leerzaam voor mij en hebben 
me frequent aangezet tot opnieuw nadenken over de resultaten.  
Naast de promotores wil ik alle (ex)leden van de MR spectroscopie groep bedanken 
voor de geweldige tijd die ik tijdens mijn promotie heb gehad. Verschillende mensen, allen 
met hun eigen expertise, hebben me geholpen in het opzetten en uitvoeren van mijn 
onderzoek. Daarnaast hebben we een hoop plezier beleefd in Nijmegen en elders tijdens 
congressen. Een unieke combinatie van werk en ontspanning op het werk die de al eerder 
genoemde onderzoekssfeer in belangrijke mate bepaalt. Zonder iemand te kort te willen doen, 
wil ik Rene in ’t Zandt even noemen. Hoewel we maar een half jaar overlap hebben gehad, 
waarin ik zoveel mogelijk moest leren om ‘jouw’ onderzoek te kunnen overnemen, was je de 
daarop volgende jaren altijd bereid vragen te beantwoorden, data op te zoeken, of uit je tenen 
te halen welk protocol je nou precies had gevolgd voor een bepaalde meting.  
Bij celbiologie wil ik de CK groep bedanken. Jullie wisten altijd tijd vrij te maken als 
deze natuurkundige weer voor een (cel)biologisch raadsel stond. Ook tijdens de vrijdag-
ochtend besprekingen, eerst in het Trigon, later in de research-toren, wilden jullie altijd 
meedenken met de resultaten van mijn MR-metingen aan jullie muizen. Frank bedankt voor 
het altijd maar weer beschikbaar hebben van voldoende muizen van meestal ☺ het juiste 
genotype voor mijn experimenten. 
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dan in het bijzonder Henk Arnts, bedanken. Naast verzorging kon ik voor diertechnische 
handelingen, zoals het zetten van een canule in de staart van de muis (waar menig lab jaloers 
op is), altijd op hen terug vallen. 
Mijn paranimfen ben ik zeer erkentelijk dat ze mij terzijde willen staan tijdens de 
verdediging van mijn proefschrift. Hugo, ik vind het erg leuk dat we na onze studie in een 
soortgelijk vakgebied terecht zijn gekomen. Dank dat ik altijd stoom bij je mocht afblazen als 
dat nodig was. Hermien, doordat jij met jouw fysiologische achtergrond een andere kijk hebt 
dan ik, en door jouw prettige manier van samenwerken, heb ik genoten van het samen met jou 
opstarten van jouw onderzoek en het afronden van het mijne. Ik hoop dat we nog vele 
discussies zullen hebben. 
 Er kan geen fijne werksituatie bestaan zonder een goede warme basis in de privé 
sfeer. Ik wil daarom alle vrienden bedanken voor hun steun en geduld de afgelopen tijd. Het 
afronden van een proefschift slokt flink wat vrije uurtjes op in de weekenden. Komende tijd 
halen we het in. Dit geldt ook voor de tijd met mijn ouders, schoonouders, broer, zussen en de 
‘kolt kent’. Mijn ouders wil ik bedanken voor hun onvoorwaardelijke steun. Al wisten jullie 
op een gegeven moment tijdens mijn studie en promotie inhoudelijk niet meer precies waar 
het over ging, ik vind het fijn dat jullie altijd geïnteresseerd bleven en naar de voortgang 
blijven vragen.  
Monique, als laatste wil ik jou bedanken voor alles. Weer een stap in ons leven, de 
volgende is al gepland. Ik zie er naar uit, en naar wat er weer achter die horizon ligt.   
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H.E. Kan, W.K.J. Renema, D. Isbrandt, and A. Heerschap; oral presentation: ‘Cr supplementation results in a 
shift in relative Pi levels in creatine deficient knockout mice.’ 
ESMRMB ’04 21st Annual meeting, Kopenhagen; Mag*ma, supplement to Vol 17 2004. 
 
H.E. Kan, W.K.J. Renema, A. Veltien, D. Isbrandt, A. Heerschap; poster presentation: ‘13C MRS detection of 1-
13C- glycogen in mouse muscle in vivo.’ 
ESMRMB ’04 21st Annual meeting, Kopenhagen; Mag*ma, supplement to Vol 17 2004. 
 
D.W.J. Klomp, W.K.J. Renema, M. van der Graaf, B.E. de Galan, A.P.M. Kentgens and A. Heerschap; oral 
presentation: ‘Coil for optimal 13C sensitivity in the human brain at 3T.’ 
ESMRMB ’04 21st Annual meeting, Kopenhagen; Mag*ma, supplement to Vol 17 2004. 
 
D.W.J. Klomp, W.K.J. Renema, M. van der Graaf, B.E. de Galan, A.P.M. Kentgens, and A. Heerschap;  oral 
presentation: ‘Broadband 1H to 13C cross polarization in the human brain at 3T.’  
ISMRM 13th Annual meeting, Miami Beach, 2005. 
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